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1. Salmonella taxonomy and characteristics 
Salmonella is a zoonotic, gram-negative bacterium with facultative-anaerobic capacities, and which 
possesses peritrichous flagellae for its motility. The bacterium belongs to the family of 
Enterobacteriaceae, as is Escherichia coli, where it diverged from 100-150 million years ago (Dougan et 
al., 2011). Salmonellae are ubiquitous pathogens, due to i) their many reservoir hosts (warm- and cold-
blooded animals) and transmission vectors (feed, farm material, rodents, pets, birds), ii) the stress-
induced faecal shedding of carriers, and iii) their environmental persistence, e.g. multiplication is 
possible between 7-45°C and 4.0-9.5 pH; survival outside a host can last for months; and freezing does 
not eliminate the organism. The genus ‘Salmonella’ consists of two species, ‘Salmonella enterica’ and 
‘Salmonella bongori’, of which the first is further divided into six subspecies (Fig. 1). 
Figure 1: Classification of the Genus Salmonella in species and subspecies (Guibordenche et al., 2010). 
 
These six subspecies of S. enterica and S. bongori comprise together 2610 characterized serotypes 
or serovars (Grimont and Weill, 2007), based on different, highly immunogenic surface antigens: the 
somatic ‘O’, flagellar ‘H’ and capsular ‘Vi’ antigens. The antigenic formulae of these Salmonella 
serovars are listed according to the White-Kauffmann-Le Minor scheme (Grimont and Weill, 2007). Some 
serovars are adapted to a single host species (e.g. S. Typhi in humans and S. Choleraesuis in swine), but 
the majority of the serovars are capable of causing disease in a broad range of hosts (e.g. S. 
Typhimurium and S. Derby). Most serovars with zoonotic potential belong to S. enterica subspecies 
enterica (Guibourdenche et al., 2010). Salmonella enterica subspecies enterica serovar Typhimurium for 
instance, or shortly ‘Salmonella Typhimurium’ in common use, has been the most and second most 
prevalent serotype in pigs and humans respectively, in the EU during the past years (Hendriksen et al., 
2011; EFSA and ECDC, 2014). This serovar Typhimurium has therefore been investigated the most in 
recent studies on control strategies in pigs (Letellier et al., 2000; Anderson et al., 2004; Nagy et al., 2008; Martín-
Peláez et al., 2010; Hur et al. 2011; Leyman et al., 2011; Arguello et al., 2013), as is the case for the transmission 
experiments and the field trial in this thesis. 
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Based on their susceptibility to antimicrobials and to a defined set of bacteriophages, Salmonella 
strains within the same serotype can be further divided. With the latter method, different phage types 
(DT) are determined within the same serotype. In the experiments conducted within the scope of this 
thesis, two different strains of a Salmonella Typhimurium were used: Salmonella Typhimurium phage 
type DT 9 (a commercial and experimental one) for immunization, and a Salmonella Typhimurium 
strain 112910a, phage type 120, for infection. More details can be found in Chapter 3. 
 
2. Salmonella infection in humans 
2.1 Epidemiology 
In 2012, 91034 and 3101 confirmed cases of human salmonellosis were reported in the EU and in 
Belgium, respectively (NRSS, 2011; EFSA and ECDC, 2014). A total of 61 deaths due to non-typhoidal 
salmonellosis were reported in the EU, resulting in an estimated case-fatality rate of 0.14 %. 
Although a significant decrease in the number of human salmonellosis cases has been observed in 
recent years (mainly related to the successful Salmonella control programmes in poultry), it was still 
the second most commonly reported zoonotic disease in 2012, after campylobacteriosis. In terms of 
reported food-borne outbreaks in the EU, Salmonella even accounted for the largest number in 2012 
(28.6 % of all outbreaks), followed by bacterial toxins (14.5 %), viruses (14.1 %) and Campylobacter 
(9.3 %) (Fig. 2; EFSA and ECDC, 2014). Globally, approximately 93.8 million cases of Salmonella-induced 
gastroenteritis occur each year, resulting in 155000 fatalities (Majowicz et al., 2010). 
Figure 2: Distribution of food-borne outbreaks per causative agent in the EU in 2012 (EFSA and ECDC, 2014). 
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Obviously, the aforementioned reported cases are an underestimation of the real salmonellosis 
occurrence in humans, since not all infected people develop symptoms, not all ill persons are sampled, 
and not all positive sample results are reported to public health authorities. 
In the past years, Salmonella Enteritidis and Salmonella Typhimurium were the most frequently 
reported serovars in confirmed human cases, not only in Belgium (20.9% and 53.7% respectively in 
2012 (NRSS, 2012)) (Fig. 3), but also in the EU (41.3 % and 22.1 % respectively in 2012 (EFSA and ECDC, 
2014)), and worldwide (43.5 % and 17.1 % respectively in 2001-2007 (Hendriksen et al., 2011)). As a result 
of a harmonised reporting and also several large outbreaks, monophasic Salmonella Typhimurium 
1,4,[5],12:i:- was the third most commonly reported serovar in the EU (7.2 %) (EFSA and ECDC, 2014). 
 
Figure 3: The main Salmonella serovars from human origin in Belgium in 2012 (NRSS, 2012). 
 
 
Although human infection can occur through direct and indirect animal contact or environmental 
contamination (Hoelzer et al., 2011), most human salmonellosis cases are caused by the consumption of 
raw or undercooked contaminated food (i.e. meat or vegetables already contaminated before 
preparation, or cross contaminated during preparation in the kitchen). In the most recent Biological 
Hazards (BIOHAZ) report from EFSA, it was estimated that approximately 56.8% of the human 
salmonellosis cases in the EU could be attributable to pigs, while the contribution associated with 
poultry (laying hens (eggs), broilers and turkeys) was 30.2% (EFSA, 2012b). In the preceding years 
(2006-2009) in Belgium, this percentage of human salmonellosis due to pork consumption was even 
estimated to be 73.7% by Pires et al. (2011). However, when observing the risk of the different sources 
related to the tonnage of consumed food, the EFSA study stated that egg consumption was still the 
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main risk for human salmonellosis in the EU, closely followed by pig meat. Considering the 
transmission of Salmonella serovars separately, human salmonellosis due to Salmonella Enteritidis is 
generally associated with the consumption of contaminated eggs and poultry meat, while Salmonella 
Typhimurium cases are mostly linked to the consumption of contaminated pig meat. 
2.2 Symptoms 
Salmonella-infections often occur asymptomatically in humans. In case a non-typhoidal 
salmonellosis takes place, this generally manifests as diarrhoea (and consequently dehydration), 
abdominal cramps, vomiting and fever. These symptoms usually begin 12 - 24h after oral uptake, and 
resolve after four to seven days without treatment. In a low percentage of diseased individuals however, 
a systemic infection develops, possibly resulting in arthritis, pneumonia, organ abscesses, kidney 
failure and even death. Certain human subpopulations are more susceptible to infection and to 
developing these symptoms: the so-called ‘YOPI’ group (young, old, pregnant and 
immunocompromised). 
 
2.3 Therapy 
Rehydration and electrolyte supplementation may be indicated in severe diarrhetic cases. 
Antimicrobial therapy of uncomplicated non-typhoidal Salmonella gastroenteritis however, is not 
routinely used, as this does not shorten the symptomatic period and may actually prolong the duration 
of carriage. Moreover, emerging antimicrobial resistance over the past 20 years has limited therapeutic 
alternatives (Crump et al., 2011). In 2012 for instance, 62.5% of the Salmonella Typhimurium isolates 
from humans in Belgium showed to be multi-drug resistant (i.e. to ampicillin, streptomycin, 
sulfonamides and tetracyclines) (NRSS, 2012). Therefore, antibiotics should be reserved for patients with 
(a high risk for) severe disease. 
 
3. Salmonella infection in swine 
3.1 Epidemiology 
The latest baseline survey in pig holdings that was carried out in the EU (EFSA, 2009), based on 
pooled faecal samples, reported an EU prevalence of 28.7% (95% CI [26.3-31.0]) Salmonella-positive 
breeding holdings and 33.3% [30.9-35.7] Salmonella-positive production holdings. For Belgium, the 
prevalence in this survey of Salmonella-positive breeding herds was 18.8% [7.3-45.1], and the 
production holdings’ prevalence was 36.4% [30.5-43.1] (EFSA, 2009). The EU-prevalence of slaughter 
pigs with Salmonella-positive lymph nodes was 10.3% in 2007, whereas 8.3% of the carcasses were 
Salmonella-positive over all EU Member States (MS) (EFSA, 2008a). The observed Salmonella 
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prevalence in Belgium amounted to 13.9% and 18.8% in the lymph nodes and on the carcasses of 
slaughtered pigs, respectively (EFSA, 2008a). 
Salmonella Typhimurium was by far the most commonly reported serovar in the EU over the period 
2004-2011 in pigs and pork, and Salmonella Derby the second. As in humans, monophasic Salmonella 
Typhimurium 1,4,[5],12:i:- was the third most frequently reported serovar in 2011 in pigs and pork 
(Fig. 4; EFSA and ECDC, 2013a). In Belgian pig isolates, the most commonly reported serovar was also 
Salmonella Typhimurium (30.8%), followed by its monophasic variant (22.3%) and Salmonella Derby 
(13.5%) (Fig. 5; CODA, 2012). 
 
 
 
 
 
Figure 4: The main Salmonella serovars from pigs and pig meat in the EU in 2004-2011 (EFSA and ECDC, 2013a). 
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Figure 5: The main Salmonella serovars from pig origin in Belgium in 2012 (CODA, 2012). 
 
 
As a slaughter pig with Salmonella-infected lymph nodes is twice as likely to yield a Salmonella-
contaminated carcass (EFSA, 2008b), it is critical to understand the dynamics of Salmonella infections in 
swine herds supplying the slaughterhouses. However, the number of potential infection sources for pig 
populations are numerous, varying from Salmonella-contaminated feed (Molla et al., 2010) or farm 
materials (Twomey et al., 2010), over Salmonella-infected rodents and pets (Barber et al., 2002; Meerburg et al., 
2007), to residual environmental pen contamination (Beloeil et al., 2007; Lurette et al., 2011). Moreover, an 
evidence-based link with outbreaks is generally lacking, since the host and vector range for pig-related 
Salmonella bacteria are wide, and the variety of environmental and management situations seemingly 
endless (Carlson et al., 2012). 
Salmonella transmission between pigs mainly occurs via the faecal-oral route (Griffith et al., 2006; 
Boyen et al., 2008a), although oral-pharyngeal secretions may also allow nose-to-nose transmission of 
Salmonella (Oliveira et al., 2007), or even aerosol transmission over short distances (Fedorka-Cray et al., 1995; 
Proux et al., 2001). Transmission studies exposing pigs to Salmonella-contaminated environments have 
shown that low numbers of the bacteria (10
2 - 103 CFU) can be sufficient for infection (Boughton et al., 
2007a) and that Salmonella can be excreted within only two hours post-infection (Boughton et al., 2007b; 
Rostagno et al., 2011). More details concerning risk factors for Salmonella transmission can be found 
below paragraph ‘5. Salmonella control on-farm’. 
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3.2 Pathogenesis, lesions and symptoms 
After oral uptake, the antimicrobial peptide β-defensin 1, present in the pig’s salivae and excreted by 
the tongue mucosa, is the first host barrier Salmonella is confronted with (Shi et al., 1999). Antimicrobial 
peptides are capable of both killing bacteria by membrane disruption and chemotactically attract 
immature T-cells and monocytes, providing a link between innate and adaptive immunity (Veldhuizen et 
al., 2007). As secondary lympho-epithelial tissue, the tonsils in the oropharynx also participate in both 
innate and adaptive immune responses, through the production of antimicrobial peptides, lymphocytes, 
cytokines and chemotactic molecules (Horter et al., 2003). However, some microorganisms can 
circumvent the tonsillar immune defences and even utilize the tonsils as a colonization site. Salmonella 
Typhimurium for instance, can reside extracellularly on the porcine tonsillar epithelium and in the 
tonsillar crypts (Fedorka-Cray et al., 1995; Van Parys et al., 2010). 
Once ingested, Salmonella bacteria encounter the acidic environment of the stomach, with a pH of 
2.5 - 4.0 in adult pigs, or up to 7.0 in weaned piglets. This gastric acidity is considered a major barrier 
for most orally ingested microbial pathogens to colonize the gastrointestinal tract (Smith, 2003). 
Salmonellae however, have been shown to possess adaptive acid stress response systems that facilitate 
survival and even enhance colonization in acidic environments (Audia et al., 2001). One such system is 
the acid tolerance response (ATR) with the production of many acid shock proteins (Baik et al., 1996; 
Viala et al., 2011). Obviously, when the gastric pH is increased, e.g. through the buffering presence of 
(fatty) feed, more bacteria will survive and reach the gut (Mikkelsen et al., 2004). 
When Salmonellae arrive in the intestines, again they are faced with several host defence 
mechanisms: the intestinal peristalsis, antibacterial bile salts, antimicrobial peptides on the intestinal 
epithelium and competitive exclusion by the normal gut microbiota (Viala et al., 2011). Yet, Salmonella 
bacteria are able to attach to the intestinal mucosa by using adhesins on their envelope, especially 
type 1 fimbriae (Althouse et al., 2003). Thereafter, Salmonellae enter the epithelial cells (enterocytes and 
microfold cells, dendritic cells and goblet cells) of the intestinal mucosa, and reach the subepithelial 
lamina propria through vacuole transport. This adhesion and invasion occurs predominantly at the 
Peyer’s Patches (Schauser et al., 2004), which harbour large populations of lymphoid (T- and B-cells) and 
non-lymphoid (macrophages, dendritic cells) immune cells. After endocytosis, the Salmonella bacteria 
can survive and even multiply inside these cells, and consequently enter the blood and lymph stream 
and spread to gastrointestinal lymph nodes (Tam et al., 2008). 
After this most efficient infection process, Salmonella pathogens can persist in the tonsils, the 
intestines (ileum, caecum and colon) and the gut-associated lymphoid tissue (Wood et al., 1989; Boyen et 
al., 2008a). These ‘carrier’ pigs often do not show any clinical symptoms, but may shed Salmonella 
intermittently (van Winsen et al., 2001). Recrudescence and re-excretion of the pathogen may occur in 
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these pigs due to stress, caused by for instance the commingling of pigs, feed withdrawal (Verbrugghe et 
al., 2011), and transport towards the slaughterhouse (Rostagno et al., 2005). This re-excretion may 
eventually result in carcass contamination. 
The abovementioned passage of Salmonella bacteria through the epithelium induces the production 
of inflammatory enzymes, and chemotactic recruitment of neutrophils and macrophages. The presence 
of these immune cells in the gut enables the pig to overcome a Salmonella infection on one hand (Foster 
et al., 2003), but this intestinal inflammation also induces mucosal and endothelial necrosis on the other 
hand. This may result in watery yellow diarrhoea, indicative for Salmonella infections (Carlson et al., 
2012). Moreover, the resorption of endotoxins into the blood stream leads to fever and consequently to 
lethargy and a decreased feed intake. Usually only few pigs die, due to endotoxemia (acute) or 
dehydration (more slowly), and some may waste chronically, the so-called ‘runts’ (Carlson et al., 2012). 
The described symptoms are mainly applicable to infections with broad host range serotypes like 
Salmonella Typhimurium, and differ from the more severe symptoms seen after infections with the 
host-adapted ones like Salmonella Choleraesuis (Boyen et al., 2008a; Carlson et al., 2012). The latter serotype 
however, is predominantly found in Asian countries, while it is only rare in the United States (Foley et 
al., 2008) and eradicated in most western European herds (EFSA and ECDC, 2012a); therefore, these 
symptoms are not deepened in this thesis. 
 
4. Salmonella detection 
As various other diseases in pigs (e.g. colibacillosis, coccidiosis, dysentery) may resemble the 
clinical signs of salmonellosis, these symptoms do not provide a clear-cut diagnosis. Moreover, 
Salmonella infections in pigs mostly occur subclinically. Confirmation of infection through 
bacteriological or serological examination is thus necessary. 
 
4.1 Bacteriology 
Many different matrices can be used for the detection of Salmonella species: faeces or intestinal 
content, oral fluid, tissues such as lymph nodes or intestines, environmental or carcass swabs, and feed. 
Regardless of the sample source, the isolation of Salmonella generally includes: (i) non-selective pre-
enrichment; (ii) selective enrichment; (iii) inoculation of plating media; (iv) biochemical confirmation 
of suspect colonies; and (v) phenotypic and genotypic characterization. Different detection methods 
were established by the International and European Standardisation Organisations (EN/ISO methods) 
for different matrices to allow an inter-laboratory comparison of the outcome. As the experiments in 
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this thesis mostly investigated faeces and tissues, ISO 6579:2002/Amd1:2007 Annex D is the main ISO 
method referred to here (Fig. 6). All following techniques are summarized in table 1 and 2. 
A direct culture by inoculating samples directly on non-selective plating media (e.g. blood agar) is 
considered useful only in clinical-disease situations, whereas the numbers of Salmonella bacteria in the 
samples from carrier animals or the environment are too low to detect with this method. 
Enrichment steps have the disadvantage to limit the assay speed, but in most cases they are 
necessary in surveillance to increase the number of Salmonella bacteria (and others) for optimal 
recovery, and to dilute the effect of possible inhibitors. In a first pre-enrichment step (Fig. 6), in which 
the revival of injured cells is enhanced, buffered peptone water (BPW) is the broth of choice (ISO, 2007). 
In this BPW, the sample is diluted 1:10 and homogenized in a stomacher if necessary (e.g. in case of 
tissues). For the subsequent selective enrichment, different fluid and semi-solid media are currently 
available. The main broths used are ‘Rappaport-Vassiliadis’ with Soya (RVS) and ‘Muller-Kauffmann 
tetra-thionate’ supplemented with novobiocine (MKTTn)), and the main semi-solid agars are 
‘diagnostic semi-solid Salmonella’ (DIASALM) and ‘modified semi-solid Rappaport-Vassiliadis’ 
(MSRV). MSRV is used in ISO 6579:2002/Amd1:2007 Annex D (Fig. 6), as it provides added 
novobiocin, more nutrients, a higher buffering capacity, and less magnesium chloride in comparison 
with RV. Although semi-solid media are considered to be the most suitable selective enrichment media, 
several authors showed that different media led to different patterns of strain dominance, so that a 
combination of these media increases the relative sensitivity (Gorski, 2012; De Busser et al., 2013). 
The next, selective isolation step is usually performed on plates of xylose-lysine-deoxycholate agar 
(XLD), xylose-lysine-tergitol-4 agar (XLT-4), brilliant green agar (BGA) and RAPID'Salmonella 
Medium (RAPID) agar. For ISO 6579:2002/Amd1:2007 Annex D, an XLD plate and a second medium 
are inoculated with a loopful from the growth zone edge on the MSRV plate. 
A biochemical confirmation is performed thereafter, when colonies with a Salmonella-typical 
morphology are present. One such colony is then inoculated in triple sugar iron agar (TSI), lysine-
decarboxylase broth and sorbitol agar according to ISO 6579:2002/Amd1:2007 Annex D (Fig. 6). 
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Figure 6: Scheme of the bacteriological isolation of Salmonella spp., performed in CODA-CERVA. 
(Based on ISO 6579:2002/Amd1:2007 Annex D) 
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Although culture methods are recommended for Salmonella detection, since they provide a 100% 
specificity (ISO, 2007), it is well recognized that their sensitivity depends on the matrix of the sample 
(faeces or tissue), on the type of sample (single or pooled) and on the used combination of culture 
media (Wilkins et al., 2010). A culture sensitivity of 74 and 90% was estimated by the systematic review 
of Wilkins et al. (2010) for faecal and lymph node samples, respectively. In addition, culture methods 
are labour-intensive and above all time-consuming, which is not desirable in cases when urgent 
diagnosis is necessary or when many samples have to be tested. Therefore, developing more convenient 
and rapid, but reliable alternatives for the culture methods has been the goal of many research so far. 
Real-time polymerase chain reaction (Real-time PCR) for instance, is the most common approach in 
rapid testing (Hoorfar, 2011). The PCR amplifies a targeted region of the Salmonella genome by a three-
step process: (i) denaturation of double-stranded DNA into single strands; (ii) annealing of specific 
primers to the single-stranded DNA; and (iii) enzymatic extension of the primers to produce an exact 
copy of the original double-stranded DNA sequence. However, PCR has a low diagnostic sensitivity 
when testing samples with a low number of Salmonella bacteria (Nga et al., 2010; Jensen et al., 2013). 
Therefore, a preceding enrichment in a culture broth is nevertheless recommended (Jasson et al., 2011). 
A more rapid, simpler and cheaper molecular detection method however, is the loop-mediated 
isothermal amplification (LAMP) assay. It relies on the autocycling amplification of six distinct regions 
of a target gene in a water-bath, after which the amplified products can be detected by turbidity 
(visually or by a turbidimeter) due to the formation of insoluble magnesium pyrophosphate 
(Techathuvanan et al., 2010). Another rapid method is the VIDAS
®
 UP Salmonella assay (Vitek Immuno 
Diagnostic Assay System), an enzyme-linked fluorescent assay (ELFA), for the detection of 
Salmonella in food products, environmental samples, and primary production samples within two days 
(Bird et al., 2013). Similarly, the antigen-capture enzyme-linked immunosorbent assay (ELISA) of Brooks 
et al. (2014) showed to detect a broad range of Salmonella serovars in field samples, this with a 
diagnostic sensitivity and specificity comparable to culture, but with a higher cost-efficiency. A very 
different detection approach is performed with matrix-assisted laser desorption ionization time-of-flight 
mass spectrometry (MALDI-TOF MS). Starting from a single colony or even a selective enrichment 
broth, this technique generates profile spectra of small (ribosomal) proteins, revealing a peak pattern 
(Sparbier et al., 2012). Matching the pattern against a reference database enables the discrimination of 
different bacterial species. 
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Table 1: Main bacteriological diagnostic techniques for Salmonella analysis. 
Technique a Characteristics Advantage(s) Disadvantage(s) 
S
a
lm
o
n
el
la
 d
et
ec
ti
o
n
 
Direct Culture  Direct inoculation of non-
selective plating media 
 Rapid (1day)  Low Se b if no clinical disease 
ISO 6579  Gold standard isolation with 
(pre)enrichment + different 
selective steps 
 Perfect Sp b (100%) 
 Further identification 
+ storage 
 Widely used and comparable 
 Slow (5-7days) 
 Moderate Se b (74-90% for faeces-lymph nodes) 
 Labour-intensive 
 Rather expensive 
Real-time PCR  Amplification of DNA 
molecules with concurrent 
detection of fluorescence 
 Very high Se b after 
enrichment 
 Rapid (1day) 
 Labour-friendly 
 Low Se b without enrichment 
 Type of pre-enrichment broth influences Se b 
 Very expensive 
 Choice of primers determines detection range 
 No further identification + storage 
LAMP  Isothermal amplification of 
six gene regions, causing 
turbidity in the medium 
 Relatively rapid (1-2days) 
 Labour-friendly 
 Rather cost-effective 
 No further identification + storage 
VIDAS® UP  Enzyme-Linked Fluorescent 
Assay (ELFA) for antigen 
detection 
 Relatively rapid (2days) 
 Labour-friendly 
 Type of pre-enrichment broth influences Se b 
 No further identification + storage 
AC-ELISA  Double-antibody sandwich 
ELISA for antigen detection 
 Rapid (1day) 
 Labour-friendly 
 Rather cost-effective 
 No further identification + storage 
MALDI-TOF 
MS 
 Mass spectrometry analysis  
of peptides/proteins, 
generating typical profile 
spectra patterns 
 Rapid (1day) 
 Rather cost-effective 
 No further identification + storage 
a ISO 6579 = ISO 6579:2002/Amd1:2007 Annex D; Real-time-PCR = Real-time Polymerase Chain Reaction; LAMP = Loop-mediated 
isothermal Amplification; VIDAS = Vitek Immuno Diagnostic Assay System; AC-ELISA = Antigen-Capture Enzyme-Linked 
Immunosorbent Assay; MALDI-TOF MS = Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry 
b Sp = Specificity; Se = Sensitivity 
 
When the identification of a Salmonella isolate is required, a phenotypic or genotypic 
characterization can be carried out. Genotypic methods are progressively replacing the phenotypic 
assays, but the latter are still routinely used in many reference laboratories (EFSA, 2013b). Often a 
combination of phenotypic and genotypic typing methods is used. 
For a phenotypic examination, options like serotyping, phage-typing and an assessment of the 
antimicrobial resistance patterns are available. Serotyping is generally performed according to the 
Kauffman-White-Le Minor scheme (Grimont and Weill, 2007; Guibordenche et al., 2010). This system 
classifies the Salmonella isolate as a certain serotype or serovar, based on the slide agglutination of 
somatic (O), flagellar (H) and capsular (Vi) antigens present on its cell surface with Salmonella-
specific rabbit-antibodies. Although serotyping by agglutination is widely used for epidemiological 
purposes for over 80 years, as serovars are discriminatory and suitable for global communication, it is 
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time-consuming, expensive, and requires carefully trained personnel as well. A more automated way of 
serotyping is possible when using Check&Trace Salmonella (or previously known as ‘Premi®Test’) 
(Check-Points), a molecular serotyping method. It combines a multiplex PCR with the simultaneous 
detection of the PCR products on a diagnostic microarray (Wattiau et al., 2008). Starting from a pure 
colony after culture, the test produces unique microarray hybridization profiles within 9 - 10h, that 
enable identification at both the genus and serovar level of the most commonly encountered Salmonella 
spp. 
Salmonella strains can also be examined by phage typing, which assesses the strains’ susceptibility 
to a defined set of bacteriophages (Tolba et al., 2010; López-Cuevas et al., 2011). However, only important 
serovars such as Salmonella Enteritidis and Typhimurium are investigated this way, and only a limited 
number of bacteriophages are available, which demand in addition a continuous quality control. Also, a 
careful inter-laboratory coordination is vital to ensure the assay’s reproducibility (Baggesen et al., 2010). 
As antimicrobial resistance is an emerging problem worldwide, another phenotypic technique is 
increasingly important: the determination of antimicrobial resistance profiles among isolated 
Salmonella strains (Miller et al., 2011; Bonardi et al., 2013; Kerouanton et al., 2013). 
Genotypic examination can be performed by several techniques as well. Pulsed-field gel 
electrophoresis (PFGE) is considered the ‘gold standard’ method for the subtyping of foodborne 
pathogens. With this technique, long strands of DNA are separated through an agarose gel matrix and 
are visualized as bands. The actual DNA content of each band is thus unknown, but the isolates can be 
identified when matching with the used reference strains. PFGE was historically one of the earliest 
DNA subtyping systems for fingerprinting Salmonella isolates and has become a frequently used 
procedure, since it has been shown to be reliable and highly discriminating (Goering, 2004; Ribot et al., 
2006), with the exception of certain strains, like Salmonella Typhimurium DT 104. Its usefulness is 
limited however, by the labour-intensive, time-consuming protocol and the expensive equipment 
required. Inter-laboratory comparisons of i.a. these PFGE fingerprints are notably improved by 
PulseNet, The International Molecular Subtyping Network for Foodborne Disease Surveillance 
(http://www.pulsenetinternational.org/networks/europe). 
Multi-locus variable-number of tandem-repeats analysis (MLVA) has recently become a widely 
used method as well for the typing of Salmonella Typhimurium (Hopkins et al., 2007; Larsson et al., 2009; 
Kruy et al., 2011), and it showed an even higher discriminatory power in comparison with PFGE (Dewaele 
et al., 2012). This method, based on the amplification and fragment size analysis of five repeat loci, is 
much more labour-friendly, but requires a specific nomenclature to match MLVA profiles between 
laboratories (Larsson et al., 2009). 
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Restriction fragment length polymorphism (RFLP) is another molecular subtyping tool in 
epidemiologic investigations (EFSA, 2013b). In this technique, a target DNA sequence known to differ 
between strains, is cleaved with restriction endonucleases to generate fragments of varying length. 
Before this cleavage, the target DNA sequence can be amplified at high annealing temperatures in a 
PCR-RFLP, to maximise stringency. The isolates are then typed by comparing their RFLP pattern after 
gel electrophoresis. RFLP-analysis provides a moderate discriminatory capability, and is moderately 
comparable between laboratories (EFSA, 2013b). 
Unlike PFGE, MLVA and RFLP, the method of multi-locus sequence typing (MLST) is based on 
DNA sequencing (Maiden, 2006). MLST determines the DNA sequence variations in multiple 
housekeeping genes depending on the degree of discrimination desired, and characterizes strains by 
their unique allelic profiles or sequence types (STs). This sequence-based typing method is considered 
moderately to highly discriminatory for general examinations, but too low for outbreak investigations. 
Its reproducibility between laboratories is however, regarded as high. Achtman et al. (2012) 
investigated isolates of Salmonella enterica from diverse hosts from all continents and showed that this 
MLST technique recognized multiple evolutionary groups that were confounded by traditional serotype 
designations. Therefore, they concluded that serotyping can be misleading concerning the disease 
potential of Salmonella sp., and they advised the replacement of serotyping by MLST or its equivalents 
for routine diagnostic purposes.Progresss is also ongoing in the whole genomic sequencing (WGS) 
technique, which results in the fully sequenced genome of a pathogen. Therefore, WGS achieves the 
maximum capability for discriminating isolates. The international harmonisation of the huge amount of 
information will be a major challenge in future however, which makes WGS not readily applicable as a 
routine subtyping method (EFSA, 2013b). 
Although these genotyping technologies become increasingly accepted, an important limitation must 
be taken into account. Namely, they only indicate that bacteria with those gene sequences are present, 
and not whether the gene is actually expressed or whether the bacterium is viable. The latter issue 
might be overcome by a method with immobilized bacteriophages capturing metabolically-active host 
bacterial cells, which can be detected afterwards using real-time PCR (Tolba et al., 2010). 
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Table 2: Main bacteriological typing techniques for Salmonella analysis. 
Technique a Characteristics Advantage(s) Disadvantage(s) 
S
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Serotyping 
(agglutination) 
 Standard classification cfr. 
Kauffman-White-Le Minor scheme 
 Agglutination of anti-Salmonella 
rabbit-antibodies with antigens on a 
slide 
 Discriminatory serotypes 
 Widely used 
 High inter-laboratory 
comparisons 
 Relatively rapid (1-2days) 
 Only possible after isolation 
 Rather expensive 
 Trained personnel 
 Little discriminatory for outbreak 
analysis 
Serotyping 
(molecular) 
 Standard classification cfr. 
Kauffman-White-Le Minor scheme 
 Multiplex PCR + microarray 
(Check&Trace®) 
 Discriminatory serotypes 
 Widely used 
 High inter-laboratory 
comparisons 
 Relatively rapid (1-2days) 
 No trained personnel 
 Best after isolation (Low Se b from 
MSRV, better Se b from BGA) 
 Very expensive 
 Little discriminatory for outbreak 
analysis 
Phage-typing  Determination of growth inhibition 
round bacteriophage drops 
 Widely used 
 Rapid (1day) 
 Only possible after isolation 
 Limited number + careful quality 
control of bacteriophages 
 Not available for all serovars 
 Trained personnel 
 Difficult inter-laboratory comparisons 
(exc. for Definite phage Types (DT)) 
Antibiogramme  Determination of growth inhibition 
round antimicrobial tablets 
 Worldwide increasing 
importance 
 Rapid (1day) 
 Only possible after isolation 
 Not very discriminatory 
S
a
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o
n
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PFGE  Gold standard genotyping 
 Separating DNA molecules in a 
gel matrix by an electric field that 
periodically changes direction 
 Widely used 
 Highly discriminatory, but 
depending on serotype 
 Moderate-high inter-laboratory 
comparisons (e.g. high with 
PulseNet protocol) 
 Only possible after isolation 
 Labour-intensive 
 Time-consuming 
 Rather expensive 
  
MLVA  Amplification + fragment length 
analysis (electrophoresis) of repeat 
loci 
 Widely used 
 Highly discriminatory 
 Labour-friendly 
 Moderate-high inter-laboratory 
comparisons (e.g. high with 
PulseNet protocol and in case 
of Salmonella Typhimurium) 
 Only possible after isolationSpecific 
assay is needed per species/serovar 
  
(PCR-)RFLP  (Amplification +) fragmenting DNA 
by restriction enzymes + gel 
electrophoresis 
 Moderately-highly 
discriminatory 
Relatively inexpensive 
 Only possible after isolation 
 Low-moderate inter-laboratory 
comparisons 
 Time-consuming 
MLST  Amplification + sequencing DNA 
in a set of genetic loci (housekeeping 
genes), producing allelic profiles 
orsequence types (ST) 
 Moderately discriminatory 
 High inter-laboratory 
comparisons 
 Correlation between ST 
and serotypes 
 Only possible after isolation 
 Little discriminatory for outbreak 
analysis 
 Expensive 
 Time-consuming 
WGS  DNA extraction + sequencing of 
entire genome 
 Usually performed on isolated 
outbreak strains 
 RapidHighly discriminatory 
 High inter-laboratory 
comparisons 
 
 Variable results between DNA 
preparation protocols 
 Complex analysis due to enormous 
dataset 
a PFGE = Pulsed-Field Gel Electrophoresis; MLVA = Multi-Locus Variable-number of tandem-repeats Analysis; (PCR-)RFLP = 
(Polymerase Chain Reaction-)Restriction Fragment Length Polymorphism; MLST = Multi-Locus Sequence Typing; WGS = Whole Genome 
Sequencing; b Se = Sensitivity 
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4.2 Serology 
The detection of Salmonella-specific antibodies in pigs can be performed on two matrices: serum 
derived from blood samples and meat juice from muscle tissues. Monitoring of Salmonella-specific 
antibodies in blood samples of fattening pigs is carried out in several countries such as Belgium and the 
Netherlands, whereas Denmark and Germany use meat juice (EFSA and ECDC, 2012a). As meat juice 
comprises serum, lymphatic moist and intracellular fluid, it is a natural diluted form of blood serum, 
and needs therefore a ten-times lower dilution in the preparation step of serological testing. Collecting 
muscle samples at the slaughterhouse is less labour-intensive than taking blood samples at the herd, but 
large variations occur in the obtained meat juice volume per gram muscle tissue. This results in an 
indefinable dilution of the present antibodies, and thus in a bias of the serological outcome. When 
comparing serum and meat juice analysis, the serum results were consistently higher than those from 
meat juice, and the overall correlation coefficient between both was moderate to low (Vico et al., 2011). 
Wilhelm et al. (2007) recommended to recalculate the optical density percentage (OD%) obtained from 
meat juice, according to a specific regression equation, to adjust the results to those obtained from sera. 
In addition, the meat juice from different muscles provides different levels of antibodies. Antibody 
levels in the meat juice from the diaphragm pillar for instance, resembled the levels in serum better 
than the levels in meat juice from neck or belly muscle (Nobmann et al., 2011). These findings suggest that 
the choice of the matrix should be carefully discussed before implementing it in a Salmonella 
surveillance programme; the ease of muscle sampling must be weighed critically against the probability 
of underestimating the actual seroprevalence when examining meat juice. A possible solution might be 
the sampling of blood at slaughter, which takes advantage of the ease of sampling at the 
slaughterhouse, and the correct estimation of the seroprevalence (cfr. monitoring in the Netherlands). 
Anyhow, a serological sampling at the slaughterhouse (meat juice or blood) enables the examination 
of pigs from the same age class. This allows a standardised herd classification according to the 
Salmonella risk (high-medium-low level of antibodies). This is in contrast with the way that blood was 
sampled in Belgium (blood from different age categories at herd level was collected according the 
Aujeszky’s disease virus (ADV) programme). 
Irrespective of the applied matrix, most serological testing in the EU is performed with indirect 
enzyme-linked immunosorbent assays (ELISA) that are based on the detection of antibodies against the 
somatic O-antigens 1, 4, 5, 6, 7 and 12. These O-antigens or lipopolysaccharides (LPS) are present on 
the cell surface of i.a. Salmonella Typhimurium and Derby (O: 1, 4, [5], 12), Salmonella Infantis and 
Mbandaka (O: 6, 7, 14), and Salmonella Enteritidis (O: 1, 9, 12). Consequently, the most prevalent 
serovars in the EU and Belgium are covered by these tests (EFSA and ECDC, 2013a; CODA, 2012). The 
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Salmonella LPS-Mix-ELISA was first developed in Denmark (Nielsen et al., 1995), and has been used in 
many countries as part of national Salmonella monitoring programmes (van der Wolf et al., 1999; Alban et 
al., 2002; Leontides et al., 2003). Various test kits have been developed and implemented in several national 
surveillance programmes so far (e.g. Herdchek
®
 Swine Salmonella, IDEXX Laboratories; Salmotype
®
 
Pig Screen, Labor Diagnostik; Priocheck
®
 Salmonella Ab porcine, Prionics). Caution is advisable 
however, when different ELISA kits are used within the same monitoring programme or herd, since 
several studies have demonstrated that the results of one same sample differed substantially after 
analysis with different test kits (Szabó et al., 2008; Vico et al., 2010). This may be due to the use of different 
cut-off values recommended in each of these kit instructions (Szabó et al., 2008). Vico et al. (2010) found 
that the Herdchek
®
 Swine Salmonella kit showed the highest overall accuracy in comparison with the 
Salmotype
®
 Pig Screen kit and the Priocheck
®
 Salmonella Ab porcine kit. 
The results of the indirect ELISA are expressed as optical density values (OD), since the level of 
antibodies present in a sample, determines the colouring extent during the assay, which is measured by 
a spectrophotometer (Fig. 7). Depending on the user’s (national) preference, these absorbance values can 
be presented as a sample-to-positive ratio (S/P) or as an optical density percentage (OD%), through the 
following formulae (Herdchek® Swine Salmonella, IDEXX Laboratories): 
 
 S/P ratio  =  (ODSample - ODNegative Kit-Control)  ÷  (ODPositive Kit-Control - ODNegative Kit-Control) 
 OD%  =  S/P ratio  ÷  2.5 * 100% 
 
 
 
Figure 7: A 96 ELISA well-plate during the last step of the indirect ELISA test, with the dark/light-coloured wells 
containing samples with a high/low level of Salmonella-specific antibodies, respectively. 
(Based on Herdchek
®
 Swine Salmonella, IDEXX Laboratories) 
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The determination of the cut-off values to define a sample as positive or negative, is depending on 
both the kit instructions and the national aims and regulations. For the IDEXX kit for instance, it is 
recommended to deviate from its suggested cut-off value of 10 OD% or 0.25 S/P for individual 
samples, when a stringent (20 OD% or 0.50 S/P) or general (40 OD% or 1.00 S/P) large-scale 
screening is performed. The first cut-off value is used for example in the surveillance programme of 
Denmark, the latter in Germany and the Netherlands. Belgium currently applies the cut-off value of 
10 OD% or 0.25 S/P for individual samples, with however, a supplementary screening regulation for 
the classification of positive herds: if the mean S/P ratio of a herd exceeds 0.60 during three 
consecutive sampling rounds (i.e. within one year), that herd is designated as a ‘risk herd’. More details 
concerning this Belgian Salmonella Action Plan (SAP) can be found in paragraph 5.5. 
In comparison with many bacteriological methods, serological testing with ELISAs has the 
advantage of being rapid and relatively cheap. In addition, it measures the pig’s response against 
previous Salmonella infection and is not dependent on the (intermittent) shedding of the pig at the time 
of sampling. Nevertheless, the actual presence of Salmonella bacteria can only be assessed by 
bacteriological examination, which remains of great importance from public health point of view. 
Only few studies report a good-to-moderate correlation between bacteriology and serology (Lo Fo 
Wong et al., 2003; Sørensen et al., 2004; Korsak et al., 2006). More studies found generally a low correlation 
between both, whether the comparison was performed between samples from serum and faeces (Nielsen 
et al., 1995; Davies et al., 2003; Laevens and Mintiens, 2005; Farzan et al., 2007), serum and tissue (Davies et al., 2003; 
Nollet et al., 2005), meat juice and faeces (Davies et al., 2003; Casey et al., 2004; Rostagno et al., 2012b) or meat 
juice and tissue (Davies et al., 2003; Belsué et al., 2011). This finding can be explained by the temporal 
disassociation of approximately two months that exists between the prevalence peak of bacteriological 
excretion and serological antibody response (Kranker et al., 2003). Also the sample size for the monitoring 
at herd level will influence the level of agreement between the bacteriological and serological results: a 
sufficiently large sample is to be taken to allow an accurate insight into the Salmonella infection status 
of the herd (Anonymous, 2012). Most of the previous authors did agree however, that bacteriological 
testing is preferable for individual animal analysis (as this provides a 100% specificity, but is rather 
expensive for screening with large sample size), and that serologic testing, using a sufficiently large 
sample size, is more appropriate at herd level (as this method is rapid and more economical for 
screening numerous samples). A general comparison of bacteriology and serology is given in table 3. 
In any case, for both methods the use of single point estimates should be dissuaded for evaluations 
of on-farm interventions and for monitoring purposes (Rostagno et al., 2012b). 
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Table 3: Comparison of bacteriogical (isolation) and serological examination. 
Criteria  Bacteriology (isolation)  Serology 
Peak of detection post-infection
 a
 
(influenced by re-infections!) 
 
2 months (excreting pigs)  4 months (seropositive pigs) 
Detection of recent infections, rare serotypes, 
infections with low antibody response 
 
High detection rate  Low detection rate 
Detection of carriers, infections with low excretion  Low positivity rate  High positivity rate 
b
 
Assay performance  Slow  Fast 
Costs  Expensive  Inexpensive 
Advisable level of Salmonella status determination  Individual (Herd) level  Herd (Individual) level 
Monitoring infection dynamics  Less appropriate  More appropriate 
Serotyping, antimicrobial resistance  Yes  No 
a 
Kranker et al., 2003 
b
 depending from cut-off value (Nollet et al., 2005) 
 
 
5. Salmonella control on-farm 
As pork is the most frequently consumed meat in the world (Narrod et al., 2011), the mitigation of any 
potential risk towards public health is justified. To increase food safety of pork products, many stages 
in the ‘farm-to-fork’, the ‘feed-to-fork’ or the ‘stable-to-table’ chain can be targeted, grouped in three 
levels: the pre-harvest level (i.e. on-farm), the harvest level (i.e. during transport to the slaughterhouse, 
in the lairage, at the slaughterline), and the post-harvest level (i.e. during processing, in retail, during 
preparation). Some authors focus on the importance of control measures in the slaughterhouse (Goldbach 
and Alban, 2006; Hurd et al., 2008; Bollaerts et al., 2010), while others prefer the optimization of interventions 
on-farm (Hotes et al., 2011; Wales et al., 2011). Most probably, the largest reduction of pork contamination 
may be expected when concurrent control measures are applied at every level of the pork production 
chain (Alban and Stark, 2005; EFSA 2008a). 
However, Salmonella may also be transmitted directly from infected pigs to humans (Hendriksen et al., 
2004), and may have an important economic impact through reducing the weight gain of infected pigs 
(Boyen et al., 2009; Davis et al., 2010; Farzan and Friendship, 2010; Gebru et al., 2010). These facts provide two 
additional arguments to focus on pre-harvest control measures. Reducing Salmonella prevalence in live 
pigs will however, demand the concurrent implementation of multiple measures at pre-harvest level. 
The potential interventions that are listed below are not likely to eliminate Salmonella presence on their 
own, but can achieve a significant Salmonella reduction when implemented together, as part of an 
overall control strategy on-farm. 
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5.1 Biosecurity 
Biosecurity is the whole of preventive measures that can be taken to avoid the introduction of 
infections on a herd (external biosecurity) or the spread of infections within a herd (internal 
biosecurity) (Casal et al. 2007; Laanen et al., 2013).These measures are related to hygiene, pest control and 
pig-related management. 
 
5.1.1 Hygiene 
The European Union has set several legislations to guarantee consumers’ food safety. Regulation 
(EC) No 852/2004 for instance (a revision of the legislation on the hygiene of foodstuffs "Hygiene 
Package"), defines the food safety objectives to be achieved by the food operators, and points out the 
importance of adopting hygienic measures in pig herds (Anonymous, 2004). 
Many studies have been conducted to identify risk factors for Salmonella prevalence in primary 
production, and all authors agreed that a great part of the identified risk factors were related to the 
hygienic actions on-farm (Lo Fo Wong et al., 2004a; Beloeil et al., 2007; Hautekiet et al., 2008; Hurd et al., 2008; 
Fosse et al., 2009; Gotter et al., 2012, Rostagno et al., 2012a). 
Two possible hygienic measures that should be implemented to improve the external biosecurity, are 
the use of boot baths (Hautekiet et al., 2008), and the presence of hygienic-lock facilities (Lo Fo Wong et al., 
2004a). Efficient cleaning and disinfection procedures between batches is of paramount importance to 
minimize residual Salmonella contamination in the pens and thus improve internal biosecurity (Lo Fo 
wong et al., 2004a; Erdman et al., 2005; Beloeil et al., 2007; Mannion et al., 2007; Hautekiet et al., 2008; Fosse et al., 
2009; Hotes et al., 2011; Lurette et al., 2011; Rostagno et al., 2012a; Gautam et al., 2013). In addition, it is generally 
accepted that the cleaning step prior to disinfection must be applied very thoroughly to remove all 
organic material. Indeed, van der Wolf et al. (2001a) pointed out that using disinfectants without a 
preceding, adequate cleaning may even result in a higher Salmonella seroprevalence than when only 
cleaning is performed. McLaren et al. (2011) investigated various disinfectant products in a wet and 
dry experimental model. They demonstrated that chlorocresol-based disinfectants provided high 
bactericidal rates in both wet and dry tests, whereas formaldehyde-containing disinfectants were less 
effective in wet environment tests, and other chemical products (i.a. quaternary ammonium 
compounds, peroxygens) were only moderately effective. Further, not only the pens themselves and the 
stables should be considered, but also tools such as brooms, transport vehicles and footwear must be 
included in the cleaning and disinfection procedures (Twomey et al., 2010). Even the washing of the 
caretakers’ hands before tending to the pigs was shown to decrease Salmonella seropositivity (Lo Fo 
Wong et al., 2004a).  
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Increased efficiency of hygienic measures can thus reduce the prevalence of Salmonella shedding at 
slaughter. As mentioned previously however, these efforts alone are not capable of reducing the 
infection in the population satisfactory, and should be combined with other intervention methods 
(Gautam et al., 2013). 
 
5.1.2 Pest control 
The efficacy of proper hygienic procedures is often reduced by Salmonella-infected rodents or 
insects that are present in the farm environment after cleaning and disinfection (Davies and Wray, 1995). 
Unfortunately, many farmers only apply rodent control measures (not always efficient ones) after a 
certain subjective threshold is passed and mainly to prevent feed losses or infrastructural damage 
(Meerburg and Kijlstra, 2007). 
The rodent-related zoonotic risks are thus frequently underestimated as a threat to both the external 
and internal biosecurity, as wild rodents – together with birds, flies and domestic pets – are the main 
reservoirs and vectors of Salmonella and various other pathogens causing disease in food animals and 
humans (e.g. Campylobacter, Leptospira, Trichinella, Toxoplasma). In a field survey on swine 
production systems, Salmonella was detected in samples from cats (12% of samples positive), birds 
(8%), flies (6%), and mice (5%), and a correlation was demonstrated with the number of Salmonella-
shedding pigs (Barber et al., 2002). 
Therefore, the importance of pest control for food safety purposes must be stressed on primary 
production sites. These control measures should be an integral part of the biosecurity package at a herd, 
and they should include the monitoring, prevention (e.g. sealing of farm buildings, removal of nesting 
material near stables, limiting access to feed and water) and control (rodenticides, insecticides, live 
traps, professional exterminator) of rodents, birds and flies (Meerburg and Kijlstra, 2007). This way, contact 
opportunities with pigs are limited as much as possible. Cats are not recommended as rodent 
exterminators in the stables, as their presence is positively correlated with Toxoplasma gondii 
seroprevalence in pigs (Meerburg et al., 2006) and they can act as Salmonella reservoir themselves (Barber 
et al., 2002). 
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5.1.3 Management 
Although room decontamination efficacy had a greater impact on Salmonella prevalence in pigs at 
slaughter, when compared to pig management practices (Lurette et al., 2011), the effect of the latter 
biosecurity measures must not be underestimated. Numerous studies have indeed demonstrated a higher 
risk for Salmonella seropositivity and/or faecal prevalence when a number of management procedures, 
explained hereafter, were inadequate. 
For instance, herds that implement proper entrance control, by the use of a fence enclosing the pig 
farm facilities and specific clothing before entering the facilities, also show a reduced risk for 
Salmonella seroconversion, in comparison with herds that lack these external biosecurity measures (Lo 
Fo Wong et al., 2004a; Beloeil et al., 2007; Hautekiet et al., 2008). Also a purchase policy with less 
than three supplier herds, was associated with lower average S/P-values (Lo Fo Wong et al., 2004a) and 
represents an important external biosecurity measure. This supports the generally accepted view that 
the herd immunity in closed farms is more stable than in open production systems that regularly 
purchase animals. 
Respecting well-defined walking lines within the farm and applying a strict all in/all out procedure 
between batches represent valuable internal biosecurity measures, as they were related with lower 
average S/P-values (Lo Fo Wong et al., 2004a; Erdman et al., 2005; Hautekiet et al., 2008; Fosse et al., 2009). The 
pig stocking density (floor space per pig, as well as batch and herd size) was another internal 
biosecurity measure that was identified as an important risk factor for Salmonella seroconversion by 
Beloeil et al. (2007), Van der Wolf et al. (2001a) and Hautekiet et al. (2008). Likewise, a decreased 
seropositivity was reported when pigs had no or restricted contact with pigs from neighbouring pens 
or with slurry by the use of slatted floors (Lo Fo Wong et al., 2004a; Twomey et al., 2010; Hotes et al., 2011). 
Also the reproductive management system may have an impact on Salmonella prevalence. In 
Belgium, approximately half of the sow herds use a more-week batch production system (Maes, 2012). 
Apart from better labour organization, such systems may also offer sanitary advantages (Vangroenweghe 
et al., 2012). Namely, the units in such a more-week batch system are used AI/AO and can be cleaned 
and disinfected more properly (with a longer sanitary transition), so that the risk for residual 
Salmonella is reduced. 
When focussing on pig health, several studies have proven the association between infections with 
Salmonella and concurrent pathogens. Porcine Reproductive and Respiratory Syndrome virus (PRRSV) 
infection (Wills et al., 2000; Erdman et al., 2005; Beloeil et al., 2007), or intestinal damage caused by Ascaris 
suum larvae (van der Wolf et al., 2001a) lead for instance to a higher risk for Salmonella seropositivity. 
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Finally, pig welfare plays a major role in Salmonella spread as well, since a recrudescence of the 
bacteria in carrier pigs occurs in situations of stress, with the consequent shedding of the pathogen in 
the environment (‘intermittent excretion’). To avoid stress situations, various measures are possible, 
from providing environmental enrichment (De Jonge et al., 1996), to not mixing batches (Coutellier et al., 
2007), and programming the room temperature in the zone of thermal neutrality (Hautekiet et al., 2008). 
In conclusion, stringent cleaning and disinfection combined with an attentive pest control and the 
optimization of the herd management, will likely not eliminate Salmonella prevalence in commercial 
swine herds, but will certainly reduce the Salmonella burden and contribute to a better overall herd 
health status (Erdman et al., 2005). To improve biosecurity however, pig farmers must be prepared to 
make investments and especially change practices, which might militate against the voluntary adoption 
of these measures (Fraser et al., 2010). Nevertheless, the improvement of the pigs weight gain when 
reducing Salmonella infection (Balaji et al., 2000; Turner et al., 2002; Boyen et al., 2009; Davis et al., 2010; Farzan 
and Friendship, 2010; Gebru et al., 2010), forms a good incentive to pay for these expenses and adopt the 
necessary biosecurity measures. 
 
5.2 Feed: contamination, characteristics and supplementations 
5.2.1 Salmonella-free feed 
In the ‘feed-to-food’ consumer safety policy, the production of Salmonella-free feed is obviously the 
first critical control point, as a link between contaminated animal feed and human salmonellosis has 
been demonstrated (Crump et al., 2002). The impact of Salmonella-contaminated feed however, is 
considered greatest in countries with a low Salmonella prevalence, whereas in high prevalence 
countries, the breeding holdings represent the most important cause of Salmonella introduction (Hill et 
al., 2011). 
The introduction of Salmonella into the feed can occur i) by using contaminated ingredients (Crump et 
al., 2002; Wierup and Häggblom, 2010), ii) during processing, iii) during transport to and storage at the farm, 
and iv) in the pig pens (Jones and Richardson, 2004). This may happen through contact with contaminated 
wildlife or rodent excreta, agricultural effluents and dust (Crump et al., 2002; Davies and Wales, 2010). In 
addition, low numbers of Salmonella present in the feed may multiply in warm, moist conditions such 
as feed troughs (Wales et al., 2010). 
Producing Salmonella-free animal feed is possible by firstly preventing Salmonella bacteria from 
entering the feed facilities, and secondly by destroying the bacteria through heat or chemical treatment 
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of the feed (Wales et al., 2010). Prevention can be achieved by purchasing Salmonella-free ingredients 
and by optimizing internal biosecurity in the feed manufacturing site. To check the intermittent or 
batch-specific contamination of the purchased ingredients, a thorough analysis of dust and aggregated 
spilled feed around mill machinery is preferable above direct feed sampling (Davies and Wales, 2010). 
Namely, these first sample types are a small subsample of a great deal of the material that passed 
through the feed manufacturing site and with a high surface area for the adherence of bacteria. This 
way, dust has proven to be a sensitive monitoring sample for Salmonella (Jones and Richardson,  2004). 
Therefore, to avoid contamination during manufacturing, feed producers should focus on an adequate 
dust and rodent control (Jones and Richardson, 2004). Heat treatment of the feed during pelleting or 
extrusion with a temperature above 80°C eliminates Salmonella in most cases (Himathongkham et al., 1996; 
Jones and Richardson, 2004). However, due to heat damage to the vitamins and other nutrients, and the 
absence of a residual antibacterial effect, most feed producers opt for chemical treatment, such as 
adding organic acids or formaldehyde, or for applying bacterial-membrane disrupting compounds. 
Chemicals do have a residual effect during storage, thereby reducing feed recontamination. 
Nevertheless, this effect might also interfere with (‘mask’) bacteriological detection of remaining, 
viable organisms (Wales et al., 2010). Mixtures of organic acids (e.g. formic, propionic, lactic and butyric 
acid) or their derivatives (e.g. potassium diformate) are commonly marketed, but the different acids 
appear to have highly variable antibacterial effects. Formaldehyde has strong disinfectant capacities 
against most bacteria (Wales et al., 2010), and therefore it is still a permitted additive in Belgium. 
However, as a genotoxicant, it is considered a carcinogenic hazard at concentrations above 1ppm (Arts 
et al., 2006). Bacterial-membrane disrupting compounds, such as terpenes or essential oils (plant-derived 
mixtures of terpenes), are often added to formaldehyde- and organic acid-containing products, as they 
improve their microbicidal effect (Trombetta et al., 2005; Carrique-Mas et al., 2007). This synergistic 
combination allows lower levels of formaldehyde and acids, and thus minimizes the corrosiveness and 
the operator risk. 
 
5.2.2 Feed characteristics 
Several publications reported associations between Salmonella prevalence in swine and different 
feed textures. Many have investigated the effect of pelleted feed versus non-pelleted feed and 
demonstrated a reducing effect on Salmonella (sero)prevalence in pigs by the latter feed (Kjeldsen and 
Dahl, 1999; Kranker et al., 2001; Lo Fo Wong et al., 2004a; Mikkelsen et al., 2004; Rajić et al., 2007; Garcia-Feliz et al., 
2009; Hotes et al., 2010), even when the pelleting proces rendered a less-contaminated product (Mikkelsen et 
al., 2004). A meta-analysis performed by Wilhelm et al. (2012) even ranked the efficacy of this 
intervention before feed supplementation with acids or vaccination. This texture effect is related to the 
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particle size (Kjeldsen and Dahl, 1999; Hedemann et al., 2005; Papenbrock et al., 2005). Feed with large particles 
(e.g. non-pelleted feed such as coarsely ground meal) increases the consistency of the stomach content, 
and thereby allows a prolonged gastric acidification. This decreases the number of Salmonellae 
entering the intestines more than is the case with small particle feed (e.g. pelleted feed and finely 
ground meal), that passes the stomach relatively rapid. Moreover, in coarse diets, less starch is 
accessible to the duodenal enzymatic digestion, rendering more unabsorbed starch and fibre towards 
the large intestine. This way, more bacterial degradation of starch is possible in this area, with 
consequently a higher production of fatty acids. These acids decrease Salmonella invasion in the 
intestinal epithelium (Boyen et al., 2008b) and promote epithelial growth (Mikkelsen et al., 2004). Hedemann 
et al. (2005) concluded in addition, that pigs fed pelleted diets secrete more mucins in the small 
intestinal area, which favour the binding and colonization of Salmonella. 
When comparing studies which evaluated wet to dry feeding systems, a general conclusion is less 
evident. Various studies have shown a bacteriological or serological reducing effect on Salmonella, 
when liquid feed is administered in comparison with dry feed (van der Wolf et al., 1999, 2001a,b; Kranker et 
al., 2001; Lo Fo Wong et al., 2004a; Nollet et al., 2004; Farzan et al., 2006; Hautekiet et al., 2008; Hotes et al., 2010; 
Twomey et al., 2010; EFSA, 2011). This might be explained by the natural fermentation process in liquid 
feed, which lowers the pH, inhibiting or reducing the numbers of Salmonella bacteria. Likely, the same 
principle is applicable to a greater extent when administering ‘fermented liquid feed’ (FLF). To 
produce FLF, acidified or fermented by-products (e.g. whey or products containing lactic acid bacteria) 
are added to the liquid feed, which allow it to ferment under controlled conditions, reducing the pH 
level more intensely than liquid feed alone (van der Wolf et al., 2001c; Lo Fo Wong et al., 2004a). In contrast, 
some authors have reported no significant differences between liquid and dry feeding practices (Van 
Winsen et al., 2002), which might be caused by the hygienic risk when using trough feeding, as 
Salmonella bacteria from faecal contamination are able to multiply several hours in this moist 
environment (van der Wolf et al., 1999). 
 
5.2.3 Feed supplementations 
Although some studies in pigs have reported a reduced Salmonella shedding after antimicrobial 
treatment (Ebner and Mathew, 2000; Gebreyes et al., 2006), most studies have concluded the opposite, namely 
no (Rajić et al., 2007) or even an increased risk of Salmonella transmission in pigs when preventive group 
level antibiotic treatment is applied (Leontides et al., 2003; Beloeil et al., 2007; Funk et al., 2007). Wilhelm et al. 
(2012) concluded from their meta-analysis that in-feed medication with tetracyclines implies a 
significant hazard for Salmonella shedding. Most probably an antimicrobial selection pressure is 
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involved in such evaluated pig populations, causing a competitive advantage for less susceptible 
Salmonellae. In addition, a disruption of the normal microbial flora may have occurred in concert with 
the previous effect, which allows an increased Salmonella colonization of the gastrointestinal tract and 
associated tissues (Funk et al., 2007). 
Anyhow, because of the emerging antimicrobial resistance worldwide and the consequent public 
health threat, the use of in-feed antibiotics has been restricted in many countries. Any prophylactic 
antimicrobial use ‒ other than in very limited, clearly defined situations like atrophic rhinitis ‒ should 
be actively discouraged (Callens et al., 2012). 
In contrast, the majority of studies evaluating feed supplementation with organic acids describe a 
reduction of the Salmonella prevalence (O’Connor et al., 2008; Wilhelm et al., 2012). The effect of organic 
acids relies on dual mechanisms in reducing Salmonella contamination. First, they decrease the pH of 
the surrounding medium, and second, they have bactericidal effects when the acid is in its non-
dissociated form. In that form, they can penetrate the bacterial cell and dissociate intracellularly, which 
lowers the cytoplasmic pH and consequently disrupts DNA synthesis (Kirchgessner et al., 1992). In 
addition, both mechanisms act synergistically, as a decreased pH implies a shift of dissociated acids to 
the non-dissociated form, which consequently intensifies the bactericidal effect (van der Wolf et al., 2001b). 
However, these effects are highly variable, depending on the type of acid used. Short-chain fatty 
acids (like formic, lactic, sorbic, propionic and butyric acid) and medium-chain fatty acids (like 
fumaric, caprylic and caproic acid) have shown to decrease virulence gene expression and invasion of 
porcine intestinal epithelial cells by Salmonella Typhimurium (Boyen et al., 2008b; Messens et al., 2010). 
Formic and lactic acid for instance, have a stronger innate bactericidal effect on Salmonella than 
fumaric acid. Propionic and sorbic acid are also active against fungi and yeasts. Coating of fatty acids 
can result in an additional protection of the acids from metabolization by the gut microbiota, and allows 
them to reach the colonization sites (ileum, caecum and colon) in their active form (Van Immerseel et al., 
2005; Boyen et al., 2008b; Messens et al., 2010). Besides this product-specific influence, also differences in the 
dosage, the age of the pigs, the treatment period, the management and Salmonella status of herds are 
responsible for the variable effect of organic acid treatments. Due to the many variations in these 
characteristics, previous studies showed both reducing (Papenbrock et al., 2005; van der Heijden et al., 2006; 
Creus et al., 2007; Taube et al., 2009; Tanaka et al., 2010) and non-reducing (Martín-Peláez et al., 2010; Walsh et al., 
2012) effects on Salmonella excretion or antibody induction. Wilhelm et al. (2012) confirmed that these 
variable effects of acid-inclusion indeed suggest a context-sensitive treatment response. Therefore 
general recommendations are difficult to make, and pig producers should evaluate these tools in their 
own farm situation. To aid pig producers in doing so, companies should provide science-based proof of 
their products’ efficacy. 
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Another possible feed treatment is the supplementation of pro- or prebiotics. The main effects of 
these feed additives are the improved resistance of the animals against colonization with pathogenic 
bacteria and enhanced host mucosal immunity. This may result in a reduced pathogen load, an 
improved health status of the animals and a reduced risk of food-borne pathogens in foods, including 
Salmonella (Gaggìa et al., 2010). 
Probiotics comprise all live-microorganisms which improve the hosts’ health when administered as 
a feed supplement in adequate amounts (FAO/WHO, 2001). The probiotics currently approved for pigs in 
the EU, include Lactobacillus spp., Bacillus spp., Lactococcus spp., bifidobacteria spp., Pediococcus 
spp., Enterococcus spp. and Saccharomyces spp. (European Commission, 2012). The Lactobacilli for 
instance, producing lactic acid, have shown reducing effects in Salmonella Typhimurium-infected pigs 
(Casey et al., 2007). Most studies have reported beneficial effects on the gut microbiota in pigs, although 
some authors observed an alleviation of diarrhoea, according to the review of Gaggìa et al. (2010). 
These inconsistent results, together with the many screening and selection procedures necessary to 
classify a probiotic (Friendship et al., 2009), make these products ‒ although promising ‒ a challenge to 
implement in a cost-effective way. 
Competitive exclusion products can also contain various beneficial bacterial species, but in 
contrast with probiotics, these cultures are not added to the feed. They are in addition derived from 
caecal contents, and thus indigenous to a particular animal species. With this oral inoculation strategy, 
enteric pathogens are excluded from the intestinal tract by preferentially colonizing it with commensal 
or beneficial bacteria, hereby facilitating the natural establishment of a healthy gut microflora in young 
animals (Anderson et al., 1999). Several Salmonella challenge experiments have demonstrated a reduced 
shedding rate (Genovese 2003) or invasion of gut tissues (Fedorka-Cray et al., 1999; Nisbet, 2002; Genovese et al., 
2003) after treating suckling piglets with competitive exclusion cultures. 
Prebiotics are non-digestible feed ingredients that selectively stimulate the growth and/or activity of 
certain beneficial bacteria in the colon, and thus these ingredients indirectly improve host health as well 
(Gibson et al., 2005). Another potentially beneficial mechanism of prebiotics is the prevention of bacterial 
adherence to the gut epithelium (Roberts et al., 2013). Prebiotics include mainly medium- to long-chain 
carbohydrates (i.e. polysaccharides such as cellulose and starch), but also short-chain carbohydrates 
(i.e. oligosaccharides, like maltose, lactose and sucrose), proteins, peptides and certain lipids. As with 
probiotics, contradictory results were obtained (Gaggìa et al., 2010). Although several human intervention 
studies on prebiotic consumption have already demonstrated a reduced epithelial adhesion of intestinal 
pathogens such as Salmonella (Roberfroid et al., 2010; Roberts et al., 2013), prebiotics have not been studied 
intensively for the control of Salmonella in pigs. 
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The restriction on in-feed antibiotics has also fueled the interest in a group of plant-derived 
products, known as botanicals, phytobiotics or phytogenetics (Windisch et al., 2008). These feed-additives 
include herbs, spices, essential oils, and oleoresins. Apart from having antioxidative effects (Jimenez-
Alvarez et al., 2008), enhancing palatability (Janz et al., 2007), improving gut functions (Platel et al., 2004), or 
promoting growth (Windisch et al., 2008), some products have demonstrated in vitro efficacy against 
certain intestinal pathogens (Cowan, 1999; Jugl-Chizzola et al., 2005; Ruiz et al., 2010). However, the potential 
in vivo benefits of phytogenics have not been fully substantiated in pigs, and studies which evaluate the 
applicability as a Salmonella control measure are currently lacking. 
Other, less well-known supplementations with less consistent results are chlorate salts, egg proteins 
and bacteriophages. The effect of chlorate salt administration is based on the respiratory nitrate 
reductase activity in Enterobacteriaceae (e.g. Salmonella spp.), which catalyzes the intracellular 
reduction of chlorate to cytotoxic chlorite (Burkey et al., 2004). As most beneficial anaerobic bacteria lack 
respiratory nitrate reductase, this treatment should theoretically not harm the gut flora (Friendship et al., 
2009). In pigs, generally intestinal reductions in Salmonella counts have been reported after sodium 
chlorate supplementation (Anderson et al., 2001; Burkey et al., 2004; Patchanee et al., 2007), although the effect 
varied between different formulations and treated age-groups. Nevertheless, the use of chlorate is 
currently not allowed in the EU (European Commission, 2012). 
Experiments have indicated that egg yolk inclusion in the feed reduced Salmonella colonization in 
poultry (Kassaify and Mine, 2004; Chalghoumi et al., 2009), which was attributed to the anti-adhesive granules 
and high-density lipoproteins in the egg yolk (Kassaify et al., 2005). In weaned piglets, Letellier et al. 
(2000) and Mathew et al. (2009) could not demonstrate an effect on Salmonella shedding after 
administrating Salmonella-immunized egg yolk powder, but more in-depth research in this matter is 
currently lacking. 
Virulent bacteriophages are natural predators of their bacterial hosts, present in the gut of food 
animals, and they complete their lifecycle by lysis of the infected bacterium (Górski and Weber-Dabrowska, 
2005). These bacteriophages are currently investigated as a potential intervention strategy against 
Salmonella in swine, and results seem promising (Callaway et al., 2011), especially when using phage 
cocktails to avoid the development of resistance in host cells (Wall et al., 2010). Recently, American 
authorities have approved a commercial bacteriophage-containing product as a ‘Generally Recognized 
As Safe’ (GRAS) food processing aid against Salmonella (SALMONELEX®, Micreos). Industrial scale 
projects in poultry are currently ongoing with this promising product, but the effect in pig industry 
remains to be investigated as well. 
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5.3 Drinking water supplementations 
Supplementing the drinking water of pigs with e.g. organic acids or chlorate, has the advantage over 
feed supplementation that animals can be treated in a more flexible way and that they can be treated 
until the moment they leave the farm to be transported to the slaughterhouse. In most cases, feed 
withdrawal is applied 12 - 18h pre-slaughter, whereas Salmonella infection and excretion often 
increases prior to loading and during transport, due to stress (Loynachan et al., 2004; Wales et al., 2010). 
Mostly, investigations of organic acids or chlorate supplementations are reported for this drinking 
water administration. 
Most of the characteristics of organic acids when supplemented in the feed, are also applicable 
when used in drinking water. The aimed pH decrease of the drinking water after supplementation 
depends on the innate pH and the buffering capacity of the water and the volume and form of organic 
acid administered. Hard, alkaline water needs to be supplemented with more acid than soft water to 
reach the same pH. Logically, a larger volume of acid obtains a lower pH of the drinking water, but 
when using organic acids with a low pKa value (e.g. formic, acetic and lactic acid), a smaller volume is 
required to reach a certain decrease in pH. Also the form of the administered acid is important, as the 
necessary bactericidal volume of certain acids cannot be added, due to a decreased pH level of the 
drinking water beyond palatability (i.e. a pH below 3.5 for pigs). Buffering these acids into a salt form 
(e.g. ammonium formate instead of formic acid) should allow the administration of more acid while 
reaching the same pH (van der Wolf et al., 2001b). 
All these characteristics may explain the high variation in results between studies which investigated 
the efficacy of organic acid supplementation of the drinking water. Some studies showed beneficial 
effects on Salmonella seroprevalence (van der Wolf et al., 2001b; van der Heijden et al., 2006), whereas others 
could not show any improvements on seroprevalence (Hansen et al., 1999) or lymph node colonization 
(Letellier et al., 2000; De Busser et al., 2009). For assessing the efficacy of supplementation, it is therefore 
important to apply a correct acid mixture and dosage, and to monitor closely the pH level during 
treatment. 
Apart from the efficacy, also some technical issues should be considered. First, acid-induced 
corrosion may occur. This problem can be alleviated by using buffered acids which are less corrosive, 
and by installing pipeline systems of PVC or stainless steel. Second, growth of fungi may be enhanced 
and may lead to the clogging of pipes and nipple drinkers. This problem can be (partly) prevented by 
adding propionic/sorbic acid, or copper/zinc to the water, and by cleaning the pipeline system 
thoroughly between batches (van der Wolf et al., 2001b). Consequently, a number of practical conditions 
(required pH of the drinking water, right acid volume, proper equipment) need to be fulfilled for a 
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successful supplementation. In chapter 4, these dose-related and practical conditions are discussed 
more detailed. 
Several experimental studies with supplementation of chlorate salts in drinking water for pigs 
(Anderson et al., 2004) and poultry (McReynolds et al., 2005; Byrd et al., 2008) have shown beneficial effects as 
well. Anderson et al. (2004) showed a significant reduction of Salmonella Typhimurium in the caecum 
of weaned pigs, but the results were not satisfactory in finisher pigs. 
 
5.4 Vaccination 
Any invading pathogen like Salmonella, is firstly attacked by the innate immune system. Initially 
‘sentinel cells’ like antigen presenting cells (APC), recognize pathogen-associated molecular patterns 
(PAMPs) on invading microorganisms. Thereafter, they produce several inflammatory cytokines for the 
chemo-attraction of phagocytic cells, which in turn eliminate the pathogen (Mastroeni et al., 2001; Tizard, 
2009). As this innate immunity lacks memory capacity, it cannot ensure resistance against re-infection 
(Dougan et al., 2011). For this, the activation of the acquired immune system is necessary, in which mainly 
T- and B-lymphocytes and their products are involved. These lymphocytes are responsible for the so-
called ‘cell-mediated’ immune response. This response is basically oriented towards intracellular 
pathogens, whereas immunoglobulins or antibodies from the B-cells mainly support the destruction of 
extracellular invaders and participate in the ‘humoral’ immune response (Tizard, 2009). 
Since Salmonella is a facultative intracellular bacterium, both cell-mediated and humoral immune 
responses are essential for protection. Although cell-mediated immunity is generally accepted to be 
more effective against facultative intracellular bacteria (Robertsson et al., 1983; Haesebrouck et al., 2004), also 
antibodies and a mucosal immune response are important for protection during the typical intestinal 
colonization and the extracellular phases of the Salmonella infection (Dougan et al., 2011; Griffin and 
McSorley, 2011; Arguello et al., 2013). 
Vaccination or immunization is defined as the administration of immunogenic substances to 
stimulate the acquired or adaptive immunity against a specific pathogen. Various vaccination strategies 
for inducing adaptive immunity against Salmonella infections will be described hereafter. For this, an 
active or passive pathway can be used, with or without certain ‘DIVA’ capacities (‘Differentiation 
between Infected and Vaccinated Animals’). 
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5.4.1 Active immunization 
Active immunisation against Salmonella in pigs can be achieved by using: i) inactivated vaccines, 
such as whole killed bacteria (bacterins) and bacterial components (subunit vaccines); and ii) 
attenuated, live bacteria. 
 
Inactivated vaccines: bacterins and subunit vaccines 
Bacterins consist of whole bacteria that have been inactivated by heat, formaldehyde or genetic 
manipulation, so that replication is blocked while antigenic particles such as lipopolysaccharides (LPS), 
flagellae or fimbriae, are still present. Upon immunisation, these particles induce some degree of T-cell 
response (Mastroeni et al., 2001), and stimulate B-cells to migrate and produce antibodies (Pape et al., 1997). 
The formalin-inactivated parenteral Salmonella Typhimurium bacterin of Farzan and Friendship 
(2010), applied to piglets at weaning, resulted in a decreased shedding of Salmonella Typhimurium 
during the fattening period. Another formaldehyde-inactivated Salmonella Typhimurium vaccine 
(DT104), administered to pigs at the beginning of the fattening period, also reduced Salmonella 
shedding and transmission during the fattening period, as well as at slaughter (Arguello et al., 2013). An 
inexpensive alternative to heat or chemically inactivated bacteria was investigated by Szostak et al. 
(1996). They constructed a bacterial ‘ghost’ of Salmonella Typhimurium via ‘E-mediated lysis’: the 
gene ‘E’ was inserted into the bacterial DNA, which encodes for a transmembrane tunnel structure in 
the cell envelope, releasing the cytoplasmatic content from the cell. In contrast with the previous 
inactivation techniques, this ‘ghost’ construction results in an intact envelope, and thus in an improved 
antigen presentation. Specific humoral and cellular immune responses against these bacterial 
components were demonstrated in mice, which significantly prolonged survival after challenge with a 
virulent Salmonella Typhimurium strain. The same ‘E’ gene was targeted by Jawal and Lee (2013), but 
without using an antibiotic resistance gene marker during construction, and thus a biosafety enhanced 
Salmonella ghost vaccine was developed. 
Subunit vaccines consist of purified bacterial components such as capsular antigens, proteins or 
exotoxins, which are presented to the immune system without introducing actual virulent particles. 
These vaccines however, often elicit weaker antibody responses than bacterins or live vaccines (Meeusen 
et al., 2007). 
The Vi capsular polysaccharide vaccine (ViCPS) against human typhoidal salmonellosis for example, 
has surely proven its efficacy, but offers only significant protection in the first two years after 
administration (Fraser et al., 2007). The vaccine of Carnell et al. (2007), based on Salmonella 
Typhimurium type III secreted proteins, reduced faecal shedding and disease severity in pigs, although 
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it did not confer long-term protection. Exotoxins are produced within the bacterial cytoplasm and are 
mostly proteins with a high molecular mass and have therefore good antigen capacities. Vaccines may 
contain the inactivated toxin or its antigenic derivative, providing a variable protection level 
(Haesebrouck et al., 2004). Rahman and Sharma (1995) found that formalin-treated enterotoxins of 
different Salmonella serotypes induced antibodies that neutralized the enterotoxic activity of crude 
enterotoxins. Also Chopra et al. (1999) showed enterotoxic and cytotoxic activities of the Salmonella 
enterotoxin from the Salmonella Typhimurium strain they examined, suggesting its role in acute 
gastroenteritis due to Salmonella. In contrast, Nakano et al. (2012) reported no association between the 
enterotoxin of Salmonella and its virulence. They demonstrated that the Salmonella enterotoxin 
regulates the localisation and levels of outer membrane protein A (OmpA) in Salmonella, and that it is 
involved therefore, in the maintenance of membrane integrity. As OmpA is one of the major 
immunogenic proteins, these authors concluded that the Salmonella enterotoxin might play an 
important role in the induction of Salmonella immune responses. 
The abovementioned sub-optimal capacity of inactivated vaccines to evoke immune responses, can 
be improved by the addition of an adjuvant (indicated by its latin origin ‘adjuvare’). This adjuvant 
presents the antigen in such a way to APCs that, depending from the adjuvant product, the humoral or 
cell-mediated immunogenicity is enhanced, in comparison with the presentation of the simple aqueous 
antigen. Consequently, this results in a reduction of the necessary antigen dose in the vaccine (Aguilar 
and Rodriguez, 2007). Adjuvanticity can be obtained by many products, e.g. mineral salts, tensoactive 
compounds, bacterial DNA, emulsions, liposomes, nano-beads, virus-like particles, cytokines, 
polysaccharides (Aguilar and Rodriguez, 2007). Freund’s incomplete adjuvant (FIA), an emulsion of 
mineral oil and water enabling a slow release of antigen from the injection site, is probably the most 
well-known adjuvant in both human (Petrovsky and Aguilar, 2004) and veterinary (Stabel et al., 1991 (nursery 
piglets); Miyamoto et al., 1999 (laying hens)) vaccines. 
 
Attenuated vaccines 
Attenuated Salmonella vaccines contain live bacteria with very low virulence, which are able to 
replicate only locally or very slowly. These vaccines are generally considered superior to inactivated 
Salmonella vaccines, probably due to: i) their ability to induce a more pronounced cell-mediated 
immune response and the induction of mucosal IgA production (Robertsson et al., 1983; Haesebrouck et al., 
2004; Meeusen et al., 2007); ii) their reproducing capacity beyond the initial vaccination, so that less boost 
immunizations are required or even single-dose protocols are possible; iii) the possibility of oral 
administration; iv) the low production cost and easy storage; and (v) the possible use as antigen carriers 
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for recombinant vaccines (Mastroeni et al., 2001). The attenuation of live vaccines can be acquired by 
several methods, as explained hereafter. 
Traditional attenuation methods are empirical and involve the passage of bacteria into different 
cultures, chemical treatments or at suboptimal temperatures, allowing selection of less virulent strains 
without actually characterising the attenuation (Meeusen et al., 2007; Tizard, 2009). Foster et al. (2003) 
constructed this way an avirulent rough mutant of Salmonella Infantis, which provided in piglets a 
rapid protection against disease and a reduced tissue invasion after Salmonella challenge. 
A second method is the manipulation or deletion of genes that are important for the bacterial 
metabolism (e.g. auxotrophic mutant strains) or for global regulating functions (Boyen et al., 2008a). 
Auxotrophic Salmonella mutants require certain metabolites that are unavailable in mammalian 
tissues and have therefore a reduced ability to grow in vivo. Lumsden and Wilkie (1992), Barrow et al. 
(2001), and Trebichavsky et al. (2006) all investigated auxotrophic aromatic-dependent (aroA) mutant 
strains of Salmonella Typhiumurium in piglets. Lumsden and Wilkie (1992) demonstrated a significant 
reduced disease severity and faecal shedding in weaned piglets after Salmonella challenge at one week 
post-vaccination, whereas Trebichavsky et al. (2006) could not establish any protection after their 
vaccination. In the latter study however, suckling piglets were vaccinated and then challenged already 
24h later. Barrow et al. (2001) emphasised the need for adequate control of potential aroA vaccines, as 
their aroA mutant strains possessed some residual virulence in piglets. Other auxotrophic mutant 
strains tested in pigs, gained more success in reducing Salmonella infection: Springer et al. (2001), 
Lindner et al. (2007), Rösler et al. (2010) evaluated the same histidine-adenine auxotrophic mutant 
Salmonella Typhimurium strain (Salmoporc®, IDT Biologika). These authors have shown that the 
Salmoporc
®
 vaccine may decrease both Salmonella colonization of intestinal mucosae and tissues and 
the shedding of Salmonella bacteria. Based on its auxotrophic feature, this vaccine can be distinguished 
from Salmonella field strains using a biochemical Salmonella Diagnostic Kit (Lindner et al., 2007; www.idt-
biologika.de). This differentiation can also be achieved by molecular typing methods (Lindner et al., 2002). 
Several mutations in global regulator genes have been explored in pig studies as well. Foss et al. 
(2013) used a mutant Salmonella Typhimurium strain ‘Δcrp’, lacking the cyclic AMP receptor protein 
gene, and proved that vaccines provide better efficacy in pigs that are challenged with a serogroup-
matching Salmonella strain. A serovar-match between vaccine and challenge strain had less impact, as 
a significant reduction of Salmonella shedding was still obtained without a match. A mutant strain of 
Salmonella Typhimurium, unable to synthesize the zinc transporter ZnuABC ‘ΔznuABC’, prevented 
clinical symptoms and decreased faecal shedding in Salmonella-challenged fattening pigs in the study 
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of Gradassi et al. (2013). Similar beneficial results were observed by Roesler et al. (2004), who 
investigated a mutant gyrA-cpxA-rpoB of Salmonella Typhimurium in piglets. 
Finally, also targeted deletions in virulence genes can be performed, which have the major 
advantage that the resulting vaccine strains are very unlikely to reverse into the wild-type strain 
(Haesebrouck et al., 2004). Clinical signs were prevented and no Salmonella was isolated from faeces of 
piglets vaccinated with the ΔcpxR-Δlon strain developed by Hur et al. (2011). A deletion of the poxA 
gene (encoding for a certain aminoacyl-tRNA synthetase) in Salmonella Typhimurium significantly 
diminished fever, reduced faecal shedding of Salmonella, and decreased Salmonella colonization of the 
tonsils in piglets (Bearson et al., 2011), indicating that this deletion exerts selective effects on stress 
survival and colonization capacities. 
Notwithstanding all abovementioned experimental advances in the development of bacterial live 
vaccine candidates, only one vaccine against Salmonella Typhimurium is currently commercialized in 
the European Union (i.e. the Salmoporc
®
 vaccine described above). Indeed, the construction of 
bacterial live vaccines is both difficult and expensive, and for licensing these vaccines at the European 
Medicines Agency (EMA), proof of the absence of zoonotic hazards must be provided. This strict 
licensing procedure is a very time-consuming process, as the guidelines demand well-defined and 
irreversible mutations, requiring extensive experimental testing (Sheridanand and Coughlin, 2010). 
 
5.4.2 Passive immunization 
Passive immunization implies the transfer of antibodies from a donor animal to a receptor animal, in 
order to confer immediate protection to the latter susceptible animal (Tizard, 2009). Obviously, this 
requires first an active immunization of the donor animal. Some methods of passive immunization 
against Salmonella are available so far. However, not all of them are efficacious. 
Vaccination of pregnant sows appears to be the most promising method to decrease slaughter pig 
prevalence of Salmonella (Hotes et al., 2011; Wales et al., 2011), and is even considered more effective than 
vaccinating suckling piglets by Ojha and Kostrzynska (2007). Maternal seropositivity to Salmonella 
protects piglets from excretion in the postweaning stage (Kranker et al., 2003; Nollet et al., 2003), and the 
theory behind this is plural. Vaccinating pregnant sows may result in i) a colostral or lactogenic transfer 
of antibodies and lymphocytes to piglets, which act locally in the piglets intestine and compensate to 
some extent for their immature intestinal immune system (Bailey and Haverson, 2006); and ii) a decreased 
excretion by these sows, and consequently in a diminished infection of their offspring (Roesler et al., 
2006). 
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Several vaccination trials in sows led to the previous assumptions. Roesler et al. (2006) for instance, 
vaccinated pregnant sows antepartum in a Salmonella Typhimurium positive herd, using an inactivated 
herd-specific Salmonella Typhimurium vaccine. This resulted in a reduction of Salmonella excretion in 
these sows, and an elimination of excretion and colonization of Salmonella in their piglets. In addition, 
these piglets showed a significantly decreased IgA and IgG antibody level. Both findings indicated a 
lower Salmonella prevalence in the offspring of the vaccinated sows. A larger and longer study than the 
previous one was performed by Lindner et al. (2007), who combined passive and active immunization 
on a subclinically infected herd, by vaccinating both the sows and their offspring with a live-attenuated 
Salmonella Typhimurium vaccine (Salmoporc
®
). At slaughter age, the vaccinated pigs showed a 
significantly reduced lymph node colonization and seropositivity level. However, the control group was 
not monitored concurrently with the vaccinated group (historic control). Another attenuated Salmonella 
Typhimurium vaccine (ΔcpxR-Δlon), was administered orally to pregnant sows by Hur and Lee (2010). 
Colostral and serum IgA and IgG levels in the vaccinated sows and their piglets, respectively, were 
significantly increased as compared to the unvaccinated animals. In addition, no Salmonella was 
isolated from faecal samples of vaccinated piglets, in contrast with several unvaccinated piglets. When 
investigating the same vaccine strain by immunization of both the sows and their offspring (Hur et al., 
2011), similar results were observed as in the previous trial. Recently, Matiasovic et al. (2013) 
demonstrated that vaccination of pregnant sows with an inactivated experimental Salmonella 
Typhimurium vaccine resulted in lower counts of a homologous Salmonella Typhimurium in the ileal 
and caecal mucosa of orally infected piglets. 
Another possibility for applying passive immunization is the oral administration of egg yolk 
containing Salmonella-specific antibodies derived from Salmonella-challenged laying hens, which was 
successfully explored in experiments with poultry (Kassaify and Mine, 2004; Chalghoumi et al., 2009). When 
feeding pigs with egg yolk however, both Lettelier et al. (2000) and Mathew et al. (2009) could not 
demonstrate such a protective effect on Salmonella shedding. Lettelier et al. (2000) suggested that this 
might be due to an alteration of the egg antibodies by the pigs’ digestive tract, which may fail to 
recognize Salmonella bacteria before they penetrate the intestinal epithelium. 
 
5.4.3 DIVA vaccines 
A major disadvantage of vaccination is its interference with many current national Salmonella 
surveillance programmes, which rely on serology for the classification of herds according to their 
Salmonella risk (high, medium or low level of antibodies). In order to overcome this problem, several 
potential Salmonella ‘DIVA’ vaccines and their accompanying diagnostic tests have been developed, 
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which claim to allow a ‘Differentiation between Infected and Vaccinated Animals’(van Oirschot, 1999). 
For several microorganisms, the DIVA strategy is applicable to both attenuated and inactivated 
vaccines (Pasick, 2004; Meeusen et al., 2007). In Salmonella-related research however, only few, live-
attenuated DIVA strains in pigs have been constructed. 
Selke et al. (2007) selected the outer membrane porine D (OmpD) as a putative suitable marker 
protein to construct a DIVA vaccine. They removed the OmpD gene from the DNA of a licensed live 
Salmonella Typhimurium vaccine (Salmoporc
®
), and immunized weaned piglets with this 
‘SalmoporcΔompD’ strain before challenging them with a Salmonella Typhimurium DT104 isolate. 
Clinical disease and colonization of lymph nodes and intestinal mucosae were significantly reduced in 
the SalmoporcΔompD-vaccinated piglets. Additionally, a differentiation of the infected unvaccinated 
and vaccinated animals was possible using an OmpD-based ELISA, which cannot detect antibodies 
directed against the SalmoporcΔompD-strain. The fact that this vaccine candidate is based on a licensed 
parent strain, should facilitate the realization of future field studies and subsequent licensing 
procedures. However, two important drawbacks can be noticed. Firstly, Selke et al. (2007) found in 
their piglet experiment that the reduction of colonization was 10-fold lower upon vaccination with the 
SalmoporcΔompD strain than with the Salmoporc® parent strain. This might be explained by the 
importance of the OmpD protein in mediating protective antibody response (Gil-Cruz et al., 2009). 
Secondly, the ELISAs used in most European Salmonella serosurveillance programmes are based on 
the detection of antibodies against the lipopolysaccharides (LPS) of Salmonella spp. (Cortiñas et al., 2009), 
since these outer membrane components are a major virulence factor of Salmonella enterica. Therefore, 
this DIVA vaccine is not directly broadly applicable as it necessitates a specific OmpD-based ELISA 
for differentiation. 
Kong et al. (2011) investigated the deletion of LPS-synthesising genes, and found that a complete 
truncation of the LPS chain (ΔrfaG) is not a valuable option for developing an efficient live oral 
Salmonella Typhimurium vaccine. When one O-antigen unit (ΔrfaJ) was retained however, the authors 
did find an adequate stimulation of protective immunity after vaccination. 
The same conclusion was drawn in the paper of Leyman et al. (2011), in which a ΔrfaJ Salmonella 
Typhimurium strain significantly protected mice against a subsequent infection with a virulent 
Salmonella Typhimurium strain. In piglets, the experimental vaccine induced a serological response 
that lacked detectable antibodies against LPS, but the effect on Salmonella excretion was not evaluated. 
With this vaccine, a differentiation of infected and vaccinated pigs was thus possible in the broadly-
used LPS-based ELISA, without reducing the strain’s protective capacities in mice. 
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5.4.4 Conclusions 
Overall, the available evidence from Salmonella vaccination studies suggests that Salmonella 
vaccines are associated with reduced Salmonella prevalence in swine. However, several arguments can 
be given why further research is necessary. Many studies were based on a limited number of animals 
and on a wide variety of target populations, sample sizes, types of vaccines, doses and dosing regiments 
(Denagamage et al., 2007). Also, no complete protection was obtained (Friendship et al., 2009; Wales et al., 2011), 
and the effect estimates in a meta-analysis study appeared very variable, which suggests a context-
sensitive vaccination response and potential confounders (Wilhelm et al., 2012). 
Therefore, in further research it is necessary to conduct transmission studies and large-scale trials to 
assess the effects of Salmonella vaccination under field conditions and to enable well-founded 
decisions concerning the potential use of vaccination in Salmonella control programmes. 
 
5.5 Salmonella monitoring and control programmes 
As pointed out in previous sections, it is of paramount importance to protect human health against 
Salmonella and other pathogens that are (in)directly transmissible between animals and humans. 
Therefore, the European Parliament published eleven years ago the Directive 2003/99/EC and 
Regulation (EC) No 2160/2003 for its Member States (MS), in order to set up targets for the 
monitoring and control of Salmonella and other food-borne zoonotic agents, respectively (Anonymous, 
2003a,b). 
When analysing the Salmonella policies in all 28 MS, 19 were applying an official Salmonella 
monitoring programme in 2010 (i.a. BE, DE, DK, NL), and nine were not (i.a. FR, UK) (Alban et al., 
2002; Anonymous, 2007b; Merle et al., 2011; EFSA and ECDC, 2012a; Anonymous, 2013a,b). The Salmonella 
approach of Belgium and its five neighbouring MS (DK, DE, FR, UK, NL), belonging to both groups, 
is described below. 
In Belgium, the Federal Agency for the Safety of the Food Chain (FASFC) implemented a national 
Salmonella Action Plan (SAP) in 2005, for farms with more than 30 fattening pigs. A herd evaluation 
was established based on the presence of Salmonella-specific antibodies in blood samples collected 
within the framework of the Aujeszky’s disease control programme (Anonymous, 1999). This serological 
examination is performed every four months, on 10-12 blood samples from randomly selected pigs of 
different weight categories (serological details are to be found in paragraph 4.2). If the resulting mean 
sample-to-positive (S/P) ratio exceeds 0.6 (=OD 24%) during three consecutive sampling occasions, 
the concerning herd is designated a ‘risk herd’ (Laevens and Mintiens, 2005). The SAP became compulsory 
in 2007 (Anonymous, 2007b). As from that moment, the ‘risk herds’ must allow a bacteriological 
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examination of pooled faecal samples from at least four different age groups. They must additionally 
complete a checklist and implement a Herd-specific Salmonella Action Plan (HSAP) together with the 
herd veterinarian, to detect and reduce present risk factors for Salmonella infection. Until now, no 
penalty consequences were attached to the result of the bacteriological examination. In case these ‘risk 
herds’ show again a mean S/P ratio above 0.6 in 3 consecutive sample events, they are mandatory 
visited by a veterinarian of Animal Health Care organisations (DGZ-ARSIA). In addition, since 2008, 
all farmers producing slaughter pigs have to report the herd health status, including their Salmonella 
risk herd designation, to the slaughterhouse 24h before arrival of the batch of slaughter pigs. This 
‘Food Chain Information’ (FCI) document allows the slaughterhouse staff to apply a logistic slaughter 
procedure and/or to take other preventive measures against contamination. The slaughterhouses in their 
turn, must sample five randomly selected carcasses once a week (i.e. a carcass sponge, taken between 
two and four hours after slaughter for bacteriological analysis) for auto-control reasons and as part of 
the Hazard Analysis and Critical Control Points (HACCP) (Anonymous, 2007d). In case 5/50 samples or 
more are Salmonella-positive, the slaughter hygiene and process control must be improved. 
Since the implementation of the HSAP in 2007 however, the Salmonella seroprevalence of the 
Belgian pig population has not significantly decreased (Méroc et al., 2012). Therefore, the sampling 
scheme and classification criteria of the current HSAP are currently under revision. Likely, the 
programme will shift from serological towards bacteriological monitoring, for which several reasons 
can be given. Firstly, the serological monitoring for Aujeszky’s disease has recently been reduced to 
one blood sampling per herd per year. Secondly, there is generally a moderate to low correlation 
between serology and bacteriology, as discussed above (Nielsen et al., 1995; Davies et al., 2003; Laevens and 
Mintiens, 2005; Nollet et al., 2005; Farzan et al., 2007; Belsué et al., 2011; Rostagno et al., 2012b). Finally, only 
bacteriological examination allows a determination of the present serovars and antimicrobial resistance. 
The Scientific Committee of the FASFC has proposed several scenarios for adapting the monitoring of 
the present SAP (Anonymous, 2012): 
i) bacteriological examination of pooled faecal samples at the farm, with a focus on breeding herds; 
ii) examination of intestinal contents or ileocaecal lymph nodes at the slaughterhouse, with feedback to 
the herds; 
iii) concurrent examination of ileocaecal lymph nodes and carcasses at the slaughterhouse, without 
feedback to the herds; 
iv) a combination of scenarios i) and iii) to gather information at both the herd- and population-level. 
Obviously, all scenarios have their own scientific and financial (dis)advantages (Chapter 4.3), which will 
be taken into consideration until a final decision is made by the Belgian Food Agency in 2014. 
Meanwhile, all blood samples within the framework of the Aujeszky’s disease programme remain to be 
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examined for Salmonella-specific antibodies as well. This implies blood sampling once a year for most 
herds, and three times for outdoor herds and breeding herds. The FCI document must contain the mean 
S/P ratio of the last blood sampling. All other former regulations on-farm remain in force (Anonymous, 
2014). From June 2014 onwards, the slaughterhouses must in addition improve their slaughter hygiene 
and auto-control programme if more than 3/50 carcass samples turn out to be Salmonella-positive. 
Denmark already launched a national Salmonella surveillance-and-control programme in 1995 
(Mousing et al., 1997). This programme has been revised several times since then (Alban et al., 2002), and 
currently targets multiple steps in the pork production chain: the feed, herd and slaughterhouse level 
(EFSA and ECDC, 2012a). 
Firstly, Denmark’s feed surveillance implies the examination of both feed ingredients and processed 
feed. Secondly, the herd surveillance consists of a monthly serological testing of breeding herds (blood 
samples) and fattening herds (meat juice samples). With these serological results of a mix-ELISA (with 
an OD cut-off value of 20%) a ‘serological Salmonella index’ is calculated to classify the herds into 
three levels (Alban et al., 2002). This index is the weighted average of the results from the preceding three 
months, the immediate month counting three times as much as both months before (60%:20%:20%). A 
herd designated level 1 (index<40), 2 (40<index<70), or 3 (70<index) thus showed recently a low, 
moderate or unacceptably high Salmonella seroprevalence, respectively. Both penalties and rewards are 
associated with this classification. Breeding herds with an index higher than five must inform the 
purchasing herds. Level-2 and level-3 fattening herds must have faeces samples examined and face a 
reduced carcass price. Fattening pigs from level-3 herds are in addition, logistically slaughtered and 
these carcasses are subjected to specific hygienic precautions (e.g. hot water decontamination) (Alban et 
al., 2010). In contrast, level-0 fattening herds (i.e. herds with no seropositive meat juice samples during 
the last three months) need to deliver less meat juice samples. Finally, slaughterhouse surveillance is 
performed by the daily examination of carcass swabs (Baptista et al., 2010b), with the implementation of a 
strict control programme if certain levels are exceeded. 
The German Salmonella monitoring programme became operational since 2002 (Blaha, 2004) and 
nationwide compulsory since 2007 (Anonymous, 2007c). It is based upon the serological examination of 
blood samples collected at the herd (within 14 days prior to slaughter) or meat juice samples from the 
slaughterhouse; the amount of samples depending on the herd size (Gotter et al., 2012). These samples are 
analysed in the framework of the ‘Qualität und Sicherheit’ (QS) meat quality programme, via a mix-
ELISA with a cut-off value of OD 40%. The percentage of yearly positive samples (re-calculated 
quarterly) is used to classify herds into three categories: Category I (0 - 20%), II (>20 - 40%), or 
III (>40%) implies a low, medium, or high Salmonella risk (Merle et al., 2011). Category II herds need to 
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fill in a checklist to scrutinize and improve their hygienic status. Category III herds must have their 
fattening pigs logistically slaughtered and are obliged to implement on-farm intervention measures. 
When no improvement is obtained and interventions are lacking, these farmers risk financial 
consequences and an exclusion from the QS system. At slaughterhouse level, surface swabs are taken 
(EFSA and ECDC, 2012a) and a Salmonella reduction plan must be implemented. 
In France, no official Salmonella monitoring is currently present (EFSA and ECDC, 2012a; Brossé DGZ 
2014, personal communication). Several preparations to implement a programme were made in 2011, but are 
currently put on hold. These preliminary plans included the sampling of all pig herds with a capacity 
over 300 fattening pigs, and this nine times per quarter. Based on the results of every last four sampling 
occasions, the herds would be classified into three levels. Depending on the assigned level, herds would 
be encouraged to take preventive measures against Salmonella, or obliged to put sanitary measures into 
practice (such as a separated transport and slaughter) (Brossé DGZ 2014, personal communication). Yet, as 
mentioned above, these plans are not executed anno 2014. 
In 2002, the British pig industry (British Pig Executive, BPEX) introduced a voluntary Zoonoses 
Action Plan Salmonella Monitoring Scheme (ZAP) for pig herds in the United Kingdom. This ZAP 
scheme was replaced in 2008, by the Zoonoses National Control Programme for Salmonella in pigs 
(ZNCP), to focus on a whole-chain risk-based Salmonella approach (Anonymous, 2013a). Like in 
Denmark and Germany, a categorization of the pig herds in three levels is made. This programme is 
based on monthly-collected meat juice samples that are analysed by a mix-ELISA with an OD cut-off 
value of 10%. Those herds with the greatest prevalence of seropositive pigs (i.e. ZAP-2 and ZAP-3 
herds, with over 65% positive samples) must implement an action plan, guided by quarterly veterinary 
visits (Cook et al., 2003; Abrahantes et al., 2009). No true sanctions are applied, but herds with a Salmonella 
seroprevalence below 10% during the preceding year are rewarded with a Platinum Pig Award. 
Slaughterhouse surveillance is performed by the examination of five carcass swabs (sponges) per herd, 
with the frequency depending on the herd size. 
Since the national average seroprevalence in British slaughter pigs had not significantly changed 
over the previous five years (Anonymous, 2013a), the meat juice testing was suspended in 2012. As from 
2013, the ZNCP launched an on-farm Salmonella risk assessment tool to help farmers identify the most 
effective control methods for each unit, and is exploring bacteriological testing (Anonymous, 2013a). 
Since 2005, the Netherlands apply a national monitoring programme somewhat similar to Belgium, 
as 12 blood samples are to be collected every four months, from herds with over 30 fattening pigs 
(Anonymous, 2013b). However, these blood samples, analysed with an OD cut-off value of 40%, may be 
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collected both at the herd (within three weeks prior to slaughter) or at the slaughterhouse. A scoring 
system is applied with this serological outcome, assigning the herds every four months a 
score 1 (OD<20%), 2 (20%<OD<40%), or 3 (40%<OD). Consequently, the sum of the scores of the 
preceding three trimesters determines the herd’s category: category 1 (sum is 3 or 4), category 2 (sum is 
5 to7) or category 3 (sum is 8 or 9) stands for a low, moderate or high Salmonella risk, respectively 
(Anonymous, 2013b). No penalties are involved so far, unless herds do not comply with the sampling 
obligations, for which they will be reprimanded or receive a fine. Concerning the Dutch slaughterhouse 
monitoring, bacteriological samples are examined from ten pooled carcasses per two weeks or from 
five individual carcasses per day in small or large slaughterhouses, respectively (Anonymous, 2013b). 
Despite all efforts in the existing Salmonella surveillance programmes, it must be underlined that 
food safety is not a result of testing, but a result of management. Namely, pork that tested negative may 
still be contaminated and cause Salmonella outbreaks in importing EU countries with a very low 
national prevalence of Salmonella (Bruun et al., 2009). Every monitoring programme thus has an 
imperfect probability to assure the quality of a certain management. Therefore, every step in the pork 
production chain must implement proper Salmonella control measures, to aid surveillance in providing 
the consumer with a safe food product. 
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Salmonellosis remained one of the most important and widely distributed foodborne diseases in the 
European Union in the past 10 years. Since 2005, successful vaccination programmes in laying hens 
resulted in a substantial decrease in the number of human Salmonella Enteritidis infections across EU 
Member States. Therefore, a focus is put on the control of human Salmonella Typhimurium infections, 
which are mainly caused by contaminated pork. Salmonella can be introduced at many different levels 
of the pig production chain, such as the feed, the primary production, the slaughterhouse, and during 
pork processing. The primary production plays a key role in this chain, as a lower Salmonella infection 
level on-farm was associated with less carcass contamination at slaughterhouse level. Moreover, 
Salmonella infections may have an important negative impact on the weight gain of pigs. It is therefore 
important to optimize control measures at farm level. Unfortunately, given the many different risk 
factors, controlling Salmonella infections in pig herds is difficult. 
The general aim of this thesis was to provide scientific underpinned advice to improve the control of 
Salmonella infections in pigs at pre-harvest level. 
In previous challenge studies, both the supplementation of the feed or drinking water with organic 
acids and the use of vaccination showed promising, but inconsistent results in reducing Salmonella 
(sero)prevalence. The first objective of this thesis was therefore to conduct a transmission study in 
weaned piglets using a Salmonella Typhimurium challenge strain, to evaluate the effect of currently 
available organic acids and vaccination on the Salmonella spread, using bacteriological and serological 
techniques. The control measures included (1) feed with coated calcium-butyrate, (2) drinking water 
with a mixture of organic acids, and (3) vaccination with a live commercial Salmonella Typhimurium 
strain. 
As most European surveillance programmes rely on serology using commercial LPS-based ELISAs, 
which do not allow differentiation between Salmonella-specific antibodies induced by vaccination or 
by infection, vaccine use may be compromised in these countries. Thus, the second objective was to 
investigate the effect of the previously evaluated commercial vaccine when modified to a DIVA 
(Differentiation of Infected and Vaccinated Animals) vaccine strain, in a similar transmission 
experiment with piglets. In addition, to assess the effect of the concurrent use of these intervention 
measures, this DIVA vaccination was evaluated with and without the administration of in-feed coated 
calcium-butyrate. 
The third objective of this thesis was to verify the effect of one control measure used in the previous 
transmission studies under field conditions. Namely, the effect on the daily weight gain and on 
serological and bacteriological parameters was to be assessed in pigs from shortly after birth until 
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slaughter age in three Salmonella Typhimurium-positive farrow-to-finish pig herds. The commercial 
vaccine – currently not registered in Belgium – was used, as it was considered an easier and more 
practical intervention candidate to decrease the Salmonella infection pressure on-farm than the 
administration of organic acids. 
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1. Evaluation of three intervention strategies 
to reduce the transmission of Salmonella Typhimurium in pigs 
(Transmission study 1) 
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Abstract 
Despite current control measures, Salmonella in pigs remains a major public health concern. In this 
in vivo study, the effect of three intervention strategies on Salmonella Typhimurium transmission in 
pigs was evaluated. The first intervention was feed supplemented with coated calcium-butyrate 
(group A); the second comprised oral vaccination with a double-attenuated Salmonella Typhimurium 
strain (group B) and the third was acidification of drinking water with a mixture of organic acids 
(group C). After challenge at eight weeks of age, animals were individually sampled for six weeks 
study (blood once per week; faeces twice per week) and were then euthanized at 14 weeks of age. Post-
mortem ileum, caecum, ileocaecal lymph nodes, and tonsils were sampled, along with ileal, caecal and 
rectal contents, and were tested for the presence of Salmonella spp. Transmission was quantified by 
calculating an ‘adjusted’ reproduction ratio ’Ra’ and its 95% confidence interval (CI). 
The proportion of pigs that excreted Salmonella via the faeces was significantly higher in group C 
(58%, P<0.01) and the positive control group (41%, P=0.03), compared to group B (15%). The 
proportion in group C was also significantly higher than in group A (23%, P=0.01). Group A had the 
lowest proportion of positive post-mortem samples (18%), followed by group B (31%), the positive 
control group (41%) and group C (64%) (P<0.03). The highest transmission was seen in the positive 
control group and group C (Ra=+∞ with 95% CI [1.88; +∞]), followed by group B 
(Ra=2.61 [1.21; 9.45]) and A (Ra=1.76 [1.02; 9.01]). 
The results of this study suggest that vaccination and supplementation of the feed with coated 
calcium-butyrate limited Salmonella transmission and might be useful control measures. 
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Introduction 
Salmonella infection in pigs is a major concern in the European Union (EU) [Regulation (EC) 
No. 2160/2003], as in the past ten years contaminated pork has been the second most important source 
of human salmonellosis in many EU countries (Hauser et al., 2010). Infection or contamination can occur 
at many different levels of the pig production chain such as via the feed, at the primary production site, 
in the slaughterhouse, and during pork processing. Salmonella infection and/or contamination at the 
primary production site plays a key role in this chain, as positive associations have been demonstrated 
between within-herd Salmonella seroprevalence and carcass contamination (Sørensen et al., 2004; Baptista et 
al., 2010b), and reducing pre-slaughter Salmonella infections increases pork safety, i.e. fewer infected 
lymph nodes and intestinal contents (Hurd et al., 2002). 
Unfortunately, controlling Salmonella infections in pig herds is difficult. The pathogen is common, 
persists in the environment, and infections with most serovars occur without any obvious symptoms 
(Davies et al., 2004; EFSA, 2008a). Although hygiene and biosecurity on-farm are of paramount importance 
in decreasing Salmonella prevalence in slaughter pigs (Hotes et al., 2011), Salmonella-free housing cannot 
be obtained simply by cleaning and disinfection regimens at farm level (Mannion et al., 2007; McLaren et al., 
2011). Hence, such regimens should be combined with other measures as part of an overall strategy to 
control Salmonella on-farm (Wales et al., 2009). 
Several studies have evaluated the effect on Salmonella control of on-farm treatment of feed or 
water with acids (Letellier et al., 2000; van der Wolf et al., 2001b; Lo Fo Wong et al., 2004a; Farzan et al., 2006; Canibe 
et al., 2005; Creus et al., 2007; Poljak et al., 2008; De Busser et al., 2009; Taube et al., 2009; Tanaka et al., 2010). The 
results varied greatly between these studies, possibly because of the large differences in the 
acidification process and dosage used (O’Connor et al., 2008). Of these different acidification methods and 
products, the use of coated butyric acid appears promising, as it decreased Salmonella shedding 
significantly in several studies (Van Immerseel et al., 2005; Boyen et al., 2008b; Guilloteau et al., 2010). 
Another possible method of on-farm control of Salmonella infections in pigs is vaccination. In most 
studies the use of Salmonella Typhimurium vaccines significantly decreased clinical signs and 
excretion of Salmonella (Springer et al., 2001; Roesler et al., 2004, 2006; Eddicks et al., 2009; Farzan and Friendship, 
2010; Hotes et al., 2011; Hur et al. 2011). However, Denagamage et al. (2007) concluded in their review that 
the design and reporting deficiencies in many studies (e.g. little detail on population type, sample size, 
type of vaccine, dose and dosing regimens) meant that the association between vaccination and 
Salmonella reduction in finisher swine was promising, but not proven. Furthermore, currently available 
serological tests do not differentiate between commercial-vaccine-induced and infection-induced 
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antibodies, so vaccine use may be compromised in countries where serology is used for Salmonella 
surveillance (e.g. Denmark, Germany, UK, Belgium; EFSA and ECDC, 2011). 
To our knowledge, the ability of such intervention measures to prevent the spread of Salmonella 
among pigs has not yet been investigated via transmission experiments. A great advantage of these 
experiments is that the reduction of both the infectivity and susceptibility of treated animals can be 
quantified, whereas traditional challenge studies only demonstrate the effect of reduced susceptibility 
(Springer et al., 2001; Roesler et al., 2004; Tanaka et al., 2010). The aim of the present study was to evaluate, 
through the estimation of an adjusted reproduction ratio, the influence of three different intervention 
strategies, namely, (1) feed with coated calcium-butyrate; (2) vaccination; and (3) acidified drinking 
water, on the transmission in pigs of Salmonella enterica subspecies enterica serovar Typhimurium – 
the most prevalent Salmonella serotype in pigs in Belgium and Europe (CODA, 2010; EFSA and ECDC, 
2012a). 
 
 
Materials and methods 
This experiment was approved by the ethical committee of the Scientific Institute of Public Health 
and the Veterinary and Agrochemical Research center IPH-VAR (100412-02). 
 
Herd selection 
For the initial survey, pig herds in the national Salmonella monitoring programme were selected, 
based on consistently low Sample-to-Positive (S/P) ratios (S/P<0.20) in three consecutive blood 
samples taken from grower-finishing pigs in the preceding year. These herds were then visited, 
bacteriological and serological samples were taken, and the supply farm was selected based on hygiene, 
management and sample results. 
 
Piglet selection 
In order to select Salmonella-negative piglets, six sows from each selected herd were chosen 
through a bacteriological and serological screening process, which was repeated three times. From each 
sow, three piglets were screened as well. Finally, the sows with the lowest S/P ratios were selected to 
provide the experimental piglets. The average S/P ratio for the sampled piglets (at the time of the third 
screening at the age of eight days) was 0.07  0.10 (standard deviation). 
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In total, 69 piglets from six different sows were selected, weaned at 19 days of age and then 
transported to the experimental animal facilities of CODA-CERVA in a thoroughly cleaned and 
disinfected trailer. 
 
Study design 
Upon arrival, the piglets were randomly assigned into five groups: Group A (n=2x8) received feed 
supplemented with 0.3% w/w coated calcium-butyrate (Greencab-70®, Sanluc International) (Table 1), 
group B (n=2x8) was orally vaccinated at 22 and 43 days of age with 5x10
8
-5x10
9
 Colony Forming 
Units (CFU) of a double-attenuated histidine-adenine auxotrophic Salmonella Typhimurium vaccine 
(Salmoporc
®
, Impfstoffwerk Dessau-Tornau), and group C (n=2x8) received drinking water adjusted to 
pH 3.6-4.0 using 0.09% v/v of a mixture of formic, propionic, acetic and lactic acid (Agrocid Super®, 
CidLines) (Table 1). This water was checked daily with a pH-meter (pHep+ATC, Hanna Instruments). A 
positive control group (infected/untreated; n=2x8) and a negative control group (uninfected/untreated; 
n=5) were also included. All treatments were applied from arrival in the experimental facilities (three 
weeks of age) until the end of the experiment (14 weeks of age). 
 
Table 1: Composition of the feed (group A) and water (group C) supplement. 
Ingredients % in supplement ‰ in feed (1) or water (2) 
(1) Feed supplement in group A: 
 Butyrate anion 
 Calcium (organic) 
 Free Fatty Acids: 
C16:0 
C18:0 
C18:1 
C14:0 
 
 70.0 
 14.0 
 10.0 
7.5-9.0 
0.5-1.0 
0.5-1.0 
<0.35 
 
 2.1 
 0.4 
 0.3 
0.23-0.27 
0.02-0.03 
0.02-0.03 
<0.01 
(2) Water supplement in group C: 
 Formic acid 
 Propionic acid 
 Acetic acid 
 Lactic acid 
(pH 2.0-3.5) 
> 50 
> 10 
> 10 
< 5 
(pH 3.6-4.0) 
> 0.044 
> 0.009 
> 0.009 
< 0.004 
Group A was given deodorized calcium-butyrate coated with plant oils in the pig meal, while group C received a 
mixture of organic acids in the drinking water. 
 
All animals were fed the same meal without antimicrobials throughout the study, except for group A 
where the feed was supplemented as described above. Every group was housed in a different room with 
two similar pens (2x8 pigs), which were separated with solid 1 m high partitions. The stocking density 
was 0.42 m
2
 per pig. 
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At 57 days of age, two pigs in each pen - except in the negative control group - were moved to a 
separate room and were orally challenged (Day -1) with 10
8 
CFU of a nalidixic acid-resistant 
Salmonella Typhimurium strain 112910a, previously isolated from a pig without clinical signs of 
salmonellosis by Boyen et al. (2009). Twenty-four hours after this challenge, these ‘seeder’ pigs were 
replaced into their original pens (Day 0). All pigs were euthanized and autopsied at 95 days of age 
(Day 37). 
 
Sampling 
The sampling scheme is shown in table 2. From three weeks of age (Day -39) until euthanasia at 
14 weeks of age (Day 37), blood samples were obtained from all 69 pigs once a week to detect 
Salmonella-specific antibodies via ELISA. From three weeks of age (Day -39) until challenge (Day -1) 
pooled faecal samples were taken weekly. After challenge, individual faecal samples were collected 
from the rectum of all pigs twice a week. At autopsy (Day 37), samples of ileocaecal lymph nodes, 
ileum, ileal content, caecum, caecal content, faeces and tonsils were taken, and examined 
bacteriologically. 
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Table 2: Experimental design with the taken samples/actions and the used diagnostics/products, in function of the age of the pigs. 
Sampling/action 
(frequency) 
Age of the pigs (weeks) Diagnostic method/product 
3 4 5 6 7 8 9 10 11 12 13 14 
Pooled faeces per pen 
(once/week) 
x x x x x x       Isolation 
a
 
Individual rectal faeces 
(twice/week) 
      x x x x x x Isolation 
a
 
Blood 
(once/week)  
x x x x x x x x x x x x ELISA 
b
 
Supplementations 
in feed (A) and water (C) 
(ad libitum) 
x x x x x x x x x x x x Feed: coated calcium-butyrate 
(Greencab-70, Sanluc International) 
Water: mixture of organic acids 
(Agrocid Super, CidLines) 
Vaccination (B) 
(twice: primer + boost) 
x   x         Commercial Salmonella Typhimurium vaccine 
(Salmoporc, IDT) 
Challenge 
(2 pigs/group) 
     x       Nalidixic acid-resistant Salmonella Typhimurium strain 
112910a 
Rectal faeces, Ileum + content, Caecum + content, 
Ileocaecal lymph nodes, Tonsils (autopsy) 
           x Isolation 
a
 
a
 According to ISO 6579:2002/Amd1:2007 Annex D: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:314:0012:0013:NL:PDF; 
b
 Commercial LPS-based ELISA kit (HerdChek Swine Salmonella , IDEXX Laboratories) 
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Bacteriological examination 
Faecal examination was initiated within two hours of collection. Salmonella was isolated using the 
ISO 6579:2002/Amd1:2007 Annex D method (ISO, 2007). Briefly, the faecal samples (10-25g) were 
inoculated in buffered peptone water (BPW, Bio-Rad) in dilution 1:10 and incubated aerobically for 
16-20 h at 37 °C. Of this solution, 0.1 mL was inoculated on a Modified Semi-solid Rappaport 
Vassiliadis plate (MSRV, Bio-Rad) and incubated aerobically at 41.5 °C for 48 h. Growth halos were 
plated on a Xylose Lysine Deoxycholate agar plate (XLD, Bio-Rad) and a Brilliant Green Agar plate 
(BGA, LabM) – the latter supplemented with 20 µg/mL nalidixic acid – and then incubated aerobically 
for 21-27 h at 37 °C. One Salmonella-suspected colony on these XLD plates (challenge or vaccine 
strain) or on the BGA plates (only the challenge strain) was inoculated in Triple Sugar Iron agar (TSI, 
Bio-Rad) and lysine decarboxylase bouillon (Oxoid) and incubated for 18-24 h at 37 °C for final 
identification. 
For samples from group B, when growth of Salmonella bacteria was only observed on XLD and not 
on BGA, the sample was additionally tested with medium A and B (Salmonella Diagnostic Kit, IDT) to 
confirm that the isolated bacterium was the vaccine strain. Quantification of Salmonella was performed 
on faecal samples 3, 7 and 24 Days Post Infection (DPI) using standard enumeration protocols (Boyen et 
al., 2009). 
The tissue samples taken at necropsy were first rinsed with phosphate buffered saline, then sliced, 
suspended in BPW (dilution 1:10) and homogenized in a stomacher (BagMixer, Interscience) for one 
minute. Further isolation was performed as for the faecal samples. 
 
Serological examination 
Blood samples were allowed to clot for 24 h at 15°C and were then centrifuged for 15 min at 1200 g. 
Serum was diluted twenty-fold and analysed for Salmonella-specific antibodies with a commercial 
ELISA kit based on lipopolysaccharide (LPS) antigens (HerdChek Swine Salmonella, IDEXX), following the 
manufacturer’s instructions. Optical densities (OD) were determined by photospectrometry with a 
650 nm filter. The outcome was expressed as a ‘Sample to Positive’ ratio: 
S/P = ODSample - mean ODnegative kit control) ÷ (mean ODpositive kit control - mean ODnegative kit control) 
Samples with an S/P ratio ≥0.25 (or OD% ≥10) were considered positive. 
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Statistical analysis 
The number of positive faecal samples collected after challenge were compared between the groups 
using Generalized Estimating Equations (GEE) (PROC GENMOD and lsmeans; SAS version 9.2). A logit link 
function, a binomial distribution and an autoregressive first order correlation matrix was assumed with 
repeated measures. A one-way ANOVA test was used to assess differences between groups in the 
number of Salmonella spp. (log10 normalized data) quantified in the faeces on Day 3, 7 and 24. 
Bacteriological results from the tissue samples (ileum, ileal content, caecum, caecal content, 
ileocaecal lymph nodes, tonsils) were compared between groups using logistic regression analysis (SAS 
version 9.2). P-values below 0.05 were considered significant. 
The S/P ratios obtained by the ELISA were analysed by repeated measures ANOVA (PROC MIXED 
and lsmeans; SAS version 9.2). Both pig and pen were considered random effects. An autoregressive first 
order correlation structure was used for the within-subject correlation. In all models the Bonferroni 
correction was used to account for the use of multiple comparisons. 
The transmission of the Salmonella Typhimurium challenge strain in each group was estimated on 
the basis of the stochastic ‘Susceptible-Infectious’ (SI) infection model using an ‘adjusted’ 
reproduction ratio ‘Ra’. This ratio expresses the mean number of secondary infections caused by one 
typically infectious animal in a fully susceptible population during a defined time period (3-14 weeks 
of age in this study) (Meyns et al., 2004). An Ra value of for example 1.76 implies that an infected pig 
from a group infects on average 1.76 pen mates during the observed period. These Ra values were 
calculated via the Maximum Likelihood Estimation (MLE), using each of the following definitions of 
infection. At least one positive sample was necessary to define an animal as Salmonella-positive based 
on: (1) individual faeces; (2) ileum and/or ileal content and/or caecum and/or caecal content; (3) 
ileocaecal lymph nodes and/or tonsils; (4) all tissue and/or all faecal samples. This was done to 
investigate the most suitable matrix for this estimation. For each of these four possible definitions the 
number of contact-infections was thus determined as variable ‘Xi’. The following equation was used 
for this estimation: 
         
  
∏ (     |       )
 
   
 
in which F(Xi, Ra│N, S0, I0) is the likelihood function for the observed Xi-value, if N (total number of 
piglets), S0 (number of susceptible piglets), I0 (number of infectious piglets) and m (number of 
experiments) are given (Meyns et al., 2004). 
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Results 
Bacteriological examination 
All faecal samples taken prior to challenge were negative for Salmonella spp. No Salmonella spp. 
were isolated from the negative control group at any timepoint, supporting the conclusion that all other 
positive isolates were from infection with the introduced challenge strain. From challenge till 
euthanasia, the number of excreting pigs in group C (58%) was significantly higher than in group A 
(23%, P=0.01) and B (15%, P<0.01). Likewise, the number of shedding pigs in the positive control 
group (41%) was significantly higher than in group B (P=0.03). No other significant differences 
between groups were observed for the faecal samples (Fig. 1). These results were consistent with the 
Salmonella bacterial counts on Day 3, 7, and 24. The mean log10-values (CFU/g faeces) were 2.5, 1.1, 
and 0.7 for group A, 1.0, 0.3, and 1.1 for group B, 3.6, 2.3, and 1.6 for group C and 2.1, 1.2, and 1.3 for 
the positive control group, with only significant differences at Day 3 and 7 when group C was 
compared with group A and B (P<0.01). 
 
 
Figure 1: Isolation of the inoculated Salmonella strain in individual faeces (ISO 6579:2002/Amd1:2007 Annex D) twice a 
week: proportion of positive animals in function of the days post infection in Group A (feed with coated calcium-butyrate), 
Group B (vaccination), Group C (water acidified with organic acids to pH 3.6-4.0), and in the Positive and Negative Control 
Group. Day -1: Oral infection with 10
8
 CFU Salmonella Typhimurium of two seeder pigs per group of eight pigs. Day 0: 
Reintroduction of seeders in their original pen. Day 38: Euthanasia and Necropsy. 
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Of all tissue samples, 18%, 31%, 64% and 41% were found to be positive for Salmonella in 
group A, B, C and the positive control group, respectively (Table 3). Group C had significantly more 
infected tissue samples than all other groups (P<0.01). In group B, 31% of all tissue samples contained 
the vaccine strain, with the proportion of vaccine-positive tonsils being higher than all other tissues 
(P<0.01) (Fig. 2). 
Table 3: Number of tissue and content samples positive for the Salmonella Typhimurium challenge strain, in the four groups 
Group
 a
 Different necropsy samples All 
necropsy 
samples Ileum 
Ileal 
Content 
Caecum 
Caecal 
Content 
Ileocaecal 
Lnn 
Tonsils 
A) Coated calcium-butyrate 
(n = 16) 
4/16 
(25%) 
2/16 
(13%) 
2/16 
(13%) 
3/16 
(19%) 
3/16 
(19%) 
3/16 
(19%) 
17/96 
(18%) 
B) vaccination 
(n = 16) 
7/16 
(44%) 
4/16 
(25%) 
3/16 
(19%) 
6/16 
(38%) 
7/16 
(44%) 
3/16 
(19%) 
30/96 
(31%) 
C) Water with organic acids 
(n = 16) 
9/16 
(56%) 
5/16 
(31%) 
10/16 
(63%) 
13/16 
(81%) 
10/16 
(63%) 
14/16 
(88%) 
61/96
b
 
(64%) 
D) Positive control 
(n = 16) 
9/16 
(56%) 
7/16 
(44%) 
6/16 
(38%) 
8/16 
(1%) 
6/16 
(38%) 
3/16 
(19%) 
39/96 
(41%) 
All groups (n=64) 
29/64 
(45%) 
18/64 
(28%) 
21/64 
(33%) 
30/64 
(47%) 
26/64 
(41%) 
23/64 
(36%) 
147/384 
(38%) 
a
 A= feed with 0.3% coated calcium-butyrate; B= vaccination at 3 and 6 weeks of age; C= water with 0.09% organic acids; 
D= positive control; 
b 
significant difference between group C and the other groups (P<0.03). 
 
Figure 2: Isolation of the Salmonella vaccine strain in different tissue samples (ISO 6579:2002/Amd1:2007 Annex D + IDT 
Salmonella Diagnostic Kit): proportion (%) of vaccine-positive samples from ileum(contents) / caecum(contents) / 
ileocaecal lymph nodes / tonsils, in function of Group B (vaccination). 
Chapter 3.1  Experimental Study 1 
 
 
 
79 
The adjusted reproduction ratios Ra for the different infection definitions are shown in table 4. 
Overall Ra values were lower in group B (Ra=2.6 [1.21; 9.45]) and A (Ra=1.76 [1.02; 9.01]) than in 
group C and the positive control group D (both Ra=+∞ [1.88; +∞]). No significant differences were 
observed between groups, except for the comparison of the lymph nodes and tonsils. In this category, 
the Ra value in group A was significantly lower than in C (P<0.03). 
Table 4: The adjusted reproduction ratio Ra for the three intervention groups A, B, C and the positive control group D. 
Group 
a
 All individual Faeces 
b
 Ileum/content/ 
Caecum/content
 b 
Ileocaecal Lnn/ 
Tonsils
 b 
All Organs/ 
All Faeces
 b 
A) Coated calcium-butyrate 
(n = 16) 
1.62 [0.85; 8.43] 0.77 [0.35; 3.80] 0.32 [0.12; 2.94] 1.76 [1.02; 9.01] 
B) vaccination 
(n = 16) 
1.16 [0.56; 3.95] 1.03 [0.56; 3.95] 1.19 [0.70; 7.18] 2.61 [1.21; 9.45] 
C) Water with organic acids 
(n = 16) 
3.53 [1.88; 11.70] 2.52 [1.67; 24.87] 3.53 [1.88; 11.65] +∞ [1.88; +∞] 
D) Positive control 
(n = 16) 
3.53 [1.88; 11.70] 1.91 [1.22; 24.78] 0.89 [0.47; 4.23] +∞ [1.88; +∞] 
P-value (A, D) 0.22 0.15 0.41 0.22 
P-value (B, D) 0.11 0.20 0.44 0.29 
P-value (C, D) 1.00 0.38 0.11 1.00 
P-value (A, B) 0.37 0.12 0.07 0.45 
P-value (A, C) 0.22 0.06 0.03
 c
 0.22 
P-value (B, C) 0.11 0.10 0.16 0.29 
a
 A= feed with 0.3% coated calcium-butyrate; B= vaccination at 3 and 6 weeks of age; C= water with 0.09% organic 
acids; D= positive control. 
b
 Using the ISO 6579:2002/Amd1:2007 Annex D, a pig was considered as infected, if at least one of the samples of four 
marked categories in every column was found positive during the transmission period. 
c 
significant difference between group A and C (P<0.03). 
 
 
Serological examination 
All pigs were seronegative before the start of the study. The evolution of Salmonella-specific 
antibody titres is illustrated for all groups in Fig. 3. During the entire experiment, titres in the negative 
control group remained very low (S/P ratios below 0.01). In group B, an increasing mean Salmonella-
specific antibody response was observed from Day -19 until Day -1 (day of challenge) and also 
subsequently until the end of the experiment. In groups A and C and the positive control group, 
Salmonella-specific antibodies increased from two weeks after challenge; no significant differences in 
titre were detected between these groups. The mean antibody titre of group B was significantly higher 
than of all other groups. 
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Figure 3: Weekly Salmonella-specific antibody detection in serum (ELISA): Mean S/P ratio in function of the days post 
infection in group A (feed with coated calcium-butyrate), group B (vaccination), group C (water with organic acids), and in 
the positive and negative control group. Day-36 and Day-15: primer and boost vaccination in group B, respectively. Day -1: 
oral infection with 10
8
 CFU Salmonella Typhimurium of two seeder pigs per group of eight pigs. Day 0: reintroduction of 
seeders in their original pen. Day 38: euthanasia and necropsy. 
 
 
Discussion 
Current control measures are not sufficient to prevent the impact of pig-related Salmonella on public 
health. The present study investigated three intervention strategies to reduce the transmission of 
Salmonella Typhimurium in pigs. Supplementation of feed with coated calcium-butyrate and oral 
vaccination with the current attenuated strain both limited Salmonella Typhimurium transmission; 
however, water acidified with the current organic acid mixture was shown non-effective in this study. 
Using the present ‘transmission’ design, where treatment was given prior to challenge (treated 
seeders were brought together with treated contact pigs), an adjusted transmission ratio Ra was 
calculated which quantified the effects of the treatments on both infectiveness and susceptibility. This 
is an important contrast to efficacy studies in which principally the susceptibility is tested, and not the 
combined effect (Springer et al., 2001; Roesler et al., 2004; Tanaka et al., 2010). A similar approach has been 
used in previous transmission experiments with other pathogens (Laevens et al., 1998; Dewulf et al., 2001; 
Velthuis et al., 2003; Heres et al., 2004; Meyns et al., 2004). 
When observing the obtained transmission ratios, higher Ra values were found in the group treated 
with acidified water (C) and in the untreated positive control group (D), independently of the definition 
of infection. This suggested a lower transmission of Salmonella in the treated groups A and B when 
compared to groups C and D. Yet, the Ra value in both group A and B – based on the detection of 
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Salmonella in faeces – was above one, indicating that there was still spread of the infection during the 
study period. 
In the present trial, the coated calcium-butyrate supplement (Greencab-70, Sanluc International) was 
chosen as one strategy, since this has been shown to be beneficial in previous experiments (Boyen et al., 
2008b; Guilloteau et al., 2010), though not with the current transmission design. In the digestive tract, 
butyrate can accelerate the renewal of necrotic areas, down-regulate Salmonella virulence, suppress 
intestinal inflammation and diminish pathogen invasion (Hamer et al., 2008). However, to reach in their 
active form the intestinal sites that Salmonella spp. use to colonize the pig (ileum, caecum and colon) , 
supplemented short-chain fatty acids need protection or ‘coating’ from the intestinal environment (Van 
Immerseel et al., 2005; Boyen et al., 2008b), because they are generally quickly metabolized and then 
absorbed by gastro-intestinal epithelial cells (Louis et al., 2007). The results of our study showed a 
tendency towards reduced Salmonella transmission in this group, in comparison with the acidified 
water group and the positive control group. Therefore, we conclude that coated calcium-butyrate may 
be helpful in the reduction of Salmonella infections in pigs. 
In contrast, the mixture of formic, acetic, propionic, and lactic acid (Agrocid Super, CidLines) that was 
added to the drinking water in this study did not reduce the transmission rate of Salmonella 
Typhimurium in comparison with the positive control group. A possible explanation is that this acid 
shock induced a stress response system, enabling Salmonella Typhimurium to survive in an extreme 
low acid environment (an acid tolerance response or ‘ATR’ (Foster and Spector, 1995; Baik et al., 1996)). 
Previous reports on the use of organic acids via drinking water have produced inconsistent results. Van 
der Wolf et al. (2001b) observed a reduction in Salmonella when a 0.2% v/v organic acid mixture was 
administered during the entire finishing period. In contrast, no reductions were observed with the same 
concentration applied for a shorter time (two weeks pre-slaughter) (De Busser et al., 2009), or using a 
lower concentration administered to weaners (0.02% v/v in Letellier et al., 2000). However, the 
comparison of these study results is hindered not only by the different duration of application or 
concentration, but also by the fact that different organic acid mixtures were used in all these studies. 
The vaccine used in this study (Salmoporc, IDT) has been demonstrated to reduce both faecal shedding 
and colonization of the intestinal tract of piglets (Springer et al., 2001). In the present transmission study, 
this vaccination resulted in the lowest number of shedding pigs and the lowest Ra (faeces results). 
However, vaccination also increased the Salmonella-specific antibodies and resulted in a proportion of 
tissue samples colonized by the Salmonella challenge strain comparable to that in the positive control 
group (31% vs. 41%, respectively). Although the vaccine and wild type strains can be distinguished 
using the Salmonella Diagnostic Kit provided by the manufacturer of the vaccine, the commercial LPS-
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based ELISA cannot differentiate between vaccination- and infection-induced antibodies in serum or 
meat juice. Vaccination may thus hamper the use of serology for Salmonella monitoring programmes, 
if blood samples are collected before 14 weeks of age. Programmes that are based on bacteriology, new 
diagnostic tests that do not detect vaccine-induced antibodies (Selke et al., 2007) or new vaccines that are 
not detected by current ELISA methods (Leyman et al., 2011) are to be considered if vaccination is going 
to become a routine part of Salmonella control. 
 
Conclusions 
Both feed supplementation with coated calcium-butyrate and particularly vaccination with an 
attenuated vaccine decreased Salmonella Typhimurium transmission in pigs. Further studies are needed 
to assess the practical issues related to the implementation of these promising interventions. For 
example, more data are needed to determine the best age groups and treatment regimens for the coated 
calcium-butyrate and on to learn how to overcome the problem of Salmonella-specific antibodies in 
vaccinated pigs. Alternative bacteriology-based monitoring programmes, diagnostic tests that do not 
detect vaccine-induced antibodies or new vaccines that are not detected by current antibody detection 
methods are required. 
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Abstract 
For satisfactory Salmonella control, good biosecurity along the pork production chain is crucial, 
although additional control measures on-farm need to be considered. This study evaluated the effect of 
two potential control measures against the spread of Salmonella Typhimurium via a transmission 
experiment with 56 piglets (3 - 15 weeks of age): two groups were orally vaccinated with 10
7
 - 10
8
 
Colony Forming Units (CFU)/2 mL of a new attenuated Salmonella Typhimurium vaccine ‘Salmoporc-
∆rfaJ’ with DIVA capacities (Differentiation between Infected and Vaccinated Animals) (n = 2x16); 
the feed of one group was additionally supplemented with coated calcium-butyrate. Two weeks post 
vaccination, four pigs per group were orally challenged with 10
7
 CFU/2 mL of a Salmonella 
Typhimurium strain 112910a. Both groups were compared with a positive (challenged/untreated; 
n = 16) and negative (unchallenged/untreated; n = 8) control group. Until six weeks post challenge, 
blood, individual faecal and finally tissue samples were examined. Adjusted transmission ratios ‘Ra’ 
were estimated, based on the challenge strain isolation from faecal and/or tissue samples. 
In both intervention groups, Ra values were lower compared to the positive control group, although 
these differences were not significant. In the combination group DIVA vaccine + coated butyrate less 
non-challenged contact animals excreted Salmonella and less tissue samples were found Salmonella-
positive in all pigs, when compared to the positive control group (P < 0.01). Seroconversion was 
detected in none of the vaccinated animals before challenge, when using commercial 
lipopolysaccharide (LPS) ELISAs targeting only Salmonella O-antigens, deleted in this vaccine. This 
was in contrast with an in-house whole-cell ELISA testing for various Salmonella antigens, in which 
Salmonella-specific antibodies were found pre-challenge in the serum of the vaccinated pigs. 
Both interventions showed a limited, non-significant reduction of Salmonella transmission between 
piglets. They may have applications towards Salmonella control and surveillance. Firstly, the number 
of Salmonella excreting contact pigs was significantly lower in the group where vaccination was 
combined with coated calcium-butyrate in the feed; secondly, the new vaccine confirmed its DIVA 
capacity. Therefore, these interventions merit further research with larger sample sizes, to optimize 
their use for Salmonella programmes. 
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Background 
Salmonella infections are one of the most important and widely distributed foodborne diseases in the 
European Union. Contaminated pork has been linked to 34.5% of the human outbreaks of Salmonella 
enterica subspecies enterica serovar Typhimurium (Salmonella Typhimurium) in the EU (EFSA and 
ECDC, 2013a). Therefore, any reduction of the Salmonella risk by pork products would contribute to the 
protection of human health. However, the control of Salmonella in pork production remains a 
significant challenge in the preharvest sector. Implementing good biosecurity and operating a high 
standard of hygiene is crucial in every link of the pork production chain (Hotes et al., 2011), but additional 
control measures on-farm are indispensable (Mannion et al., 2007). 
Vaccination is one possible supplementary measure that can be implemented in Salmonella control 
programmes. It is currently used successfully in the poultry industry of several European countries 
(Collard et al., 2008; EFSA and ECDC, 2012a). Also in pigs, various vaccine studies have demonstrated a 
significant decrease in clinical signs and excretion of Salmonella (Hotes et al., 2011; Roesler et al., 2004; 
Farzan and Friendship, 2010; De Ridder et al., 2013a). Most European serosurveillance programmes however, 
rely on commercial lipopolysaccharide (LPS) ELISAs, which do not allow differentiation between 
Salmonella-specific antibodies induced by vaccination or by infection (Abrahantes et al., 2009). Several 
DIVA vaccines (Differentiation of Infected and Vaccinated Animals) have recently been developed 
(Selke et al., 2007; Leyman et al., 2011), of which one vaccine, a Salmonella Typhimurium strain without the 
‘rfaJ’ gene, induces antibodies undetectable with LPS-based ELISA (Leyman et al., 2011). Another 
control measure with promising features against Salmonella infections, is the oral administration of 
butyrate, especially in its coated form (Van Immerseel et al., 2005; Boyen et al., 2008b). Not only does this 
organic acid enhance pig performance by improving gut function, it also down-regulates Salmonella 
virulence gene expression (Guilloteau et al., 2010). None of these studies however, have investigated the 
effect on the actual transmission rate of Salmonella between pigs. 
The aim of the present study was to evaluate the effect of a commercial vaccine that was modified to 
a DIVA vaccine strain, and its combination with coated calcium-butyrate in the feed on the 
transmission of Salmonella Typhimurium in weaned pigs. 
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Methods 
Study design 
At three weeks of age, 56 Salmonella-negative piglets were randomly assigned to four different 
stables in the experimental animal facilities of CODA-CERVA, with two separated pens each 
(Table 1). Group A (n = 2x8) was orally vaccinated at four and seven weeks of age with 10
7
 - 10
8
 
Colony Forming Units (CFU)/2 mL of a live LPS-mutant Salmonella Typhimurium strain, named the 
‘Salmoporc-∆rfaJ’ strain, in reference to the deletion of the ‘rfaJ’ gene (Leyman et al., 2011) in a 
commercial vaccine (Salmoporc®, IDT Biologika); group B (n = 2x8) was vaccinated similarly and received 
additionally feed supplemented with 0.3% coated calcium-butyrate throughout the experiment 
(Globamax Performant, Sanluc International); a positive control group C (challenged/untreated; n = 2x8) and a 
negative control group D (unchallenged/untreated; n = 8) were included as well. Each group, except the 
negative control group, consisted of two replicates to increase the power of the experiment. 
 
 
Table 1: Design of the transmission study with the samples/actions and diagnostics/products, as a function of the pigs’ age. 
Age of pigs 
in weeks 
Sampling/action 
(Group) 
Frequency 
(Number of samples n) 
Diagnostic method/product 
3 - 8 Floor faeces 
(group A, B, C, D) 
Once/week 
(1 pool/pen; n = 7) 
Isolation 
(ISO 6579:2002/Amd1:2007 Annex D) 
9 - 15 Rectal faeces 
(group A, B, C, D) 
Twice/week 
(individually; n = 56) 
Isolation 
(ISO 6579:2002/Amd1:2007 Annex D) 
3 - 15 Blood 
(group A, B, C, D) 
Once/week 
(n = 56) 
ELISA 
a
 
3 - 15 Feed supplementation 
(group B) 
Ad libitum 
(n = 15) 
Coated calcium-butyrate 
(Globamax Performant, Sanluc 
International) 
4 + 7 Oral vaccination 
(group A, B) 
Twice: primer + boost 
(n = 16(A); n = 15(B)) 
10
7
 - 10
8
 CFU of DIVA vaccine 
‘Salmoporc-∆rfaJ’ 
9 Oral challenge 
(group A, B, C) 
Once; in a separate stable, 
with replacement 24 h later 
(2 pigs/pen; n = 12) 
10
7
 CFU of nalidixic acid-resistant 
Salmonella Typhimurium strain 112910a 
15 Rectal faeces, Ileum + content, 
Caecum + content, Ileocaecal Lnn, 
Tonsils (group A, B, C, D) 
At necropsy 
(n = 56) 
Isolation 
(ISO 6579:2002/Amd1:2007 Annex D) 
a
 Two ELISA tests were performed: (1) commercial LPS-based ELISA (HerdChek Swine Salmonella, IDEXX); (2) In-
house whole-cell ELISA (Leyman et al., 2011). 
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The pens were separated with solid concrete partitions and had a semi-solid concrete floor (half grid, 
half rubber mats). The pig stocking density was 0.42 m
2
 per animal. In all groups, the same starter and 
pig meal without antimicrobials was administered throughout the study, (i.e. from arrival in the 
experimental facilities at three weeks of age until euthanasia at 15 weeks of age), except in group B for 
which the feed was supplemented as described above. The pigs were housed at natural day-night 
rhythm with ad libitum access to water and feed. Each group of eight pigs was provided with a rubber 
ball as environmental enrichment. 
With the exception of the negative control group, two pigs per pen were orally challenged at nine 
weeks of age with 10
7
 CFU/2 mL of a nalidixic acid-resistant Salmonella Typhimurium strain 112910a 
(Boyen et al., 2009) in a separate pen. Twenty-four hours later, these challenged ‘seeder’ pigs were 
replaced with the naive, non-challenged contact pigs (0 Days Post Contact or ‘DPC’), and all pigs were 
monitored until 15 weeks of age (42 DPC). This day (0 DPC) was considered as the start of the 
transmission experiment. Before challenge at nine weeks of age, individual blood samples and pooled 
faecal pen samples were taken once a week. After challenge, blood samples were obtained once a 
week, whereas individual rectal faeces were collected twice a week from all pigs. At necropsy, rectal 
faeces, ileum, ileal content, caecum, caecal content, ileocaecal lymph nodes and tonsils were sampled. 
The experimental design was approved by the Animal Care and Ethical Committee of the IPH-VAR 
(Approval number 100412–02). 
 
Sample analysis 
All faecal samples were examined using the ISO 6579:2002/Amd1:2007 Annex D method (ISO, 
2007). Firstly, the samples (10-25g) were diluted 1:10 in buffered peptone water (BPW, Bio-Rad) and 
aerobically incubated for 16-20 h at 37°C. Of this solution, 0.1 mL was inoculated on a modified semi-
solid Rappaport-Vassiliadis plate (MSRV, Bio-Rad) (one sample per plate) and aerobically incubated for 
46-50 h at 41.5 °C. After this period, a loopful of the growth area in this MSRV enrichment must be 
plated out on a xylose lysine deoxycholate agar plate (XLD, Bio-Rad) and another agar for choice. In this 
study was opted for a brilliant green agar plate (BGA, Lab M), known to allow satisfactory growth of 
both the vaccine and challenge strain. The latter plate was supplemented with 20 μg/mL nalidixic acid 
for differentiating these Salmonella Typhimurium strains. For 21-27 h, both plates were given an 
aerobic incubation at 37 °C. A Salmonella-suspected colony on the BGA plates was expected to be 
only the nalidixic acid-resistant challenge strain, whereas on the XLD plates, colonies of both the 
challenge and vaccine strain were able to grow. From these XLD or BGA plates, one Salmonella-
suspected colony was inoculated in triple sugar iron agar (TSI, Bio-Rad) and lysine decarboxylase 
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bouillon (Oxoid) and incubated for 18-24 h at 37 °C for final confirmation. After preparation, the tissue 
samples were investigated similarly to the faecal samples. 
The blood samples were allowed to coagulate at room temperature and were then centrifuged for 
15 min at 1200 g. The serum collected thereafter, was diluted twenty-fold and analysed with two 
ELISA tests: (1) a commercial ELISA kit based on LPS O-antigens of serogroup B, C1 and D (HerdChek 
Swine Salmonella, IDEXX); (2) an in-house whole-cell ELISA, based on a variety of surface-antigens on 
the Salmonella Typhimurium strain 112910a (Leyman et al., 2011). Consequently, antibodies against the 
‘Salmoporc-∆rfaJ’ vaccine strain, which expresses no O-antigens, should only be detectable with this 
whole-cell ELISA. Other Salmonella strains on the other hand, will be detected in both ELISA tests. 
Optical densities (OD) in both ELISAs were determined by photo spectrometry with a 650 nm filter. 
Samples with a Sample-to-Positive (S/P) ratio ≥0.25 (= OD% ≥10) were defined as positive. 
 
Statistical analysis 
Based upon all faecal samples, the numbers of excreting pigs were compared via generalized 
estimating equations (GEE), using the proc genmod procedure in SAS 9.2 (SAS Institute Inc., USA). For 
this, a binomial distribution and logit link function were used. Bacteriological results from the tissue 
samples (ileum, ileal content, caecum, caecal content, ileocaecal lymph nodes, tonsils) were compared 
between groups (DIVA vaccine, DIVA vaccine + Coated Butyrate, Positive Control) using logistic 
regression analysis in SAS 9.2. P-values below 0.05 were considered significant. 
The transmission of Salmonella Typhimurium in each group was estimated on the basis of the 
stochastic ‘SI’ infection model (Susceptible-Infectious), using an ‘adjusted’ transmission ratio ‘Ra’ for 
the observed period of six weeks, which is derived from the basic reproduction ratio R0 for the entire 
infectious period (de Jong and Diekmann, 1992). In this study, each intervention group contained n = 8 
piglets, of which initially two challenged animals were infectious (I0 = 2) and six contact animals were 
susceptible (S0 = 6). An Ra value below or above one means respectively, that each infected animal will 
pass the infection on to less or more than one naive contact animal during the observed period of six 
weeks. This Ra value was estimated via the Maximum Likelihood Estimation (MLE) based on the final 
size of the study, which represents the total number of contact infections (Meyns et al., 2004). A contact 
animal was considered infected, when at least one sample was positive in: i) individual faeces, or ii) 
ileum, caecum and/or their content, or iii) ileocaecal lymph nodes and/or tonsils, or iv) all tissues 
and/or all faeces collected. Ra values were calculated for each of the previous four categories, and 
significant differences between groups were assessed (Kroese and de Jong, 2001). 
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Results 
Bacteriological examination 
In each group, all pooled faecal samples taken prior to challenge were Salmonella-negative. All 
individual faecal samples from the negative control group remained negative during the whole 
experiment. One contact pig of group B died at -1 DPC due to a polybacterial bronchopneumonia and 
was excluded from the study (no respiratory pathogens could be identified at necropsy). 
After challenge, no significant differences between the groups were observed in the numbers of 
Salmonella-excreting animals, when considering all challenged and non-challenged pigs (Fig. 1). If the 
challenged seeder pigs were not taken into account for all 11 sampling points however, significantly 
fewer Salmonella-positive samples were obtained in group B (9/121), when compared to group C 
(30/132) (P < 0.01). At the end of the trial, respectively 8/12 (67%), 7/11 (64%) and 12/12 (100%) non-
challenged contact pigs from group A, B and C had excreted Salmonella in their feces on at least one 
sampling occasion (Table 2). From all necropsy samples of both challenged and non-challenged pigs, 
27, 13 and 41% were found positive for the challenge strain in group A, B and C, respectively, with a 
significant difference between group B and C (P < 0.01) (Table 3). Respectively 6/12 (50%), 2/11 
(18%) and 10/12 (83%) non-challenged contact pigs from group A, B and C had one tissue sample or 
more colonized with Salmonella. Both the faecal shedding and tissue colonization are presented 
individually in table 2. 
Figure 1: Proportion of Salmonella challenge strain positive faecal samples per groups, as a function of time (DPC: days 
post contact).  DIVA vaccine;  DIVA vaccine + Coated calcium-butyrate;  Positive Control;  Negative Control. 
DPC = -1: Replacement and oral challenge with 10
7
 CFU/2 mL Salmonella Typhimurium of 2 seeder pigs per group of 8 
pigs, with reintroduction of seeders in their original pen 24 h later. 
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Table 2: Presentation of the individual Salmonella-positive faecal and necropsy samples (grey) per sampling occasion and 
tissue, respectively. 
Group
 §
 Pig
 a
 Faeces Tissue
 b
 
Days Post Challenge Excreting 
pig 
I Ic C Cc L T 
Colonized 
Pig -1 2 6 10 13 17 20 24 27 31 34 42 
A) DIVA vaccine 
(n = 16) 
S             Yes       Yes 
S                         Yes             Yes 
C                         No             No 
C                         No             No 
C                      
  
  Yes             Yes 
C                         No             Yes 
C                         Yes             No 
C                         Yes             Yes 
S                         Yes             Yes 
S                         Yes             Yes 
C                         Yes             No 
C                         Yes             Yes 
C                         Yes             No 
C                         Yes             Yes 
C                         Yes             Yes 
C                         No             No 
B) DIVA vaccine + 
Coated Butyrate 
(n = 15) 
S                         Yes             Yes 
S                         Yes             Yes 
C                         Yes             Yes 
C                         Yes             No 
C                         Yes             No 
C                         Yes             No 
C                         Yes             No 
C                         Yes             Yes 
S                         Yes             No 
S                         Yes             Yes 
C - - - - - - - - - - - - - - - - - - - - 
C                         No             No 
C                         No             No 
C                         No             No 
C                         No             No 
C                         Yes             No 
C) Positive control 
(n = 16) 
S                         Yes             Yes 
S                         Yes             Yes 
C                         Yes             Yes 
C                         Yes             Yes 
C                         Yes             No 
C                         Yes             No 
C                         Yes             Yes 
C                         Yes             Yes 
S                         Yes             Yes 
S                         Yes             Yes 
C                         Yes             Yes 
C                         Yes             Yes 
C                         Yes             Yes 
C                         Yes             Yes 
C                         Yes             Yes 
C                         Yes             Yes 
a
 S = Seeder pig (in italics); C = Contact pig. 
b
 Tissue: I = Ileum, Ic = Ileal content, C = Caecum, Cc = Caecal content, L = Ileocaecal Lymph nodes, T = Tonsils. 
§
 A) oral vaccination at four and seven weeks of age with 10
7
 - 10
8
 CFU/2 mL of the live ‘Salmoporc-∆rfaJ’-strain; B) 
vaccination of (A) plus feed supplemented with 0.3% coated calcium-butyrate; C) positive control that was challenged 
without being treated. 
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Table 3: Results of the descriptive and logistic regression analysis of the necropsy samples positive for the Salmonella 
challenge strain in the three groups. 
Group 
§
 Parameters Different necropsy samples All necropsy 
samples 
Ileum Ileal 
Content 
Caecum Caecal 
Content 
Ileocaecal 
Lnn 
Tonsils 
A) DIVA vaccine 
(n = 16) 
Number 
(Proportion) 
4 
a
 
(25%) 
4 
ab
 
(25%) 
6 
a
 
(38%) 
5 
ab
 
(31%) 
3 
a
 
(19%) 
4 
a
 
(25%) 
26 
ab
 
(27%) 
OR* 0.67 0.21 2.23 0.23 0.49 0.25 0.55 
P-value 0.66 0.10 0.38 0.07 0.41 0.18 0.05 
B) DIVA vaccine  + 
Coated Butyrate 
(n = 15) 
Number 
(Proportion) 
2 
a
 
(13%) 
1 
a
 
(7%) 
2 
a
 
(13%) 
3 
a
 
(20%) 
1 
a
 
(7%) 
3 
a
 
(20%) 
12 
a
 
(13%) 
OR* 0.25 0.03 0.34 0.12 0.15 0.14 0.30 
P-value 0.18 0.01 0.33 0.02 0.10 0.08 <0.01 
C) Positive control 
(n = 16) (ref) 
Number 
(Proportion) 
5 
a
 
(31%) 
8 
b
 
(50%) 
4 
a
 
(25%) 
10 
b
 
(63%) 
5 
a
 
(31%) 
7 
a
 
(44%) 
39 
b
 
(41%) 
a, b
 Numbers in a column, not sharing the same letters in superscript, are significantly different: ileal and caecal content 
(P < 0.02) and all necropsy samples (P < 0.01). 
*   Odds Ratios (OR) >1 or <1, define the intervention of group A or B as a risk or protective factor, respectively, for having 
Salmonella-positive tissue samples, when compared to the positive control group. 
§
   A) oral vaccination at four and seven weeks of age with 10
7
 - 10
8
 CFU/2 mL of the live ‘Salmoporc-∆rfaJ’ strain; B) 
vaccination of (A) plus feed supplemented with 0.3% coated calcium-butyrate; C) positive control that was challenged 
without being treated. 
 
 
The adjusted transmission ratios Ra, based on the faecal and/or tissue results of all challenged and 
non-challenged pigs, were lower in all four categories in both vaccinated groups A and B, when 
compared to the unvaccinated group C (Table 4). These differences between groups were not 
significant (P > 0.05). 
 
 
Table 4: Adjusted reproduction ratio Ra [95% confidence interval] in group A/B/C, as a function of four different categories. 
Group 
§
 Individual faeces 
a
 Ileum / content / 
Caecum / content 
a
 
Ileocaecal Lnn / 
Tonsils 
a
 
All tissues / 
Individual faeces 
a
 
A) DIVA vaccine 
(n = 16) 
1.76 [1.02; 9.01] 1.03 [0.56; 3.95] 0.77 [0.35; 3.80] 2.37 [1.46; 10.02] 
B) DIVAvaccine + 
Coated Butyrate 
(n = 15) 
2.52 [0.99; 9.62] 0.50 [0.17; 5.82] 0.37 [0.14; 4.64] 2.52 [0.99; 9.62] 
C) Positive control 
(n = 16) 
+∞ [1.88; +∞] * 2.52 [1.02; 9.01] 1.19 [0.70; 7.18] +∞ [1.88; +∞] * 
P-value (A, C) 0.22 0.25 0.21 0.37 
P-value (A, B) 0.47 0.38 0.21 0.27 
P-value (B, C) 0.19 0.31 0.07 0.19 
a
 Using the ISO 6579:2002/Amd1:2007 Annex D, a pig was considered as infected, if at least one of the samples of four 
marked categories in every column was found positive during the transmission period. 
§
 A) oral vaccination at four and seven weeks of age with 10
7
 - 10
8
 CFU/2 mL of the live ‘Salmoporc-∆rfaJ’-strain; B) 
vaccination of (A) plus feed supplemented with 0.3% coated calcium-butyrate; C) positive control that was challenged 
without being treated. 
* +∞ = plus infinity 
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Serological examination 
In the commercial LPS-based ELISA, all pigs were seronegative for Salmonella-specific antibodies 
before challenge (Fig. 2). In contrast, the in-house whole-cell ELISA showed that the mean S/P ratio 
increased already one week before challenge in both vaccinated groups A and B, whereas the increase 
occurred two weeks after challenge in the positive control group C (results not shown). 
Figure 2: Weekly detection (LPS-based ELISA, IDEXX) of Salmonella-specific antibodies (mean S/P ratio), as a 
function of time (DPC: days post contact).  DIVA vaccine;  DIVA vaccine + Coated calcium-butyrate;  Positive 
Control;  Negative Control. DIVA vaccine; DIVA vaccine + Coated calcium-butyrate; Positive Control; Negative 
Control. DPC = -1: Replacement and oral challenge with 10
7
 CFU/2 mL Salmonella Typhimurium of 2 seeder pigs per 
group of 8 pigs, with reintroduction of seeders in their original pen 24 h later. 
 
 
Discussion 
The increase of global meat consumption during the next decades is expected to be largely due to 
increases in pork (Kearney, 2010). The reduction of any pig-related public health risk is therefore of 
considerable importance. Salmonella Typhimurium represents a most relevant pig-associated risk 
despite current control measures (EFSA and ECDC, 2013a), and was therefore selected for the present 
transmission experiment in weaned pigs. This study aimed to assess the effect of a DIVA vaccine 
(Leyman et al., 2011), with and without coated calcium-butyrate in the feed. 
As a consequence of the study design (transmission experiment), in which the treatment was applied 
to all pigs before challenge, the combined treatment effect on both the excretion of the inoculated pigs 
and the susceptibility of the contact animals is evaluated. This is an important difference with efficacy 
studies in which mainly the susceptibility is assessed and not the combined effect (Roesler et al., 2004; 
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Taube et al., 2009; Tanaka et al., 2010). This study concept also allows a better simulation of the field 
situation, namely infection of a treated pig which may subsequently infect other treated pigs in the area. 
Several other bacterial diseases have been investigated in similar experiments (Meyns et al., 2004; Velthuis 
et al., 2003; Heres et al., 2004; Dewulf et al., 2004; Bohez et al., 2008; Vrancken et al., 2009; Villarreal et al., 2011; 
Crombé et al., 2012; Claes et al., 2013). As the Ra values were higher than one in this experiment, the present 
interventions will not eradicate infection with Salmonella Typhimurium during the studied period. 
However, the treated groups demonstrated statistically non-significant lower Ra values for every 
matrix, in comparison with the positive control group. Therefore, a more distinct reducing effect might 
be expected when observing pigs for a longer time, as was demonstrated in previous efficacy studies 
(Farzan and Friendship 2010; van der Wolf et al., 2001b; Canibe and Jensen, 2003), which investigated the effect of 
vaccination, acidified drinking water, and fermented liquid feed during the entire finishing period, 
respectively. This expected enlarged difference between groups might be explained by a prolonged 
potential spread of Salmonella in the untreated control group, while no further spread is expected in the 
treatment groups. 
Concerning vaccination, different studies have demonstrated a reduction of Salmonella shedding 
and/or Salmonella seroprevalence in pigs (Roesler et al., 2004; Farzan and Friendship 2010; Selke et al., 2007; 
Springer et al., 2001; Hur et al., 2011). Vaccine-induced antibodies should be distinguishable however, from 
those induced by infection in order not to hamper monitoring programmes based on serology. Selke et 
al. (2007) developed a DIVA vaccine of which the induced antibodies were not detectable in their in-
house ELISA, but the DIVA vaccine of Leyman et al. (2011) induced antibodies undetectable with a 
commercial LPS-based ELISA that is commonly used in serosurveillance programmes (HerdChek Swine 
Salmonella, IDEXX). Consequently, the latter vaccine would be suitable for use in European 
serosurveillance programmes, whereas the first vaccine would not. In the present study, the method of 
Leyman et al. (2011) was therefore applied on the commercial vaccine Salmoporc
®
, resulting in the 
‘Salmoporc-∆rfaJ’ strain. The commercial vaccine Salmoporc® has proven its effectiveness previously 
(Springer et al., 2001) using the same administration procedure as the current study, and Leyman et al. 
(2011) demonstrated a similar protection after immunization with either a wild-type Salmonella 
Typhimurium strain or its DIVA variant. Therefore, the ‘Salmoporc-∆rfaJ’ strain used in this study was 
expected to have the same protective effect as the Salmoporc
®
 parent strain. Whereas the in vivo study 
of Leyman et al. (2011) involved four unchallenged vaccinated piglets, this new DIVA strain was 
evaluated in 16 challenged piglets. Although the ‘Salmoporc-∆rfaJ’ strain as single intervention 
resulted in a limited statistically non-significant reduction of transmission, serological surveillance 
using the commercial ELISA tests remains applicable. Therefore, it may be considered a promising tool 
in future Salmonella surveillance, worthy of further investigation for optimization. 
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Previous studies with organic acids in the feed showed both reducing (Tanaka et al., 2010; Creus et al., 
2007) and non-reducing (Martín-Peláez et al., 2010; Walsh et al., 2012) capacities on Salmonella excretion or 
antibody induction. In this study, we opted for supplementing the feed with coated calcium-butyrate, as 
earlier studies (Van Immerseel et al., 2005; Boyen et al., 2008b) have shown that coating of fatty acids is 
needed to let them reach the colonization sites (ileum, caecum and colon) in their active form. In 
addition, the in-feed coated butyrate was combined with the current DIVA vaccine, as these two control 
strategies are believed to be complementary. Namely, both strategies have a different working 
mechanism to combat Salmonella transmission, i.e. the vaccination enhancing the host’s immune 
response and the coated butyrate targeting Salmonella bacteria in the gut environment and improving 
intestinal epithelial growth. In the current study, Salmonella transmission in the DIVA vaccine + 
butyrate group was not significantly different from the one in both other challenged groups. In this 
group however, significantly less non-challenged contact animals excreted Salmonella and significantly 
less organ samples of all challenged and non-challenged pigs were found Salmonella-positive, when 
compared to in the positive control group. An additional beneficial effect was thus observed in the 
combination group, in comparison with the DIVA vaccine intervention on its own, which might be 
explained by this dual approach to Salmonella infection. However, the combination of both strategies 
would also incur considerable additional costs, in comparison with the single interventions. Therefore, 
more research including a cost-benefit analysis and while monitoring pigs for a longer period (e.g. from 
weaning till market age), is warranted. 
 
Conclusions 
Both interventions in this study did not show a significant reduction of Salmonella Typhimurium 
transmission. Significantly less contact pigs excreted Salmonella however, in the group where 
vaccination was combined with coated butyrate in the feed, and the vaccine itself confirmed its ‘DIVA’ 
capacity. Therefore, these interventions merit further research to improve their applicability in 
Salmonella control programmes. 
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Abstract 
Efficient control programmes for Salmonella in pig herds are important to reduce the risk for 
salmonellosis in humans and to limit performance losses incurred by Salmonella-infected pigs. 
Vaccination against Salmonella may constitute an interesting control strategy at farm level. 
In this study we investigated the usefulness of an attenuated Salmonella Typhimurium strain to 
control Salmonella infections in three Salmonella Typhimurium-positive, farrow-to-finish pig herds. 
Within each herd, 120 piglets were orally vaccinated at three and 24 days of age, and 120 piglets were 
left unvaccinated as controls. At specific time points, all pigs were weighed and faeces, ileocaecal 
lymph nodes, caecal contents and carcass swabs were examined for Salmonella by isolation; serum was 
analysed for Salmonella-specific antibodies via ELISA. Prior to slaughter, a significantly higher mean 
daily weight gain (546.8g), significantly less Salmonella-excreting pigs (8.9%) and a significantly 
lower Salmonella-specific mean antibody titre (S/P 1.07) were observed over all vaccinated animals of 
the three herds, compared to the controls (509.3g; 27.8%; S/P 1.51). Overall, no significant differences 
in the proportions of Salmonella-positive slaughter samples were found between the vaccinated vs. the 
control group for ileocaecal lymph nodes (36.3% vs. 40.0%), caecal contents (30.6% vs. 42.6%), and 
carcass swabs (29.0% vs. 28.6%). In the vaccinated vs. the control group of two herds however, 
significantly less Salmonella-positive lymph node samples (57.8% vs. 77.0%) and caecal contents 
samples (18.4% vs. 54.5%) were present. From 3.0%, 2.0% and 8.3% of all faecal, lymph node and 
caecal contents samples from the vaccinated pigs respectively, a Salmonella strain was isolated with the 
same auxotrophic characteristics and genotype as the vaccine strain. 
Our findings indicate that the currently used vaccination protocol improves daily weight gain and 
reduces Salmonella shedding on Salmonella problem herds, however without consistent reduction of 
Salmonella loads and possible persistence of the vaccine strain in tissues. 
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Introduction 
The largest number of reported food-borne outbreaks in the EU is currently caused by Salmonella 
(26.6% of all outbreaks). In 2011, approximately 56.8% of the human salmonellosis cases could be 
attributed to pigs (EFSA and ECDC, 2013a). Although most infected pigs do not show clear clinical signs, 
Salmonella infections may reduce the weight gain significantly (Boyen et al., 2009; Davis et al., 2010; Farzan 
and Friendship 2010). Therefore, interventions that decrease Salmonella prevalence at farm level are of 
utmost importance for both humans and swine. 
Biosecurity measures, such as all in/all out management, pest control, cleaning and disinfection may 
help to decrease the Salmonella infection level (Lo Fo Wong et al., 2004a; Fosse et al., 2009; Baptista et al., 
2010a), but they are often insufficient as stand-alone measures. Therefore, additional control strategies 
on-farm are indispensable. 
Numerous studies have described the effect of feed or water supplementation with organic acids on 
Salmonella infection in pig herds, but with inconsistent results (Letellier et al., 2000; van der Wolf et al., 
2001b; Creus et al., 2007; Walsh et al., 2007, 2012; Boyen et al., 2008b; Tanaka et al.2010; De Ridder et al., 2013a,b). 
Also the feed characteristics can influence Salmonella prevalence in pigs, e.g. coarsely versus finely 
ground feed, and liquid against dry feed (Canibe et al., 2005; Farzan et al., 2006; Visscher et al., 2009; Wilhelm et 
al., 2012). However, these feed or water interventions are not readily applicable in every farm, as 
substantial additional investments may be required, like extra pumps and corrosion-resistant materials. 
Vaccination of pigs against Salmonella could represent an interesting control measure, which does 
not need such infrastructure changes. A Salmonella Enteriditis vaccine is currently successfully used in 
laying hens in several European countries (Collard et al., 2008; EFSA and ECDC, 2012a), and in pigs most 
vaccination studies against Salmonella generally report beneficial effects (Springer et al., 2001; Roesler et 
al., 2004; Lindner et al., 2007; Selke et al., 2007; Rösler et al., 2010; Leyman et al., 2012; Arguello et al., 2013). 
However, most studies in pigs were conducted with a limited number of suckling (Rösler et al., 2010) or 
weaned piglets (Springer et al., 2001; Roesler et al., 2004; Selke et al., 2007; Leyman et al., 2012; De Ridder et al., 
2013a,b), and used a challenge infection protocol. Their relevance for field conditions needs to be 
verified with a large number of finisher pigs (Lindner et al., 2007; Farzan and Friendship 2010; Arguello et al., 
2013). 
At the moment, only one Salmonella vaccine is commercially available for use in pigs in the EU 
(Salmoporc
®
, IDT Biologika). It is a live Salmonella Typhimurium vaccine, authorized only in Germany 
and Poland, that has been evaluated on large-scale in sows and weaned piglets at three and six weeks of 
age (Lindner et al., 2007). In a small-scale infection experiment, the double administration of this vaccine 
to suckling piglets at three and 28 days of age significantly reduced organ colonization and faecal 
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excretion (Rösler et al., 2010). This early vaccination scheme at three and 28 days of age minimizes 
farmers work load, but its efficacy needs to be confirmed by large-scale studies while monitoring the 
pigs until slaughter age. In addition, the possible interference of this vaccination protocol with 
Salmonella serosurveillance, requires investigation. 
Therefore, we evaluated the weight gain, the Salmonella-specific antibody titre and Salmonella 
presence in faeces and organ tissues of pigs, after oral immunisation at 3 and 28 days of age with this 
commercially available live Salmonella Typhimurium vaccine. 
 
Materials and methods 
Herd selection and experimental animals 
Three pig herds (A, B, C) were selected based on the following inclusion criteria: i) a high 
Salmonella-specific antibody level in finishing pigs as determined by the Belgian national Salmonella 
Surveillance Programme, in accordance with the EU Regulation No 2160/2003 (Van der Stede et al., 2008), 
ii) being a closed farrow-to-finish herd, iii) the possibility to monitor piglets from birth till slaughter, 
iv) the farmer’s agreement to apply the same management during the experiment as before. The 
presence of Salmonella Typhimurium on these herds was confirmed prior to the study, by analysing 
pooled faecal samples from sows and fattening pigs, and ileocaecal lymph nodes from slaughter pigs. 
The size of the pens in the nursery units ranged from 25 to 30, and in the fattening units from 10 to 15 
pigs; both units had fully slatted floors in the three herds. The biosecurity level of herd A and C were 
comparable, while this level was markedly lower in herd B (considering pest control and hygiene). All 
pigs received non-medicated feed during the trial. The weaned piglets were fed dry meal in all herds; 
the fattening pigs were given meal in herd A, and pellets in herd B and C. 
In spring 2012, 20 pregnant sows (Topigs20) in each farm were selected three days after farrowing, 
and their piglets were randomly allocated at litter-level to either a vaccinated or unvaccinated group. 
All suckling piglets of each sow were included in the study and monitored until slaughter age. The 
sows from the piglets in each group had the same parity distribution. The study was approved by the 
ethical committee of the Faculty of Veterinary Medicine, Ghent University (EC 2011/196). 
Vaccination and sampling design 
The details of the trial design are summarized in figure 1. Briefly, in each herd, approximately 120 
piglets from 10 litters received an oral vaccination at three and 28 days of age with an attenuated 
histidine-adenine auxotrophic Salmonella Typhimurium strain (Salmoporc®, Lot nr. 0130311, IDT Biologika) 
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(V=vaccination group), while 120 piglets from 10 other litters were left unvaccinated (C=control 
group). Transfer of piglets from one sow to another was not allowed after three days of age. All piglets 
were weaned at 28 days of age. From weaning until slaughter age, the pigs of the vaccinated and 
control group were kept separately on the farm, during transport to the slaughterhouse and in the lairage 
area. In the fattening period, the degree of separation differed between herds as follows: it was most 
strict in herd C (separated rooms), followed by herd A (separated pens, vaccinated pens grouped 
together) and herd B (separated pens, vaccinated pens dispersed among unvaccinated ones). All pigs 
were individually weighed to calculate the daily weight gain (DWG) between 3 days and 29 weeks of 
age. Within each herd, 30 randomly selected pigs per group were sampled serially at different time 
points for individual rectal faeces and blood. In all herds, the pigs were transported to the 
slaughterhouse in two times, with both groups equally represented at every occasion. The pigs of 
herd A and C were all slaughtered in slaughterhouse 1 (2x morning) and 2 (2x noon), respectively; 
herd B pigs were slaughtered in slaughterhouse 2 (noon) and 3 (morning) at the first and second 
occasion, respectively. At slaughter, the following samples were collected from each group: caecal 
contents from these same 30 pigs, ileocaecal lymph nodes from these 30 pigs together with 40 other 
randomly selected slaughter pigs, and swabs from every 10
th
 carcass at the slaughter line. 
Sample analysis 
Salmonella was isolated from the faecal samples (rectal and caecal; ca. 10-25g) using the 
ISO 6579:2002/Amd1:2007 Annex D (ISO, 2007). Briefly, the samples were diluted 1:10 in buffered 
peptone water (BPW, Bio-Rad) and incubated for 16 - 20 h at 37°C. From every pre-enrichment solution, 
100 μl was spotted onto one modified semi-solid Rappaport-Vassiliadis plate (MSRV, Bio-Rad) and 
incubated for 46 - 50 h at 41.5°C. After this period, a loopful from the edge of a typical migration zone 
on each MSRV plate was streaked onto a xylose lysine deoxycholate agar plate (XLD, Bio-Rad) and a 
brilliant green agar plate (BGA, Lab M). Both plates were incubated at 37°C for 21 - 27 h. When 
Salmonella presumptive colonies were present on both the XLD and BGA plates, one colony was 
inoculated in triple sugar iron agar (TSI, Bio-Rad), sorbitol agar (Becton Dickinson) and lysine 
decarboxylase broth (Oxoid) and incubated for 18 - 24 h at 37°C for final confirmation. 
Before bacteriological examination of the ileocaecal lymph nodes (ca. 10-13g), they were flamed 
briefly to decontaminate the surface, sliced, diluted 1:10 in BPW and then homogenized with a 
stomacher blender (BagMixer, Interscience) for one minute. The carcass swabs were immersed directly in 
BPW without preparation. Further isolation was performed identically as for the faecal samples. 
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Isolates from samples from the vaccinated pigs, were additionally tested using the Salmonella 
Diagnostic Kit
®
, produced by the manufacturer of the vaccine (IDT Biologika). This kit distinguishes 
wild-type Salmonella strains from the vaccine strain through the use of two fluid media A and B. As 
the vaccine strain is histidine-adenine auxotrophic, it only grows in medium B which contains histidine 
and adenine, whereas wild-type strains show growth in both media. Additionally these strains were 
typed by Multiple-Locus Variable-number tandem repeat Analysis (MLVA) (Larsson et al., 2009) and 
analysed by a Pulsed-Field Gel-Electrophoresis (PFGE) (Peters, 2009). 
Blood samples were centrifuged after coagulation for 5 min at 1500 g to collect serum. This serum 
was diluted twenty-fold and analysed for Salmonella-specific antibodies under blinded conditions with 
a commercial ELISA kit based on lipopolysaccharide (LPS) O-antigens of serogroup B, C1 and D 
(HerdChek Swine Salmonella, IDEXX Laboratories). The results were expressed as a ‘Sample to Positive’ ratio; 
samples with an S/P ratio ≥0.25 (= OD% ≥10) were defined as positive. 
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Figure 1: Flowchart of the study design in the three farrow-to-finish herds. 
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Statistical analysis 
The daily weight gain between three days and 29 weeks of age of each pig (excl. pigs that died 
before slaughter), was normally distributed and was compared between the vaccinated and control 
group using an independent-samples t-test in SAS 9.2 (SAS Institute Inc., Cary, NC, USA). 
The number of positive faecal samples was compared between vaccinated and control animals by 
means of generalized estimating equations (GEE) (Proc Genmod in SAS 9.2). A logit link function, a 
binomial distribution and an exchangeable correlation structure was used (correlation is the same 
among any two observations from the same animal). Mortality and isolation data at slaughter were 
analysed using the Pearson Chi-square test in SAS 9.2. In these analyses, samples containing the 
vaccine strain were considered Salmonella-negative. 
The differences in S/P ratios between vaccinated and control animals were analyzed by repeated 
measures ANOVA, using the Proc Mixed procedure with lsmeans and slice options in SAS 9.2. Time 
and group (vaccinated and control) were included in the model as fixed effects and the herd as random 
effect. An unstructured covariance structure was selected, based on the lowest AIC value (Akaike 
Information Criterion). To adjust for the multiple comparisons in this procedure, the Ryan-Einot-
Gabriel-Welch (REGWQ) test was used. 
P-values below 0.05 were considered significant (two-sided tests). 
 
Results 
Some animals in both groups were lost for follow-up, due to mortality (runts, physical abnormalities 
or idiopathic causes) or lost ear tags (Fig. 1). There was no significant difference in mortality (P = 0.90) 
between the vaccinated (V) (50/347) and control (C) group (59/362). 
Daily Weight Gain (DWG) 
For the three herds, a significantly higher DWG (P < 0.01) was observed in group V (n = 289; 
DWG = 546.8g, 95% CI = [537.7-555.8]), when compared to group C (n = 302; DWG = 509.3g, 95% 
CI = [499.4-519.2]) (Table 1). This result was consistent in each herd of the study, since the following 
differences in the mean DWG were found between the V and C groups (P<0.01): 29.6g (herd A), 37.2g 
(herd B), and 38.9g (herd C) (Table 1). 
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Table 1: Daily Weight Gain (DWG; gram) between 3 days and 29 weeks of age. Presented for the vaccination and control 
group, for the three farrow-to-finish pig herds A, B, C separately and over all herds. 
Herd  Mean DWG [95% CI]  Difference DWG 
(P < 0.01)  Vaccination Control  
A  593.0 [578.8-607.3] 563.4 [549.0-577.9]  29.6 
B  504.3 [488.9-519.8] 467.1 [452.5-481.7]  37.2 
C  535.6 [520.9-550.4] 496.7 [482.3-511.0]  38.9 
A+B+C  546.8 [537.7-555.8] 509.3 [499.4-519.2]  37.5 
 
 
Bacteriological analysis of faecal samples taken in the herd 
The proportions of Salmonella-positive faecal samples collected on-farm, are shown for the three 
sampling occasions in figure 2. Some data are missing, due to an empty rectum or lost ear tags (Fig. 1). 
Over all herds, the proportions of Salmonella-excreting pigs in group V and C did not differ 
significantly at the first two sampling occasions: 9/99 (9.1%) (V) vs. 11/98 (11.2%) (C) at 10 weeks of 
age (P = 0.46), and 9/89 (10.1%) (V) vs. 11/82 (13.4%) (C) at 16 weeks of age (P = 0.50). Two weeks 
prior to slaughter however, at 29 weeks of age, this proportion was significantly different between both 
groups: 7/79 (8.9%) (V) vs. 22/79 (27.8%) (C) (P < 0.01). 
When analysing each herd separately, the proportion of Salmonella-excreting pigs was also lower in 
herd B (1/29 (3.4%) (V) vs. 12/29 (41.4%) (C) (P < 0.01)) and in herd C (0/22 (0.0%) (V) vs. 
6/22 (27.3%) (C) (P < 0.01)), whereas this was not the case in herd A (6/28 (21.4%) (V) vs. 
4/28 (14.3%) (C) (P = 0.49). 
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Figure 2: Salmonella-excreting pigs (%) and Salmonella-specific antibody levels in blood (mean S/P ratio) per group 
and herd. Presented for four sampling occasions: 1) 3 days of age (3 D), 2) 10 weeks of age (10 W), 3) 16 weeks of age 
(16 W), and 4) 29 weeks of age, i.e. 2 weeks prior to slaughter (29 W). The error bars represent the 95% confidence 
interval. The asterisks (*) below the graphs indicate a significant difference between the control (black) and vaccination 
(grey) animals per herd (A, B, C). 
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Bacteriological analysis of samples taken in the slaughterhouse 
The proportions of Salmonella-positive samples from ileocaecal lymph nodes, caecal contents and 
carcass swabs, collected in the slaughterhouse, are presented in table 2. Some data are missing, due to 
lost ear tags (Fig. 1). 
Over all herds, no significant differences in the proportions of Salmonella-colonized samples were 
found between the V and C group for ileocaecal lymph nodes: 73/201 (36.3%) (V) vs. 72/180 (40.0%) 
(C) (P = 0.46); for caecal contents: 37/121 (30.6%) (V) vs. 49/115 (42.6%) (C) (P = 0.06); and for 
carcass swabs: 9/31 (29.0%) (V) vs. 8/28 (28.6%) (C) (P = 0.97). 
When analysing each herd separately, the following significant differences were found in the 
proportions of isolation-positive samples between the V and C group of two herds: in the lymph nodes 
from herd B: 37/64 (57.8%) (V) vs. 47/61 (77.0%) (C) (P < 0.03), and in the caecal contents from 
herd C: 9/49 (18.4%) (V) vs. 24/44 (54.5%) (C) (P < 0.01). 
 
 
Table 2: Proportion of slaughter samples positive for Salmonella wild-type strains, presented per herd and group. 
Presented for each vaccination (Vacc) and control (Contr) group of herd A, B and C, in function of three sampled matrices: 
(1) ileocaecal lymph nodes (Lnn); (2) caecal content (Cc); and (3) carcass swabs (Sw). 
Sampled 
matrix 
 Herd
 1 
 A  B  C  A+B+C 
 Vacc Contr  Vacc Contr  Vacc Contr  Vacc Contr 
Lnn 
 25/66
 
(38%) 
14/63
 
(22%) 
 37/64
 a 
(58%) 
47/61
 b 
(77%) 
 11/71
 
(16%) 
11/56
 
(20%) 
 73/201 
(36%) 
72/180 
(40%) 
Cc 
 6/39
 
(15%) 
5/37
 
(14%) 
 22/33
 
(67%) 
20/34
 
(59%) 
 9/49
 a 
(18%) 
24/44
 b 
(55%) 
 37/121 
(31%) 
49/115 
(43%) 
Sw 
 0/10
 
(0%) 
1/10
 
(10%) 
 9/10
 
(90%) 
7/8
 
(88%) 
 0/11
 
(0%) 
0/10
 
(0%) 
 9/31 
(29%) 
8/28 
(29%) 
1
 Proportions in a row, underlined and with different letters in superscript, are significantly different between the 
Vaccination (Vacc) and Control (Contr) group: Ileocaecal lymph nodes in herd B (P<0.03); Caecal content in herd C 
(P = 0.02). 
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Detection of the vaccine strain 
In the biochemical kit (Diagnostic Kit®, IDT Biologika), 3/99 (3.0%), 2/89 (2.2%) and 3/79 (3.8%) of the 
faecal samples from the vaccinated pigs tested histidine-adenine auxotrophic at 10, 16 and 29 weeks of 
age, respectively. Similarly, the kit suggested the presence of a histidine-adenine auxotrophic strain in 
4/201 (2.0%), 10/121 (8.3%) and 0/31 (0.0%) samples of the lymph nodes, caecal contents and carcass 
swabs, respectively. In the MLVA, the strains from all kit-positive samples belonged to the same 
MLVA type as the vaccine strain (Table 3). The PFGE (Table 3) demonstrated in addition, that all kit-
positive samples shared the same PFGE-profile as the vaccine strain, with the exception of one isolate 
(lane 13) (Figure 3). The proportion of samples that tested positive for the Salmonella vaccine strain, 
are presented per herd in table 4. 
 
 
Figure 3: Pulsed-field gel electrophoresis (PFGE) images of the 22 strains derived from the vaccinated pigs, which tested 
positive for the vaccine strain in the biochemical Diagnostic Kit (IDT Biologika). Lanes ‘1-8’ contain isolates from faeces 
from herd A (1,2), B (3,4), and C (5-8); Lanes ‘9-12’ contain isolates from lymph nodes from herd A (9), and C (10-12); 
Lane ‘V’ contains the vaccine strain Salmporc® and lane ‘+’ a Salmonella Braenderup strain (PulseNet control strain; Lanes 
‘13-22’ contain isolates from caecal contents from herd A (13,14), B (15,16), and C (17-22). 
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Table 3: Results of the different analyses, performed on the 22 strains derived from the vaccinated pigs, which tested 
positive for the vaccine strain in the biochemical Diagnostic Kit (IDT Biologika), presented per herd. 
Herd  Sample
a
  Kit
b
  MLVA (New nomenclature alleles)
c
  PFGE
d
 
profile    STTR9 STTR5 STTR6 STTR10 STTR3  
 SSI1 (Control) 
 
- 
 
6 9 13 10 0211 
 
A 
 Salmoporc®(Vaccine) 
 
+ 
 
2 17 5 14 0212 
 
B 
A 
 
F10W-Pig564  
 
+ 
 
2 17 5 14 0212 
 
B 
  
F10W-Pig572  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Lnn-Pig512  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Cc-Pig512  
 
+ 
 
2 17 5 14 0212 
 
  B? 
  
 
Cc-Pig529  
 
+ 
 
2 17 5 14 0212 
 
B 
B 
 
F10W-Pig344  
 
+ 
 
2 17 5 14 0212 
 
B 
  
F17W-Pig326  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Cc-Pig316  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Cc-Pig383  
 
+ 
 
2 17 5 14 0212 
 
B 
C 
 
F17W-Pig199  
 
+ 
 
2 17 4 14 0212 
 
B 
  
F29W-Pig150  
 
+ 
 
2 17 5 14 0212 
 
B 
  
F29W-Pig179  
 
+ 
 
2 17 5 14 0212 
 
B 
  
F29W-Pig199  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Lnn-Pig130  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Lnn-Pig137  
 
+ 
 
2 17 5 15 0212 
 
B 
  
Lnn-Pig151 
 
+ 
 
2 17 5 14 0212 
 
B 
  
Cc-Pig127  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Cc-Pig143  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Cc-Pig150  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Cc-Pig152  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Cc-Pig178  
 
+ 
 
2 17 5 14 0212 
 
B 
  
Cc-PigRV37  
 
+ 
 
2 17 5 14 0212 
 
B 
a 
SSI1= Salmonella Typhimurium strain; Salmoporc
®
=histidine-adenine auxotrophic Salmonella 
Typhimurium strain; F10W/17W/29W= Faeces sampled at 10/17/29 weeks of age; Lnn= Lymph nodes; Cc= 
Caecal content; 
b 
Diagnostic Kit
®
, IDT Biologika; 
c 
MLVA= Multiple-Locus Variable-number tandem repeat Analysis; 
d 
PFGE= Pulsed-Field Gel-Electrophoresis 
 
 
 
Table 4: Proportion of samples from the vaccinated pigs, which tested positive for the Salmonella vaccine strain, presented 
per herd. Presented per herd A, B, C and over all herds, in function of four sampled matrices: 1) faeces at 10 (F 10W), 16 
(F 16W) and 29 (F 29W) weeks of age, 2) ileocaecal lymph nodes (Lnn), 3) caecal content (Cc), and 4) carcass swabs (Sw). 
Herd  Matrix 
 F 10W F 16W F 29W Lnn Cc Sw 
A  2/35 (5.7%) 0/32 (0.0%) 0/28 (0.0%) 1/66 (1.5%) 2/39 (5.1%) 0/10 (0.0%) 
B  1/30 (3.3%) 1/28 (3.6%) 0/29 (0.0%) 0/64 (0.0%) 2/33 (6.1%) 0/10 (0.0%) 
C  0/34 (0.0%) 1/29 (3.4%) 3/22 (13.6%) 3/71 (4.2%) 6/49 (12.2%) 0/11 (0.0%) 
A+B+C  3/99 (3.0%) 2/89 (2.2%) 3/79 (3.8%) 4/201 (2.0%) 10/121 (8.3%) 0/31 (0.0%) 
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Serology 
The Salmonella-specific antibody levels (mean S/P ratio) are shown for each group, herd and 
sampling occasion in figure 2. At three days of age, just prior to vaccination, the mean S/P ratio over all 
herds was comparable between both groups: 1.50 ±0.87 (STDEV) in group V (n = 120) and 1.53 ±0.79 
in group C (n = 119) (P = 0.73). However, in herd A the mean S/P ratio of V group (S/P =2.11 ±0.68; 
n = 40) and C group (S/P =1.75 ±0.58; n = 40) differed significantly (P < 0.03). 
At ten weeks of age, the mean S/P ratio in both groups was three- to five-fold lower than at three 
days of age. The mean S/P ratio over all herds was significantly higher in the V group (mean 
S/P 0.49 ±0.51; n = 100) compared to the C group (mean S/P 0.31 ±0.46; n = 102) (P < 0.01). This is 
mainly due to the significant difference between both groups in herd A and herd C: the mean S/P ratio 
was 0.43 ±0.33 (n = 35) (V) vs. 0.18 ±0.21 (n = 36) (C) for herd A (P < 0.02), and 0.71 ±0.70 (n = 33) 
(V) vs. 0.09 ±0.21 (n = 37) (C) for herd C (P < 0.01). The opposite was true for herd B with a mean S/P 
ratio of 0.32 ±0.36 (n = 32) (V) vs. 0.66 ±0.66 (n = 29) (C) (P < 0.01). 
At 29 weeks of age, the S/P ratio over all herds was significantly higher in the C group (P < 0.01): a 
mean S/P ratio was detected of 1.07 ±0.55 (n = 89) (V) vs. 1.52 ±0.68 (n = 87) (C). This outcome was 
mainly attributable to the results obtained in herd A and herd C, as a mean S/P ratio of 0.94 ±0.39 (V) 
vs. 1.53 ±0.55 (C) was detected in herd A (P < 0.01), and 0.86 ±0.54 (V) vs. 1.69 ±0.71 (C) in herd C 
(P < 0.01). No significant difference was observed in the mean S/P ratios of herd B: 1.39 ±0.58 (V) vs. 
1.34 ±0.75 (C) (P = 0.71). 
 
Discussion 
In this study, a live vaccine applied orally in pigs at 3 and 28 days of age yielded overall beneficial 
results towards daily weight gain. Salmonella excretion in faeces and serum antibody levels were also 
lower in the vaccinated animals than in the controls, prior to slaughter. Apart from these beneficial 
effects, some limitations of the vaccine to be used under field conditions were found as well, and are 
discussed below. 
The significantly higher daily weight gain of the vaccinated pigs implies a clear incentive for pig 
producers to control the Salmonella infection pressure in their herd. Because most Salmonella 
infections are subclinical in pigs, they might not have realized the full impact of Salmonella on pig 
performance so far. The feed intake could not be recorded for both groups separately, however. 
Consequently, the feed conversion ratio, an economically important parameter, could not be measured. 
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Additional research addressing all economically important performance parameters is warranted for a 
more accurate insight in the vaccine’s influence on this. 
The overall bacteriological and serological results of this study were promising, but there was a 
considerable variation between the three herds. Over all herds, significantly less vaccinated pigs 
excreted Salmonella prior to slaughter, in comparison with the control pigs. This is an important 
finding, as finishing pigs may introduce Salmonella this way into the slaughterhouse environment 
(Letellier et al., 2009). Also a significantly lower Salmonella-specific antibody level was observed before 
slaughter among the vaccinated animals over all herds, suggesting a decreased Salmonella infection 
pressure in the preceding period (Lo Fo Wong et al., 2004b; Baptista et al., 2009). The variable individual 
results between the three herds might be due to several reasons. Firstly, in field conditions pigs are 
infected at different points in time, with a herd- and even batch-dependent variability in both infection 
pressure and host response (Beloeil et al., 2003; Lo Fo Wong et al., 2004b; Rostagno et al., 2012b). Secondly, the 
presence of herd-specific Salmonella strains might have influenced the vaccination effect as well (Van 
Parys et al., 2013). In addition, some study-specific variation may have altered the outcome, since the 
degree of separation of the vaccinated from the control groups was not identical in the three farms. 
Unlike herd A and B (with the vaccinated and control pens in one room), both the antibody titre and 
faecal excretion in herd C (with all vaccinated pens in a room separated from the control pens) were 
significantly reduced in the vaccinated finishing pigs. This may indicate that vaccination will attain its 
most distinctive effect when all pigs in a stable or herd are vaccinated. This corroborates with another 
recent vaccination study, in which faecal excretion and organ colonization were reduced the most, 
when all pigs in the barn were vaccinated instead of the pigs in certain pens only (Arguello et al., 2013). 
Finally, a different maternal antibody level in the piglets at the moment of vaccination on the three 
herds might have contributed to the herd variation as well. In our study, we chose to vaccinate the pigs 
early at three and 28 days of age, in order to induce protection against possible infections occurring 
already in the nursery period. Vaccination at these time-points has also some practical advantages as 
the pigs can be taken up easily to apply the vaccine orally, and because piglets are handled anyway at 
weaning before moving them to the nurseries. No interference by maternal antibodies was expected 
upon this early prime vaccination, as Rösler et al. (2010) could not demonstrate a negative effect of 
maternal antibodies on the Salmonella vaccination using the same vaccine in suckling pigs. In the 
present study however, the herd with the highest maternal Salmonella-specific antibody levels in pigs at 
first vaccination was the only herd without a significant decreased Salmonella excretion in the 
vaccinated pigs at finishing stage. This observation suggests that maternal immunity might have 
interfered with the oral vaccination. Further field studies on the role of maternal immunity on the 
efficacy of this vaccine are therefore needed before recommending the current vaccination scheme. 
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No persistence of the vaccine strain was expected in the vaccinated groups of this study, as a 
previous experiment with the current vaccine could not detect the vaccine strain in the lymph nodes of 
slaughter pigs that had been vaccinated at 21 and 42 days of age (Lindner et al., 2007). In contrast, this 
study suggested the presence of the vaccine strain in the faeces throughout the fattening period in all 
three herds, and in the lymph nodes and caecal content at slaughter. No clear explanation is available 
for this persistence of the vaccine strain or occurrence of a vaccine-like strain. Anyhow, this finding 
might have important implications for bacteriological monitoring programmes, since supplementary 
bacteriological testing would be necessary to avoid Salmonella-positive results in vaccinated herds. 
Although the histidine-adenine auxotrophic Salmonella Typhimurium strain used here is most probably 
attenuated in humans too, further studies are necessary to address possible public health implications of 
our findings. 
In conclusion, the early vaccination scheme with the current live Salmonella Typhimurium vaccine 
in herds with a high Salmonella infection level, improved daily weight gain, reduced faecal excretion, 
and induced a lower Salmonella-specific antibody titre at slaughter age, when compared to non-
vaccinated pigs. This vaccine could therefore, be a helpful tool in the control of Salmonella infection. 
However, the effects were variable between herds, and a possible persistence of the vaccine strain until 
slaughter age requires further studies. 
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1. Introduction 
Directive 2003/99/EC and Regulation (EC) No 2160/2003 demanded targets for the monitoring and 
control of food-borne zoonotic agents in all EU Member States (MS). Currently, many MS have 
already implemented national control programmes to reduce Salmonella prevalence in poultry 
(Anonymous, 2007a; EFSA and ECDC, 2012a) or pigs (Alban et al., 2002; Anonymous, 2007b; Merle et al., 2011; EFSA 
and ECDC, 2012a; Anonymous, 2013a,b). For poultry, most MS met the Salmonella reduction targets thanks 
to a successful Salmonella control programme, and in particular by vaccinating laying hens. This 
vaccination became mandatory in Belgium in 2007 (Anonymous, 2007a). It is assumed that the vaccination 
of laying hens was the main reason for the decrease in the number of Salmonella Enteritidis infections 
in humans, reported in the EU over the period 2008-2011 (EFSA and ECDC, 2013a). The number of 
Salmonella Typhimurium cases in humans however, has remained constant in the same period, or has 
even increased if the monophasic Salmonella Typhimurium cases are taken into account (EFSA and 
ECDC, 2013a; Fig. 8). As Salmonella Typhimurium is by far the most common serovar isolated from pigs 
and pork (EFSA and ECDC, 2013a), this might indicate that the control programmes of several reporting 
MS are currently insufficient to reduce Salmonella prevalence in pig production. 
 
 
 
Figure 8: Number of reported confirmed human salmonellosis cases in 25 EU Member States, 
shown per month in 2008-2011 (EFSA and ECDC, 2013a). 
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In Belgium, a national pig Herd-specific Salmonella Action Plan (HSAP) was implemented in 2007, 
but since then no significant improvement was observed of the Salmonella seroprevalence of the pig 
population (Méroc et al., 2012), neither was there a reduction recorded in the human Salmonella 
Typhimurium cases (NRSS, 2012). 
This might be explained partially by the fact that highly efficacious measures are currently not 
available. As such, there is little confidence in any measure, which may lead to poor compliance. In 
addition to that, Salmonella control measures were not mandatory, but merely recommended for herds 
that were assigned ‘at risk’ in the HSAP, which also hinders significant improvements. 
Apart from the control measures, also the Salmonella monitoring and follow up was inefficient in 
Belgium. Méroc et al. (2012) recently pointed out that the observed serological improvement of one-
third of the risk herds from the HSAP, was probably due to random variation in the serological 
response. The different pig weight categories that were sampled, as demanded for the Aujeszky’s 
disease programme, may have led to variable mean S/P ratios within a herd from one sampling round to 
the next. Moreover, farms that should be assigned as ‘high risk’ might be missed, as these authors 
showed that the current sample size (12 serum samples per farm visit) is too small to attain a herd-
sensitivity above 95%. Consequently, these facts may have resulted in an erroneous determination of a 
herd’s risk status. As Belgium is one of the five largest exporting countries of pig meat in the EU 
(Anonymous, 2010), the need for more efficacious control measures and a more accurate monitoring 
programme is urging. 
This general discussion elaborates on the control measures that were evaluated during the 
experimental work performed in this thesis and on the possible monitoring scenarios that are 
considered for the future SAP. 
 
2. Salmonella control in primary production 
To investigate the effect of possible control measures, different study designs are available. In this 
thesis, two experimental transmission studies in piglets and one field study in fattening pigs were 
performed to evaluate such control measures. 
The design of the transmission studies implied that treatment (‘the control measure under study’) 
was applied to all pigs before some of them (the ‘seeder’ pigs) were experimentally infected. With this 
study design, the seeder pigs in each ‘treatment’ group transmitted different amounts of bacteria 
towards the contact animals (Chapter 3.1). 
On the one hand, this design allowed investigating the combined effect of the treatment on both the 
excretion of the challenged pigs and the susceptibility of the naive contact animals. This is for instance 
not the case in more commonly used efficacy studies, in which all treated pigs are challenged and thus 
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mainly the susceptibility is assessed (Roesler et al., 2004; Taube et al., 2009; Tanaka et al., 2010). Transmission 
studies may therefore provide a better simulation of the field situation, since control measures do have 
an effect in the field on both the excretion of and susceptibility to Salmonella. In other words, a treated 
pig may indeed be infected and subsequently infect other treated pigs in the same area. Only 
considering the reduction of the susceptibility of the contact animals may thus underestimate the 
treatment effect. This has also been demonstrated in the past with the vaccination against Aujeszky’s 
disease virus in pigs. Based on classical efficacy studies, the vaccine appeared insufficiently effective 
(Baskerville, 1981; Wittmann, 1986, 1991), whereas in transmission experiments, it was shown that the 
vaccine reduced transmission and could eventually result in an elimination of the virus (Stegeman, 1995; 
Bouma et al., 1996; van Nes, 2001). Afterwards, this turned out to be correct in many European countries. 
Since then, transmission studies have been conducted for many different pathogens (Velthuis et al., 2003; 
Dewulf et al., 2004; Heres et al., 2004; Meyns et al., 2004, 2006; Bohez et al., 2008; Vrancken et al., 2009; Villareal et al., 
2011; Crombé et al., 2012; Claes et al., 2013). 
On the other hand, these different amounts of bacteria excreted by the treated seeders in 
transmission studies provide an unpredictable challenge level towards the contact animals, whereas in 
efficacy studies exactly definable challenge doses are administered. Therefore, the results of the latter 
studies are generally more reproducible. 
Anyhow, the experimental conditions used in both transmission and efficacy studies warrant some 
caution when extrapolating the results towards field conditions. In commercial herds, pigs are infected 
with many different pathogens and the housing, nutrition and management conditions may not be 
optimal. These factors may all influence the treatment effect. Therefore, the experimentally evaluated 
interventions in piglets need to be verified under field conditions, using a large number of animals 
monitored until slaughter. Because of time and financial restrictions, only one promising intervention 
of both transmission studies (vaccination) was further evaluated in this thesis, using a large field study. 
As pointed out in the general introduction (Chapter 1), many control measures to decrease the 
Salmonella infection pressure at primary production are described, such as improved biosecurity, 
nutritional changes and vaccination. As biosecurity measures alone are not sufficient in reducing 
infection levels in the population, they should be combined with other intervention methods (Gautam et 
al., 2013). The intervention strategies studied in this thesis will be discussed hereafter, namely the 
supplementation of organic acids (two in-feed products and one drinking water additive), as well as the 
oral vaccination with a live commercial non-marker vaccine (early- and older-age protocol) and a live 
experimental marker vaccine. 
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2.1 In-feed organic acids 
The first in-feed organic acid evaluated, butyric acid, is a short-chain fatty acid and a main end-
product of intestinal microbial fermentation of dietary fibres, celluloses, starches and sugars. Butyrate 
(the salt form of butyric acid) was proven to reduce the Salmonella load ex vivo in the feed, and to exert 
potent effects in vivo on pathogen control and on a variety of intestinal mucosal functions (Guilloteau et 
al., 2010). Similar to other organic acids, non-dissociated butyrate enters the bacterial cell and 
dissociates due to the higher intracellular pH. This in turn lowers the pH in the bacterial cell and 
prevents DNA synthesis and hence replication (Kirchgessner et al., 1992). Besides this bactericidal effect, 
butyrate can also down-regulate the expression of invasion genes that are located on the Salmonella 
Pathogenicity Island 1 (SPI-1) (Lawhon et al., 2002; Gantois et al., 2006). At the time of our transmission 
studies, an uncoated and coated formulation of butyrate was available on the market. Only the coated 
products, ‘microencapsulated’ by mineral or lipid carriers, are able to reach the intestinal invasion site 
of Salmonella. Uncoated organic acids are resorbed in the upper part of the intestinal tract (Van 
Immerseel et al., 2005; Boyen et al., 2008b). In addition, coated butyric acid has proven superior in controlling 
Salmonella colonization, compared to coated formic and acetic acid (Van Immerseel et al., 2004; Boyen et al., 
2008b). Therefore, coated calcium-butyrate – the salt form being less odorous and volatile than the free 
form – was used in our transmission experiments. 
In the first transmission study (Chapter 3.1), the number of piglets with Salmonella-positive faeces and 
tissues was reduced in the group treated with 0.3% in-feed coated calcium-butyrate (Greencab-70®, 
currently named Globamax Performant
®
, Sanluc International), resulting in a lower adjusted transmission ratio Ra 
( although statistically not-significant), when compared to the positive control group. The treated 
piglets in this group also had a significantly higher daily weight gain than the positive control piglets. 
In the second transmission experiment (Chapter 3.2), piglets were treated with the same product, but they 
were additionally orally vaccinated with an experimental Salmonella Typhimurium marker vaccine. In 
this second study, the treated group had again a significantly lower number of contact animals 
excreting Salmonella and a significantly lower number of Salmonella-positive tissue samples at 
necropsy, when compared to the positive control group. The adjusted transmission ratios Ra in the 
treated group were lower than in the positive control group, but the difference was not statistically 
significant. The daily weight gain was not significantly improved in this group. This indicates that the 
combination of the coated calcium-butyrate and the current vaccination may not be an optimal 
combination. The butyrate might have inhibited the orally administered live vaccine strain, resulting in 
a lowered efficacy of the vaccination. It is however also possible that more pronounced effects would 
have been obtained if more pigs were monitored for a longer period, e.g. until slaughter age. Another 
way to achieve a more distinct effect might be the administration of butyrate at an even earlier age. Le 
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Gall et al. (2009) have demonstrated that a more retarded gastric emptying is induced by feeding 
sodium butyrate pre-weaning instead of post-weaning. Consequently, this prolonged gastric presence 
also implies an increased feed digestibility at pre-weaning age and thus a better performance. 
Similarly, Boyen et al. (2008b) found a reduced Salmonella excretion in a challenge experiment 
with piglets, by administering 0.2% coated butyric acid. Biagi et al. (2007), using 0.1% to 0.4% 
uncoated butyrate in the feed, could not demonstrate an influence on intestinal counts of 
Enterobacteriaceae in piglets, nor on their growth. Similar to both previous findings, Salmonella-
reducing effects were observed in piglets after adding other coated organic acids to the feed (0.4% 
microencapsulated fumaric, sorbic, malic, and citric acid in piglets by Piva et al., 2007), whereas this was not the case 
when administrating uncoated organic acids (0.4% fumaric, lactic, propionic, citric, benzoic acid by Walsh et al. 
(2007) and 0.4% formic, lactic acid by Martín-Peláez et al. (2010)). In some studies uncoated organic acid 
products in the feed did yield beneficial effects, but these authors used a higher dose (1.2% K-diformate by 
Papenbrock et al. (2005) and Taube et al. (2009); 2.8% lactic acid by Tanaka et al. (2010)), or treated older pigs for a 
longer period (0.4 to 0.6 % formic, lactic acid during the fattening period by Creus et al., 2007) than was the case in 
the above mentioned experiments. 
Another organic acid feed-additive that was investigated in the second transmission experiment, was 
a commercial, non-coated premix of 0.5% benzoic acid and 0.3% citric acid (results not published). No 
significant reduction in Salmonella shedding or transmission was observed in this premix group when 
compared to the positive control group, and the daily weight gain was even significantly lower. 
Similar non-beneficial effects on faecal Salmonella prevalence and weight gain were seen in 
challenged piglets that were treated with a lower dose of only benzoic acid (0.3%) via the drinking 
water (Walsh et al., 2012). The fact that both additives were not microencapsulated, as described above, 
might partially explain the lack of effect in our experiment and the one of Walsh et al. (2012). Another 
study in non-infected growing pigs, fed with a 1% benzoic acid diet, could not demonstrate an 
improved weight gain or feed conversion ratio either (Bühler et al., 2006). In contrast, both Guggenbuhl et 
al. (2007) and Papatsiros et al. (2011) have shown that a similar in-feed dosage of benzoic acid (0.5%) 
to non-infected weaned piglets improved their growth performance significantly. Since these three 
studies showed that growth was enhanced in weaned piglets and not in growing pigs, this suggests that 
an early administration might be more efficient to improve pig performance. However, as Bühler et al. 
(2006), Guggenbuhl et al. (2007) and Papatsiros et al. (2011) did not challenge the pigs with 
Salmonella, the impact of this feed-additive on Salmonella-infection could not be assessed. Further 
challenge studies with benzoic acid, preferably in the coated form, are thus recommended to judge its 
applicability in Salmonella-infected herds. 
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In conclusion, our results and those published in literature showed that microencapsulation improves 
the effect of in-feed organic acids on Salmonella shedding and on growth performance of pigs, 
irrespective of the acid type. However, many other parameters may influence their effect, e.g. the 
dosage, the treatment period and the age of the treated pigs. 
 
2.2 Organic acids in drinking water 
The third organic acid product examined in our transmission study was added to the drinking water. 
This organic acid mixture was applied at a dosage of 0.09% v/v, resulting in a final concentration of 
0.05% formic, 0.01% propionic, 0.01% acetic and 0.005% lactic acid in the drinking water, and a 
drinking water pH of 3.6 - 3.8. Unfortunately, the number of Salmonella-excreting piglets in this group 
was higher significantly higher than the number in the positive control group. Also significantly more 
tissue samples were Salmonella-positive in this group than in the positive control group. This suggests 
that the addition of this organic acid mixture via water even enhanced the excretion of Salmonella spp. 
Similar poor results with acidifying the drinking water were found in weaned piglets by Letellier et 
al. (2000). These authors observed no reduced Salmonella colonization of mesenteric lymph nodes after 
challenge, when administering drinking water with 0.02% formic acid. A rather low amount of acids 
was supplemented in both our study and the one of Letellier et al. (2000), which probably led to an 
insufficient bactericidal effect. No higher dosage was possible with both supplemented products 
however, as adding more product would further decrease the pH of the drinking water below 3.5 and 
affect palatability (De Busser et al., 2008). This might explain the lack of effect in the study of Hansen et 
al. (1999), in which the pH of the drinking water of fattening pigs was 3.1 after adding a higher dosage 
of 0.1% formic acid. This low pH of 3.1 might have caused adaptive acid responses inside the 
Salmonella bacteria (de Jonge et al., 2003), and/or an insufficient water intake by the pigs. Both Van der 
Wolf et al. (2001b) and van der Heijden et al. (2006) demonstrated however, that the administration of 
approximately 0.1% formic acid was possible to reach a drinking water pH of only 3.8, if half of the 
acids were buffered as ammonium formiate. Their studies have shown a decreased seroprevalence at 
slaughter when treating pigs during the entire fattening period. Therefore, the application of organic 
acids in their buffered salt form might be a solution for attaining a sufficiently bactericidal effect 
without the palatability problems or the induction of Salmonella adaptive responses to a low pH. De 
Busser et al. (2009) could not find a decreased Salmonella-colonization of slaughter samples 
unfortunately, although they provided drinking water with an acceptable pH of 3.6 - 4.0 and with a 
satisfactory amount of formic acids (i.e. 0.1% formic acid, along with 0.05% acetic, 0.03% propionic, 
and 0.002% sorbic acid). This might have been due to the short treatment period of two weeks prior to 
slaughter, or to cross-contamination in the slaughterhouse. 
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2.3 Vaccination with a live commercial non-marker vaccine 
Another intervention method investigated in this thesis through in vivo studies, was the oral 
vaccination against Salmonella. Two different live vaccines were evaluated for the first time in 
Belgium. 
The first vaccine, the only commercially available Salmonella vaccine for pigs in the EU (Salmoporc®, 
IDT), is a histidine-adenine auxotrophic vaccine. It was used in the first transmission experiment (Chapter 
3.1) and in the field trial (Chapter 3.3). The transmission trial was performed according to the initial 
vaccination protocol recommended by the manufacturer (i.e. oral vaccination at three and six weeks of 
age), whereas the currently recommended protocol was applied in the field study (i.e. early oral 
vaccination at three days and three weeks of age). The latter vaccination protocol was not validated by 
the manufacturer at moment of the transmission study, but it is the preferred protocol, since it 
minimizes the farmers’ work load at the moment of vaccination. 
The transmission study demonstrated that the vaccine was capable of decreasing the number of 
Salmonella-excreting piglets and the adjusted transmission ratio Ra, when compared to the 
unvaccinated positive control group. The mean Salmonella-specific serum antibody titre of the 
vaccinated group however, was significantly higher throughout the experiment until D38 after 
inoculation, compared to the positive control group. The proportion of tissue samples colonized with 
the Salmonella challenge strain, did not differ significantly from the one in the positive control group at 
euthanasia, six weeks post challenge (i.e. 14 weeks of age). Moreover, as many Salmonella vaccine 
strain-positive as Salmonella challenge strain-positive tissue samples were found, when using a 
differentiating biochemical kit provided by the manufacturer of the vaccine (Salmonella Diagnostic Kit®, 
IDT). In other words, without performing this additional differentiation, the vaccinated group would 
have shown twice as much Salmonella-positive tissue samples 52 days post vaccination, when 
compared to the positive control group. According to the manufacturer, the maximum persistence of 
the vaccine strain is 42 days after vaccination (Eddicks et al., 2009), so this period was slightly exceeded in 
the first transmission experiment (Chapter 3.1). Springer et al. (2001) also administered the current 
vaccine to weaned piglets before challenging them with Salmonella Typhimurium. Their study ended 
already one week post challenge and no conclusions were reported concerning the persistence of the 
vaccine strain. These authors also observed a significantly higher antibody response in the vaccinated 
animals, but found a significantly lower number of challenge strain organisms per gram of lymph 
nodes, ileal and caecal contents in the vaccinated than in the unvaccinated group. 
Despite the promising effect of this commercial vaccine of reducing Salmonella excretion in our 
transmission experiment, the presence of vaccine-induced antibodies and the longer persistence of the 
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vaccine strain raised questions concerning the possible use of the vaccine in the current HSAP. As the 
transmission experiment and also most previous vaccination studies were based on a limited number of 
animals, these issues needed further investigation on a larger scale. This led to the conduction of our 
field trial, in which the vaccine was tested in three Salmonella problem herds, and pigs were monitored 
from shortly after birth until slaughter age. 
At the end of the fattening period, a significantly lower Salmonella-specific antibody titre and 
significantly less Salmonella-excreting pigs were observed in the vaccinated group over all herds, 
compared to the control group. The vaccinated animals of one herd showed additionally significantly 
less Salmonella-positive samples in the lymph nodes, while this was the case for caecal contents in 
another herd. These results might indicate that the current vaccination strategy decreased the overall 
Salmonella infection pressure. Lindner et al. (2002; 2007) implemented the same vaccine in one herd, 
according to the initial vaccination protocol (vaccination at three and six weeks of age). They also 
found a significant decreased number of Salmonella-colonized lymph nodes in the vaccinated slaughter 
pigs. In the vaccinated group of each herd, the daily weight gain (DWG) between three days and 29 
weeks of age of the vaccinated group was significantly higher than the non-vaccinated control group. A 
similar outcome in finisher pigs was reported in the vaccination trial of Farzan and Friendship (2010). 
The better DWG among the vaccinated fattening pigs supports the hypothesis that the vaccination 
yielded a lower Salmonella infection pressure, as Salmonella infections cause a reduction of the weight 
gain (Balaji et al., 2000; Turner et al., 2002; Boyen et al., 2009; Davis et al., 2010). 
However, our serological and bacteriological results differed largely between the three herds. Prior 
to slaughter, a significantly lower Salmonella-specific antibody titre in the vaccination group of two 
herds was associated with either a significantly lower faecal Salmonella prevalence (herd C), or a 
slightly higher faecal prevalence (herd A), when compared to the control group. Also the opposite 
situation was observed, as a slightly higher antibody titre in the vaccination group (herd B) was found 
together with a significantly lower faecal prevalence. Similar variations were observed between the 
herds at earlier stages of the trial. This finding underlines that the effect of Salmonella vaccination may 
differ largely between pig herds. This may be due to different factors, such as the infection course and 
infection level (Lo Fo Wong et al., 2004b), the presence of herd-specific Salmonella strains (Van Parys et al., 
2013), the maternal antibody levels (Chapter 3.3) and possible indirect contacts with non-vaccinated 
animals (Chapter 3.3; Arguello et al., 2013). Also differences in the cell-mediated response, which is 
generally recognized to be more important than humoral responses in protection against Salmonella 
(Meeusen et al., 2007), might have influenced the vaccination effect. The cellular response was however, 
not investigated in our trial. Hence, this herd variablility indicates that different measures, targeting all 
components of the farm system, are indispensable, as they are mutually supportive with vaccination 
(Hotes et al., 2011). In addition, it is advisable to vaccinate all pigs in a compartment or herd instead of 
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certain pens, in order to improve the overall vaccination effect (Our field trial, Chapter 3.3; Arguello et al., 
2013). 
Another finding that needs attention in further research, was the isolation of a Salmonella 
Typhimurium strain with the same auxotrophic characteristics and genotype as the vaccine strain, until 
slaughter. This strain was found in all three herds, in faecal samples as well as in samples of lymph 
nodes and caecal contents. Surprisingly, none of the lymph node samples of slaughter pigs tested 
positive for the vaccine strain in the trial of Lindner et al. (2007). Therefore, a thorough investigation of 
the isolated strain from our field study is essential, since the possible persistence of the vaccine strain 
might have important implications for bacteriological monitoring programmes. In that case, 
supplementary bacteriological testing would be necessary to avoid Salmonella-positive results in 
vaccinated herds. This would evidently increase the costs and prolong the time for diagnostic 
confirmation. Although the auxotrophic vaccine was found genetically-stable after five passages in 
piglets, and it was not detected in human isolates investigated by the Roberts Koch Insitute in the last 
ten years (Springer, personal communiation), the potential public health risk (e.g. the risk for YOPI) should 
in addition be investigated. 
Overall, our results indicated that vaccination decreased the Salmonella infection pressure in the 
herds. However, it is not clear yet whether vaccination in pig production with the current Salmonella 
live vaccine would attain the same spectacular drop of human salmonellosis, as did vaccination in the 
laying hen industry in the EU. The described variability of the vaccination effect between herds might 
be reduced overtime if vaccination would be applied on large-scale in primary production, and if cross-
protection between Salmonella serovars could be provided by a multivalent Salmonella vaccine (Farzan 
and Friendship, 2010). 
 
2.4 Vaccination with a live experimental marker vaccine 
As the Salmoporc
®
 vaccine-induced antibodies are not distinguishable in LPS-based ELISAs from 
antibodies induced by natural Salmonella infections, they might interfere with most current European 
serological monitoring programmes (Osterkorn et al., 2001; Alban et al., 2002; Laevens and Mintiens, 2005; 
Anonymous 2013a,b). Indeed, in our first transmission experiment, vaccination with Salmoporc
®
 induced a 
higher seropositivity rate in the vaccinated than in the unvaccinated piglets, until D38 after inoculation. 
The same outcome was seen in slaughter pigs in the vaccination study of Lindner et al. (2007), using 
Salmoporc
®
 as well. That is, when applying a cut off level of OD% 40 (i.e. S/P 1.00) (Lindner et al., 2007) 
or OD%10 (i.e. S/P 0.25) (Chapter 3.1). Although a lower seropositivity rate was observed prior to 
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slaughter in the vaccinated than in the unvaccinated pigs of our field study (Chapter 3.3), the mean S/P 
ratio of all vaccinated pigs (S/P=1.07) then exceeded the OD% 40 as well.  
 
To overcome this antibody distinction issue in serosurveillance programmes, several DIVA vaccines 
(Differentiation of Infected and Vaccinated Animals) have recently been developed (Selke et al., 2007; 
Nagy et al., 2008; Kong et al., 2011; Leyman et al., 2011). These last three studies describe the useful deletion of 
certain LPS-encoding genes in the Salmonella genome, resulting in candidate-vaccine strains that 
induce antibodies undetectable with LPS-based ELISAs. Protective serological responses were induced 
in mice by the ΔrfaJ Salmonella Typhimurium strains of Kong et al. (2011) and Leyman et al. (2011). 
The last authors also developed a whole-cell ELISA, which could detect antibodies induced by the 
candidate-vaccine strain. 
The protective effect of such a vaccine in weaned piglets was assessed in our second transmission 
experiment (Chapter 3.2). The same deletion described by Leyman et al. (2011) was applied to the 
Salmoporc
®
 parent strain, resulting in the ‘Salmoporc-ΔrfaJ’ vaccine candidate. When comparing the 
unvaccinated group and the two vaccinated groups after challenge with a Salmonella Typhimurium 
strain, less tissue samples were colonized and a lower transmission ratio was observed in both 
vaccinated groups. In the vaccinated group without in-feed coated calcium-butyrate, these results were 
not significant though, and the daily weight gain was not significantly improved. Also in our field study 
with the parent strain of the marker vaccine, no reducing vaccination effect was seen in serum at 10 
weeks of age nor in faeces at 16 weeks of age. By the time of slaughter however, the vaccinated pigs 
did gain more weight and were less likely to excrete Salmonella when compared to the non-vaccinated 
pigs. It is therefore reasonable to speculate that the piglets in the DIVA vaccination groups of this 
transmission study might have demonstrated a more distinct beneficial effect, when monitored for a 
longer period than the first 14 weeks of life (e.g. the entire fattening period). When measuring the 
Salmonella-specific antibody titres by an LPS-based ELISA, also no significant difference was 
observed between both vaccinated groups and the positive control group. After vaccination and before 
challenge however, Salmonella-specific antibodies were absent in the LPS-based ELISA and present in 
the whole-cell ELISA. This finding confirmed the DIVA capacities of the Salmoporc-ΔrfaJ vaccine 
strain, and merits further research with larger sample sizes to further investigate the efficacy and safety 
of the vaccine. 
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2.4 Feasibility of the evaluated interventions in practice 
Supplementing the drinking water is a more flexible and controllable way for the farmer to 
administer organic acids, than is the case if the feed is supplemented by the feed company. For the farm 
equipment however, the use of organic acids has greater implications when administrating acidified 
drinking water rather than acidified feed. Firstly, installations of stainless steel are required to avoid 
corrosion of the pipe lines and damage to the concrete under the drinkers. Together with the purchase 
of a dosing pump, the costs for the farmer may be substantial, unless this equipment can be used for 
other administration purposes as well. Secondly, clogging of the drinking nipples due to fungal growth 
might occur. This can be partly circumvented by adding sorbic or propionic acid to the mixture. 
Nevertheless, serious clogging problems were still observed in the study of van der Wolf et al. (2001b), 
despite the use of sorbic acids. Although Salmonella seroprevalence can be reduced by acidifying the 
drinking water with efficacious acid components and a correct dosing (van der Wolf et al., 2001b; van der 
Heijden et al., 2006), it might be a less expensive and more practical solution to supplement the feed with 
organic acids. The calculated cost for our acid mixture in the drinking water was €1.60 per slaughter 
pig, when applied during the entire fattening period (equipment costs not included however). Van der 
Wolf et al. (2001b) estimated in their field trial that the costs per slaughtered pig would be 2.49€ for 
their product, and 0.41€ for the equipment (2.90€ in total). Van der Heijden et al. (2006) calculated 
these total costs for acidifying the water to be 2.53€ per pig. The coated calcium-butyrate used in our 
study would require €3.96 per pig at the administered dose of 3kg/ton feed (incl. mixing costs). For this 
in-feed product, no administration problems are to be expected and thus no additional material costs 
on-farm are to be added. Lowering the doses and shortening the periods of acid administration can 
reduce costs, but this may have a negative impact on the efficacy (Creus et al., 2007). It must be noted 
however, that the faecal concentration of Salmonella in naturally infected pigs is usually 10
5
 times 
lower than the experimental infection dose used in the transmission studies (Pires et al., 2013). 
Therefore, it is reasonable to expect that an administration dose of the coated calcium-butyrate of 
2kg/ton, resulting in 2.64€ per slaughtered pig, would obtain similar reducing results in practice as in 
our transmission studies. In contrast, the commercial vaccine that was implemented in our transmission 
and field trial does not demand any of the previous equipment expenses. It would cost the farmer €1.60 
per slaughter pig (excl. veterinarion costs). Similar to the commercial vaccine, the evaluated DIVA 
vaccine would not request notable extra equipment or production costs. Even though the method to 
construct such a DIVA strain is patented, no price per slaughter pig is available yet, as validation 
procedures are currently still ongoing. 
Anyhow, without governmental financial support, these costs may be considered too high by pig 
producers. Since pig producers already bear many of the costs of Salmonella control, while the benefits 
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are mainly reaped by the pork consumers, they have little incentive to invest in Salmonella control 
(Goldbach and Alban, 2006). However, a lower Salmonella infection level may also lead to a better growth 
of the pigs (Balaji et al., 2000; Turner et al., 2002; Boyen et al., 2009; Davis et al., 2010). This indicates that the 
costs of efficacious intervention strategies might be compensated by the benefits of an improved weight 
gain (Farzan and Friendship, 2010) and consequently may be cost-efficient. To clarify this, further 
economical evaluations are necessary, which take into account all costs and benefits of the 
interventions. 
Obviously, not only the reduced pig productivity is of concern when discussing Salmonella-related 
economic losses. The total annual human health losses for instance (i.e. costs due to healthcare and loss 
of labour), caused by Salmonella in pigs, were estimated to amount €90 million in the EU (Anonymous, 
2010). Given the scale of these costs, it is important to investigate how the human health risks by 
consuming pork can be minimized. Therefore, a consortium of the Federal Communications 
Commission (FCC) (comprising Food Control Consultants Ltd. and Agri-Livestock Consultants Ltd.) 
developed a cost-benefit analysis to test the economic profitability of targeting Salmonella reduction in 
slaughter pigs (Anonymous, 2010). In this analysis, four intervention scenarios were evaluated: i) the 
establishment of a support unit and increased sampling, ii) the first scenario plus improved feed 
practices and farm-level biosecurity, iii) the first scenario plus interventions targeting the purchase of 
Salmonella-free pigs or feed in high- or low-prevalence countries, respectively, and iv) the third 
scenario plus all transport and slaughterhouse measures. Unfortunately, the analysis did not show an 
economic benefit in any of these scenarios. Additional sensitivity analyses did suggest however, that 
there is some economic rationale for a gradual development of Salmonella control at farm level. The 
consortium concluded that it is still worthwhile continuing the investigations for possible Salmonella-
reducing interventions (Anonymous, 2010). In this matter, it is imperative to investigate companies’ 
claims that their products are able to reduce Salmonella prevalence. Governmental directives should be 
developed, demanding Salmonella-specific in vitro, in vivo and field trials which demonstrate the 
efficacy of these products. Although it is widely accepted that individual products are not equally 
effective across all pig farms, this certification of products would aid pig producers in choosing the 
most applicable product for their specific herd. This tailored combination of interventions is 
indispensable for an effective Salmonella approach, as no universal control measure has been identified 
so far and all components of the farm-system can be targeted this way. 
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3 The future Salmonella Action Plan 
Pig producers are dependent on the advice from public and private veterinary services for the 
implementation of management strategies that limit both Salmonella introduction and spread in a farm. 
Therefore, the implementation of an accurate monitoring and efficient control programme at farm-level 
is critical for reducing Salmonella prevalence in finishing pig units. The current herd-Specific 
Salmonella Action Plan (HSAP) in Belgium however, did not lead to a significant decrease of the 
Salmonella seroprevalence in the Belgian pig population, since it entered into force in 2007 (Méroc et al., 
2012). This lack of improvement in the Salmonella status together with several additional reasons as 
described in the general introduction, led to the suggestion of four adaptation scenarios by the 
Scientific Committee of the FASFC, which each have certain advantages and disadvantages (Anonymous, 
2012). 
The first suggested scenario, describing the bacteriological examination of pooled faecal samples at 
the farm, has the advantage that the presence of certain Salmonella serovars can be demonstrated 
unambiguously. A clear determination of the herd infection pressure would be impeded however, since 
the intermittent excretion of Salmonella (van Winsen et al., 2001) might cause false-negative results if the 
sample size is too small. Neither would it be possible to evaluate the evolution of the Salmonella 
prevalence, as there would be little certainty about the age of the sampled pigs. In addition, this 
sampling strategy at herd-level would have considerable financial implications, since many samples are 
required to attain a statistical significant evaluation of the herd prevalence. These monitoring costs 
would be augmented even more if the evaluated current commercial vaccine (Salmoporc®, IDT) would be 
used (Chapter 3.3), since in that case, bacteriological confirmation testing might be necessary to avoid a 
misclassification at herd level. 
The examination of intestinal contents at the slaughterhouse, described in the second scenario, 
would allow a relevant determination of the risks for carcass contamination. Moreover, as all sampled 
pigs have approximately the same age at slaughter, the evolution of Salmonella prevalence within herds 
could be evaluated as well. The intended feedback to the herds might not be reliable however, since 
cross contamination is possible during transport and in the lairage (Hurd et al., 2001; Loynachan et al., 2004; 
Rostagno et al., 2005; Wales et al., 2010; De Busser et al., 2011), due to a stress-induced recrudescence and 
excretion of Salmonella (Verbrugghe et al., 2011). The sampling of the intestines would in addition imply 
major logistic difficulties along the slaughter line, particularly the risk of direct carcass contamination. 
Boughton et al. (2007b) have shown that the caecum may represent a major source of Salmonella 
contamination at slaughter in the absence of careful evisceration techniques. Also, similar financial 
efforts as for scenario one would be required, as a result of the necessary sample size. 
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The examination of the ileocaecal lymph nodes would allow a better – though no absolute – 
indication of the Salmonella prevalence on a herd. Namely, a rapid Salmonella infection of both 
intestinal and associated lymphoid tissues was observed after exposing pigs to a contaminated 
environment, although this effect was much more distinct in caecal contents than in lymph nodes 
(Boughton et al., 2007b). The logistic difficulties are less critical in this scenario, as the risk for carcass 
contamination when sampling lymph nodes is less evident in comparison with the collection of fluid 
intestinal content. The other advantages of this third scenario are similar to the previous one, as are the 
financial disadvantages. 
Scenario four aims at evaluating both the Salmonella prevalence in slaughter pigs and the cross 
contamination at the slaughterline. For this, the ileocaecal lymph nodes and the surface of the same 
carcass would be examined concurrently. As no feedback to the individual herds is intended for this 
scenario, but only an evaluation of the Salmonella prevalence at population level, a simulation model 
showed that 1000-times less samples would be required (Anonymous, 2012). Consequently, this could 
redirect resources towards prevention and sensitization at both the pre-harvest and harvest level. On the 
other hand, the withdrawal of the herd classification might decrease the motivation of pig producers to 
implement Salmonella control measures. The Scientific Committee therefore suggested a combined 
approach of scenario one and four: an annual examination of pooled faecal samples at herd level, plus 
an extensive investigation of lymph nodes and carcasses at slaughterhouse level. This would obviously 
increase the examination expenses again, with in addition the issue of false-negative results (especially 
if only one herd sample per year would be required). 
Scenario four appears most promising for national implementation in terms of the practical and 
financial aspects. The results obtained in this thesis indicate that better prevention measures and an 
increased sensitization at herd level are indeed important targets to decrease the Salmonella burden. 
However, the combined approach of scenario one and four would imply considerable financial 
consequences. An increased awareness of pig producers with relation to the negative impact of 
Salmonella on pig performance could remain an incentive and could compensate partially for a possible 
decreased motivation due to the withdrawal of the herd classification. Instead of the previous combined 
approach, a concurrent serological examination of blood collected at the slaughterhouse (after stunning) 
could be applied. Firstly, this is logistically a better way of sampling when compared to pooled faecal 
samples at farm level, and secondly, it is also a cheaper diagnostic method than bacterial isolation. In 
addition, a more accurate follow up of the seroprevalence than in the previous years is expected, since 
only one age category is sampled at the slaughterhouse. In the long term, the comparison of the 
obtained data from lymph nodes, carcass swabs and blood might provide a better insight in the 
Salmonella epidemiology at population level, and might determine the most cost-efficient diagnostic 
method for the SAP. 
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Besides the suggested adaptation of the monitoring for the future Salmonella Action Plan, also the 
current control should and probably will be modified. The focus will not only be on the primary 
production, but also on other links of the pork production chain. Firstly, the introduction of Salmonella 
via contaminated feed could be avoided through an intensified feed control program. This is of lesser 
importance in high-prevalence MS like Belgium however, since pig feed mainly becomes an important 
Salmonella source once the environmental contamination by sows or slaughter pigs is reduced to low 
levels (Hill et al., 2011). Further, the on-farm interventions, such as vaccination, should be implemented 
primarily on the breeding holdings to decrease the introduction and spread of Salmonella-positive pigs 
in the purchasing herds. Minimising cross contamination during transport (Loynachan et al., 2004; Rostagno 
et al., 2005) by decreasing stress factors (e.g. high pig density, suboptimal temperatures, commingling of 
pig batches or herds) and increasing hygiene of the vehicles, is another important point in the chain to 
be targeted. An intensification of the control efforts at harvest level (i.e. in the lairage (Hurd et al., 2001; 
De Busser et al., 2011) and at the slaughterline) is also of major significance, since several studies 
concluded that interventions at the harvest level are more economically profitable than those at herd 
level (Miller et al., 2005; Goldbach and Alban, 2006; Bollaerts et al., 2010). 
In general, the ‘farm-to-fork’ concept implies that the responsibility of controlling Salmonella in 
pork must be shared among the different partners of the entire pork production chain, and should not 
only lie with the pig producers. Belgium is currently one of the major pork exporters in the EU (next to 
Denmark, Germany, The Netherlands and Spain) (Anonymous, 2010), and a more integrated approach of 
the Salmonella Action Plan of the whole pork production chain is indispensable to meet with the 
demands of the market. 
 
4 Perspectives for further research: Salmonella interventions in pigs. 
Several intervention strategies for on-farm use were evaluated in this thesis, which yielded a better 
insight of their effect on the Salmonella infection pressure among pigs, and their applicability in 
practice. However, remaining questions or new concerns need further investigation. 
First of all, relevant data on the costs and benefits associated with the implementation of on-farm 
interventions against Salmonella in pigs are generally lacking. The consortium of the Federal 
Communications Commission (FCC) published a report in this matter (Anonymous, 2010), in which no 
significant economic benefit was found from any of the four investigated intervention scenarios. 
However, several measures that were included in these scenarios, did not have a (reported) beneficial 
impact on pig performance. Such measures are indeed unlikely to show an economic benefit, unless the 
costs are shared by different partners of the pork production chain (Friendship et al., 2009). Hence, to 
convince farmers to invest in Salmonella intervention methods, emphasis must be put on the improved 
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weight gain of the pigs and their resistance to other pathogens, when Salmonella prevalence is reduced. 
Additional cost/benefit analyses with the products of this thesis that did improve the pigs’ weight gain 
(i.e. coated calcium-butyrate in the feed and the commercial vaccine) are therefore advisable. 
Further research is also necessary to investigate the potential persistence of the vaccine strain in 
slaughter pigs and pork. Moreover, the interaction between host and vaccine strain should be 
determined and safety studies should evaluate the consequences for human health. Whether the 
occurrence in the field of Salmonella wild-type strains with similar characteristics, or the reversion of 
the vaccine strain’s auxotrophic features might be possible, needs to be the subject in further research. 
Once the previous questions become clarified without any remaining concerns for public health, 
more field trials are recommended to determine the most efficient administration strategy within the 
framework of the Salmonella Action Plan. It should be investigated whether vaccination of both the 
sows and their offspring obtains the best Salmonella reducing effects, or if an approach of vaccinating 
solely the sows or the piglets, would be satisfactory. As passive immunity against Salmonella 
disappears progressively in piglets (Schwarz et al., 2011), the vaccination of the sows and also their piglets 
seems a valuable approach to compensate for this infection vulnerability window in weaned piglets. 
Rösler et al. (2010) already showed promising results with this vaccination scheme in a small-scale 
sow-piglet experiment, indicating the usefulness of field trials in this matter. However, a combination 
of vaccinating sows and administrating organic acids to weaned piglets, might be a more practical 
solution on-farm. 
As this commercial Salmonella Typhimurium vaccine provides little cross-protection against other 
Salmonella serovars (Sven Springer, personal communication 2013), also the investigation of the effect and 
applicability of autovaccines could be an interesting avenue worth exploring (Farzan and Friendship, 2010). 
Finally, various feed and water additives are marketed with the claim to reduce Salmonella 
infections in pigs. As described in this thesis, the effect of such products on Salmonella prevalence is 
greatly depending on i.a. the formulation, the dosage and the duration of application. Therefore, 
companies should provide science-based proof of efficacy. For this, legislative directives should be 
established to specify the requirements for such certificates (e.g. Salmonella-specific in vitro, in vivo 
and field trials), as is already the case for new vaccines. 
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1. Summary 
Salmonella enterica subspecies enterica is one of the leading causes of bacterial foodborne disease 
in the world. Annually, approximately 93.8 million, 95500 and 3200 human salmonellosis cases are 
reported in the world, in the EU and in Belgium, respectively. The real salmonellosis occurrence in 
humans is most probably even 10 - 100 times higher, since only a fraction of all infections is officially 
recorded. Ten years ago, EU Member States were asked to set out targets for Salmonella reduction by 
implementing national control programmes in livestock. The Salmonella control programme in poultry 
(especially the vaccination of the laying hens) has been proven successful in Europe, as a spectacular 
drop of human Salmonella Enteritidis cases has occurred in the EU since its implementation. Recently, 
57% and 74% of the reported human cases were estimated to originate from pigs in the EU and 
Belgium, respectively. This indicates that the main Salmonella source for human illness has shifted 
from poultry to pig production. No less than 8.3% and 18.8% of the pig carcasses in the EU and 
Belgium were indeed found Salmonella-positive, respectively. Chapter 1 describes the occurrence, the 
epidemiology and symptoms associated with Salmonella infections in both humans and pigs. 
Despite the many research on Salmonella and the implementation of the Salmonella Action Plan 
(SAP) during the past years, little improvements were attained in the Salmonella seroprevalence in 
Belgian pig herds. As Belgium is one of the largest pork-exporting countries in the EU, the pressure is 
high to meet with the Salmonella reduction targets of the importing countries. Salmonella infections 
have in addition an important negative impact on the weight gain of pigs. Therefore, Salmonella 
monitoring and control procedures in the Belgian pig production must urgently be improved. In 
Chapter 1 an overview is given of current diagnostic methods for Salmonella in pigs, of possible 
control measures on-farm, and of the current Salmonella control programme in Belgium and other EU 
countries. 
The general aim of this thesis (Chapter 2) was to investigate and optimize control measures against 
Salmonella infections in pigs at pre-harvest level. 
In Chapter 3.1, the effect of three intervention strategies on Salmonella Typhimurium transmission 
in three- to 14-week old piglets was evaluated. The first intervention in this transmission experiment 
included the use of feed supplemented with 0.3% w/w coated calcium-butyrate. The second 
intervention strategy comprised oral vaccination with a commercial, attenuated histidine-adenine 
auxotrophic Salmonella Typhimurium strain at three and six weeks of age. The third included the 
acidification of the drinking water with 0.09% v/v of a mixture of organic acids, to a pH of 3.6-3.8. At 
eight weeks of age, several piglets of each intervention group were orally challenged with a Salmonella 
Typhimurium strain. To monitor the challenge strain’s transmission towards the other naive contact 
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animals in the six weeks thereafter, individual blood samples and faecal and tissue samples from all 
pigs were analysed with an LPS-based ELISA and with the ISO 6579:2002/Amd1:2007 Annex D 
method, respectively. Transmission was quantified by an ‘adjusted’ reproduction ratio ’Ra’ for the 
bacteriological results. 
The mean serum antibody titre of the vaccinated group was significantly higher throughout the 
experiment, compared to the challenged/untreated positive control group. The lowest proportions of 
challenge strain-positive faecal and tissue samples were found in the vaccination group and in the 
group with in-feed coated calcium-butyrate, when compared to the positive control group and the group 
with acidified water. The vaccination group however, counted as many vaccine strain-positive as 
challenge strain-positive tissue samples, when using a differentiating biochemical kit provided by the 
manufacturer of the vaccine. The lowest transmission ratio Ra over all bacteriological matrices was 
seen in the feed-supplemented group, closely followed by the vaccination group, whereas the positive 
control group and the acidified water group showed a much higher Ra. The results of this study 
suggested that vaccination with the commercial Salmonella Typhimurium live vaccine and the feed 
supplementation with the used dosage of coated calcium-butyrate limited Salmonella transmission in 
pigs and might be useful control measures. The acidification of the drinking water with the current acid 
components and at the applied dosage however, did not appear to provide any protection to the piglets 
during the supplemented period. 
The antibodies induced by the commercial vaccine used in the first transmission experiment were 
not distinguishable in LPS-based ELISAs from antibodies induced by natural Salmonella infections. 
Therefore, they might interfere with most current European serosurveillance programmes. A second, 
similar transmission experiment was conducted (Chapter 3.2) to evaluate the protective capacities of 
an oral ‘DIVA’ vaccine candidate against Salmonella Typhimurium infection. This live ‘Salmoporc-
ΔrfaJ’ vaccine candidate ‘Differentiates Infected from Vaccinated Animals’, since it lacks LPS-
encoding genes and thus induces antibodies which are only detectable in an in-house whole-cell ELISA 
and not in the commercial LPS-based ELISAs. It was evaluated as a stand-alone measure in one group 
of piglets and combined with in-feed coated calcium-butyrate in another group. 
No significant differences in the Salmonella-specific antibody titres were observed between the 
intervention groups and the positive control group. In the combination group DIVA vaccine + coated 
calcium-butyrate, significantly less Salmonella-positive samples were present in the faeces of the 
contact animals and in the tissue samples of all pigs, when compared to the positive control group. Both 
vaccinated groups demonstrated only a non-significantly lower transmission ratio, but confirmed the 
DIVA capacity of the ‘Salmoporc-ΔrfaJ’ vaccine candidate in the in-house whole-cell ELISA. The 
Chapter 5  Summary 
 
 
 
141 
vaccine thus merits further research with larger sample sizes to optimize its use for Salmonella 
programmes. 
The effect of one control measure from the two transmission studies was investigated on a larger 
scale under field conditions (Chapter 3.3). The commercial Salmonella Typhimurium live vaccine was 
selected in this field trial for several reasons. Firstly, the oral vaccination at three and 28 days of age 
with this vaccine (i.e. the most recent vaccination protocol) was considered an easier and more practical 
intervention candidate to investigate than the administration of organic acids to water or feed. 
Secondly, certain results of our first transmission experiment needed further investigation in the field, 
namely the promising reduction of Salmonella excretion on the one hand, and the possible persistence 
of vaccine-induced antibodies and the vaccine strain itself on the other hand. In addition, although 
currently not registered in Belgium, this vaccine is readily available for use in primary production, 
whereas the evaluated DIVA vaccine candidate is not. The field trial was conducted in three 
Salmonella Typhimurium-positive farrow-to-finish pig herds. Vaccinated pigs were compared with 
non-vaccinated ones from suckling till slaughter age, by collecting data on the weight gain, and 
serological and bacteriological parameters. 
At the end of the fattening period, a significantly lower Salmonella-specific antibody titre and 
significantly less Salmonella-excreting pigs were observed in the vaccinated group over all herds, 
compared to the control group. The vaccinated animals of one herd showed additionally significantly 
less Salmonella-positive samples in the lymph nodes, while this was the case for caecal contents in 
another herd. In the vaccinated group of each herd, the daily weight gain between three days and 29 
weeks of age was significantly higher than in the non-vaccinated control group. These results indicate 
that the current vaccination strategy decreased the overall Salmonella infection pressure. However, the 
serological and bacteriological results differed largely between the three herds throughout the trial. This 
points out that different measures targeting all components of the farm system are indispensable, and 
that all pigs in a compartment or herd should be vaccinated to improve the overall vaccination effect. 
Another important finding was the isolation in all three herds of a Salmonella Typhimurium strain with 
the same auxotrophic characteristics and genotype as the vaccine strain, from faecal, lymph node and 
caecal content samples. Further research on this isolated strain is warranted. 
Based on the results of both transmission studies, the field trial and literature findings, several 
conclusions regarding control measures on-farm are discussed in Chapter 4. The beneficial effects of 
the organic acid administration on Salmonella (sero)prevalence may be influenced by different factors, 
such as the formulation, the dosage, the application route (feed or drinking water), the treatment 
duration, and the age of the treated pigs. Further, it was concluded that vaccination with the commercial 
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Salmonella Typhimurium live vaccine decreases the Salmonella infection pressure on-farm and 
improves the daily weight gain. However, the observed herd variability in the serological and 
bacteriological effect makes it difficult to predict to what extent this vaccination would decrease human 
salmonellosis in the EU. Moreover, clarifications regarding the possible vaccine strain persistence are 
indispensable, since this might have important implications for bacteriological monitoring programmes, 
and might be a possible public health concern. The experimental ‘Salmoporc-ΔrfaJ’ vaccine appeared 
to give little protection against Salmonella transmission in piglets after weaning. Its DIVA capacity 
merits further research however, to improve its efficacy. 
The feasibility in practice of these intervention strategies were described in Chapter 4 as well. The 
costs of control measures like vaccination or the administration of organic acids, may be considered too 
high by pig producers compared to the benefits of a better pig performance. Therefore, without 
governmental support, too few pig producers might voluntarily implement these control measures. 
Not only Salmonella control, but also the monitoring procedures in Belgium need adaptations in the 
near future. In Chapter 4, the (dis)advantages of the possible scenarios for optimizing the current SAP 
are discussed, as are the perspectives for further research, based on our experiments. 
Several possible interventions are presented in this thesis, but the future for Salmonella control will 
involve a continuous exploration of new control measures, together with the maintenance of high 
biosecurity levels. In order to tackle the Salmonella problem in swine and humans effectively, this 
approach must be applied not only in primary production, but in all links of the pork production chain. 
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2. Samenvatting 
Salmonella enterica subspecies enterica is één van de voornaamste oorzaken van bacteriële 
voedselgerelateerde ziekten ter wereld. Jaarlijks worden er wereldwijd, in de EU en in België 
respectievelijk ongeveer 93,8 miljoen, 95500 en 3200 humane salmonellose-gevallen gerapporteerd. 
Het echte voorkomen van salmonellose bij mensen is naar alle waarschijnlijkheid zelfs 10 tot 100 keer 
hoger, aangezien slechts een fractie van alle infecties officieel gemeld wordt. Tien jaar geleden werd 
aan de EU lidstaten gevraagd om targets te stellen voor een Salmonella reductie, via het implementeren 
van nationale controleprogramma’s in de veestapel. Het Salmonella controleprogramma voor pluimvee 
(voornamelijk via vaccinatie van de leghennen) is succesvol gebleken in Europa, na de waargenomen 
spectaculaire daling in het aantal humane Salmonella Enteritidis gevallen in de EU sinds de 
implementatie ervan. Recent werd 57% en 74% van de gerapporteerde humane salmonellose-gevallen 
in respectievelijk de EU en België toegewezen aan varkens. Dit wijst er op dat de belangrijkste 
Salmonella-bron voor humane ziekte zich verplaatst heeft van de pluimvee- naar de varkensindustrie. 
Maar liefst 8,3% en 18,8% van de varkenskarkassen in respectievelijk de EU en België werden 
inderdaad Salmonella-positief bevonden. Hoofdstuk 1 beschrijft het voorkomen, de epidemiologie en 
symptomen geassocieerd met Salmonella infecties in mensen en varkens. 
Ondanks het vele onderzoek naar Salmonella en de implementatie van het Salmonella Actie Plan 
(SAP) tijdens de voorbije jaren werd er weinig verbetering gezien in de Salmonella seroprevalentie in 
de Belgische varkensbedrijven. Aangezien België één van de grootste varkensvlees-exporterende EU-
landen is, is de druk groot om te voldoen aan de eisen van de importerende landen omtrent Salmonella-
reductie. Salmonella-infecties hebben bovendien een belangrijke negatieve impact op de 
gewichtsaanzet van varkens. Daarom dient de Salmonella-monitoring en -controle in de Belgische 
varkensproductie dringend verbeterd te worden. In Hoofdstuk 1 is een overzicht gegeven van de 
huidige diagnostische methoden voor Salmonella in varkens, van mogelijke controlemaatregelen op het 
bedrijf, en van de huidige Salmonella controle programma’s in België en andere EU landen. 
Het algemene doel van deze thesis (Hoofdstuk 2) was het onderzoeken en optimaliseren van 
controlemaatregelen tegen Salmonella-infecties in varkens op het bedrijf. 
In Hoofdstuk 3.1 werd het effect geëvalueerd van drie interventiestrategieën op de transmissie van 
Salmonella Typhimurium in drie- tot 14-weken oude biggen. De eerste interventie in dit transmissie 
experiment omvatte het gebruik van 0,3% m/m gecoat calcium-butyraat als voedersupplement. De 
tweede interventiestrategie bestond uit een orale vaccinatie met een commerciële, verzwakte histidine-
adenine-auxotrofe Salmonella Typhimurium stam op drie en zes weken leeftijd. De derde interventie 
was een drinkwateraanzuring tot een pH van 3,6-3,8 d.m.v. een 0,09% vol organische-zuren-
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mengeling. Op acht weken leeftijd werden enkele biggen van elke interventiegroep oraal geïnfecteerd 
met een Salmonella Typhimurium stam. De transmissie van deze infectiestam naar de naïeve 
contactdieren werd opgevolgd in de zes weken nadien d.m.v. een LPS-ELISA van individuele 
bloedstalen en d.m.v. de ISO 6579:2002/Amd1:2007 Annex D analyse van stalen van faeces en weefsel 
bij alle varkens. Transmissie werd gekwantificeerd via een ‘aangepaste’ reproductie-Ratio ‘Ra’ voor de 
bacteriologische resultaten. 
De gemiddelde serum-antistoffentiter van de gevaccineerde groep was significant hoger doorheen 
het experiment, in vergelijking met de geïnfecteerde/onbehandelde positieve-controlegroep. De laagste 
proporties van infectiestam-positieve faecale en weefselstalen werden gevonden in de vaccinatiegroep 
en in de groep met gecoat calcium-butyraat in het voeder, in vergelijking met de positieve-
controlegroep en de groep met aangezuurd drinkwater. De vaccinatiegroep telde echter evenveel 
vaccinstam-positieve als infectiestam-positieve weefselstalen, wanneer een differentiërende 
biochemische kit van de vaccinfabrikant gebruikt werd. De laagste Ra over alle bacteriologische 
matrices heen werd genoteerd in de voedersupplementgroep, kort gevolgd door de vaccinatiegroep, 
terwijl de positieve-controlegroep en de groep met aangezuurd drinkwater een veel hogere Ra 
vertoonden. De resultaten van deze studie suggereerden dat de vaccinatie met dit commerciële, levende 
Salmonella Typhimurium vaccin en de voedersupplementatie met de gebruikte dosis gecoat calcium-
butyraat de Salmonella-transmissie in de biggen limiteerden en nuttige controlemaatregelen zouden 
kunnen zijn. De aanzuring van het drinkwater met deze zuurcomponenten aan de toegepaste dosis leek 
de biggen echter geen bescherming te bieden gedurende de behandelde periode. 
De antistoffen geïnduceerd door het commerciële vaccin, dat in de eerste transmissiestudie gebruikt 
werd, zijn in LPS-ELISA’s niet te onderscheiden van de antistoffen geïnduceerd door natuurlijke 
Salmonella-infecties. Daardoor kunnen deze eerste interfereren met de meeste huidige Europese 
serosurveillance-programma’s. Een tweede, gelijkaardig transmissie-experiment werd uitgevoerd 
(Hoofdstuk 3.2) om de beschermende capaciteiten te evalueren van een orale ‘DIVA’-vaccinkandidaat 
tegen Salmonella Typhimurium-infecties. Dit levende ‘Salmoporc-ΔrfaJ’ vaccin differentieert 
geïnfecteerde van gevaccineerde dieren, aangezien het LPS-coderende genen mist en dus antistoffen 
induceert die niet detecteerbaar zijn in de commerciële LPS-ELISA’s, maar wel in een in-house volle-
kiem-ELISA. Het vaccin werd geëvalueerd als alleenstaande maatregel in één groep biggen en 
gecombineerd met gecoat calcium-butyraat gesupplementeerd voeder in een andere groep. 
Er werden geen significante verschillen gevonden in de Salmonella-specifieke antistoffentiters van 
de interventiegroepen en de positieve-controlegroep. In de combinatiegroep DIVA + gecoat calcium-
butyraat waren significant minder Salmonella-positieve stalen aanwezig in de faeces van de 
contactdieren en in de weefselstalen van alle dieren in vergelijking met de positieve-controlegroep. 
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Beide gevaccineerde groepen vertoonden slechts een niet-significant lagere transmissieratio, maar 
bevestigden wel de DIVA-capaciteit van de ‘Salmoporc-ΔrfaJ’ vaccinkandidaat in de in-house volle-
kiem-ELISA. Verder onderzoek met staalnames op grotere schaal zijn dus vereist om het gebruik van 
het vaccin in Salmonella programma’s te optimaliseren. 
Het effect van één controlemaatregel uit de twee transmissiestudies werd onderzocht op grotere 
schaal onder veldomstandigheden (Hoofdstuk 3.3). Het commerciële, levende Salmonella 
Typhimurium-vaccin werd geselecteerd voor deze veldstudie omwille van verschillende redenen. Ten 
eerste werd de orale vaccinatie op drie en 28 dagen leeftijd met dit vaccin (i.e. het meest recente 
vaccinatieprotocol) beschouwd als een gemakkelijkere en praktischere interventie om te evalueren dan 
de toediening van organische zuren via drinkwater of voeder. Ten tweede vereisten bepaalde resultaten 
van het eerste transmissie-experiment verder onderzoek in het veld. Dit betreft zowel de veelbelovende 
reductie van de Salmonella-excretie als de mogelijke persistentie van vaccin-geïnduceerde antistoffen 
en de vaccinstam zelf. Dit vaccin is bovendien, hoewel nog niet geregistreerd in België, wel 
onmiddellijk beschikbaar voor gebruik in de primaire productie, hetgeen niet geldt voor de 
geëvalueerde DIVA-vaccinkandidaat. De veldstudie werd uitgevoerd op drie Salmonella 
Typhimurium-positieve gesloten varkensbedrijven. Gevaccineerde varkens werden van zoog- tot 
slachtleeftijd vergeleken met niet-gevaccineerde varkens via het verzamelen van gegevens over de 
gewichtsaanzet en over serologische alsook bacteriologische parameters. 
Aan het einde van de mestperiode werd er een significant lagere Salmonella-specifieke 
antistoffentiter waargenomen in de gevaccineerde groep over alle bedrijven heen, alsook significant 
minder excreterende varkens in vergelijking met de controlegroep. De gevaccineerde dieren van één 
bedrijf vertoonden daarbij ook significant minder Salmonella-positieve stalen in de lymfeknopen, 
terwijl dit het geval was voor de caecuminhoud van een ander bedrijf. In de vaccinatiegroep van elk 
bedrijf was de dagelijkse gewichtsaanzet tussen drie dagen en 29 weken leeftijd significant hoger dan 
in de controlegroep. Deze resultaten indiceren dat de gebruikte vaccinatiestrategie de algemene 
Salmonella-infectiedruk verlaagde. De serologische en bacteriologische resultaten varieerden echter 
sterk tussen de drie bedrijven doorheen de studie. Dit wijst er op dat verschillende maatregelen, die alle 
bedrijfscomponenten aanpakken, onmisbaar zijn, en dat alle varkens in een compartiment of bedrijf 
gevaccineerd zouden moeten worden om het algemene vaccinatie-effect te verbeteren. Een bijkomende 
belangrijke bevinding was de isolatie van een Salmonella Typhimurium stam uit stalen van faeces, 
lymfeknopen en caecuminhoud in de drie bedrijven met dezelfde auxotrofe eigenschappen en hetzelfde 
genotype als de vaccinstam. Verder onderzoek naar deze geïsoleerde stam is aan te raden. 
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Gebaseerd op de resultaten van beide transmissiestudies, de veldproef en literatuurbevindingen, 
werden er in Hoofdstuk 4 meerdere conclusies besproken betreffende controlemaatregelen op het 
bedrijf. De gunstige effecten van de toediening van organische zuren op Salmonella (sero)prevalentie 
kunnen beïnvloed worden door verschillende factoren, zoals de formulatie, de dosering, de 
toedieningsweg (voeder of drinkwater), de behandelingsduur, en de leeftijd van de varkens. Voorts 
werd er geconcludeerd dat vaccinatie met het commerciële, levende Salmonella Typhimurium vaccin 
de Salmonella-infectiedruk op het bedrijf verlaagt en de dagelijkse gewichtsaanzet verbetert. De 
waargenomen bedrijfsvariabiliteit in de serologische en bacteriologische resultaten maakt het echter 
moeilijk om te voorspellen in hoeverre deze vaccinatie de humane salmonellose zou kunnen verlagen 
in de EU. Verklaringen omtrent de mogelijke persistentie van de vaccinstam zijn bovendien 
noodzakelijk, aangezien dit belangrijke implicaties kan hebben voor bacteriële 
monitoringprogramma’s, en ook een mogelijke probleem vormt voor de volksgezondheid. Het 
experimentele ‘Salmoporc-ΔrfaJ’ vaccin leek weinig bescherming te bieden tegen Salmonella-
transmissie in gespeende biggen. Zijn DIVA-capaciteiten moedigen verder onderzoek echter aan om de 
efficaciteit te verbeteren. 
Ook de haalbaarheid in de praktijk van deze interventiestrategieën werd beschreven in Hoofdstuk 4. 
De kosten van controlemaatregelen zoals vaccinatie of de toediening van organische zuren zouden te 
hoog beschouwd kunnen worden door de varkensproducenten, in vergelijking met de baten van betere 
varkensprestaties. Zonder overheidssteun zullen wellicht te weinig varkensproducenten deze 
controlemaatregelen vrijwillig implementeren. 
Niet alleen de Salmonella-controle, maar ook de Salmonella-monitoringsmethodes in België dienen 
aangepast te worden in de nabije toekomst. In Hoofdstuk 4 werden de voor- en nadelen besproken van 
de mogelijke scenario’s om het huidige SAP te optimaliseren, alsook de perspectieven voor verder 
onderzoek, gebaseerd op onze experimenten. 
Verschillende mogelijke interventies werden voorgesteld in deze thesis, maar de toekomstige 
Salmonella-controle zal een voortdurende exploratie van nieuwe controlemaatregelen vragen, samen 
met de handhaving van hoge bioveiligheidsnormen. Om het Salmonella-probleem in varkens en 
mensen efficiënt aan te pakken, dient deze benadering bovendien niet alleen in de primaire productie 
toegepast worden, maar in alle schakels van de varkensvleesproductieketen. 
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Nee hoor, geen probleem dat u meteen doorbladert naar het dankwoord...   Zonder de mensen die 
hieronder vernoemd worden, was deze thesis er namelijk simpelweg niet geweest. Zij verdienen dus 
zeker een last-but-not-least plaatsje in dit boekje... 
Niet minder dan vier promotoren hebben mij begeleid tijdens dit SalmoSu-project, en hen wil ik 
hierbij als eersten bedanken voor de voorbije ondersteuning. Yves, na ons eerste telefoongesprek voor 
mijn sollicitatie, is de ‘SalmoSu-bal’ aan het rollen gegaan. Die bal kreeg te maken met enige dataset-
bulten en artikelputten in de grasmat, maar die werden mede dankzij jou vakkundig gelijk getrokken! 
Met dit boekje kwam die bal uiteindelijk ook in de Salmonella-goal terecht... Bedankt om mij de 
afgelopen jaren zo geduldig met raad en daad bij te staan – tot in de autopsiezaal toe –, ookal had je het 
zelf niet altijd makkelijk en vaak heel druk. Ik wens je het allerbeste toe samen met Nele! Een 
gelijkaardige drukte is ook jouw dagelijkse habitat Dominiek, maar niettemin kon ik altijd rekenen op 
je ultrasnelle (desnoods nachtelijke) reacties en grondige verbeteringen. Dankjewel daarvoor! Bedankt 
ook Jeroen, voor het helpen boetseren van abstracts en artikels, met in het bijzonder ‘the statistical 
analysis’. De ‘Epi-meetingen’ zullen me altijd bijblijven! Patrick, merci voor die allereerste, befaamde 
rondleiding in het CODA die deze nieuwe etappe in mijn leven inluidde, en voor alle vrijheid en steun 
in de jaren nadien. 
Ook heel wat co-auteurs en project-partners ben ik dankbaar voor hun hulp en constructieve feed-
back tijdens dit onderzoek: proffen Frank Pasmans en Freddy Haesebrouck, Bregje Leyman, Charlotte 
Brossé, Estelle Méroc, Stefan Roels, Erwin Wauters en Ludwig Lauwers. 
Zo gaat mijn dank eveneens uit naar de leden van de lees- en examencommissie, Dr. Peter van der 
Wolf, Prof. Dr. Marc Heyndrickx, Prof. Dr. Lieven De Zutter, Dr. Tamara Vandersmissen, Dr. Erik 
Mijten, Dr. Jozef Hooyberghs en Dr. Filip Boyen, die deze thesis wilden doornemen en mij hun zeer 
nuttige commentaren bezorgden. Dankzij hen werd dit werk zeker een niveau hoger getild. 
Nog voor er enige schrijfsels te verbeteren vielen, werd dit onderzoekswerk in de eerste plaats 
mogelijk gemaakt dankzij de financiële steun van de Federale Overheidsdienst Volksgezondheid, 
Veiligheid van de Voedselketen en Leefmilieu en het CODA-CERVA, waarvoor uiteraard 
respectievelijk dank aan Dr. Dominique Vandekerchove en Dr. Pierre Kerkhofs. 
De verschillende producten en materialen van beide transmissieproeven en de veldproef konden dan 
weer ingeschakeld worden dankzij de hulp van Edwin Vanhees, Veerle Hautekiet, Sam Millet, Trees 
Loncke, Heiko Rüdiger en Sven Springer. Dankuwel allemaal hiervoor! 
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Zoals ik hulp kreeg van promotoren en co-auteurs uit zowel Ukkel als Merelbeke, zo mag ik 
uiteraard ook alle helpende labo-handen van beide locaties niet vergeten! 
In Ukkel, de SalmoSu-locatie van mijn eerste twee doctoraatsjaren, kon ik meteen op veel sympathie 
rekenen dankzij de doordringende mestaroma’s waarmee ik wekelijks de hele gang vulde . 
Heidi (fijne carpoolgenote, altijd paraat met raad en daad), Danielle (het hart op de tong ), Mieke 
(immer goedgezind en behulpzaam), Andy (Cacaman avec un grand C ) : merci voor alle hulp en 
‘mentale bijstand’ bij het hele geurende gebeuren! Natuurlijk kon ik voor die bijstand toen ook terecht 
bij mijn collega-doctoraatstudenten boven in Blok A: Wannes (Lord of the Office, gezeteld op zijn 
verhoogde blokken-bureau), Flo (merci voor de fijne babbels, zie je wel dat “alles komt goed” ook voor 
jou geldt), Stéphanie (courageuse parmi les néerlandophones!), Leon (de al-even-moedige hollander 
tussen die onverstaanbare Belgen ). Ondanks de onvermijdelijke PhD-‘grmbls’ af en toe, hebben we 
toch wat afgelachen, bedankt daarvoor! Boven op dezelfde Ukkelse ‘Groeselenberg’ zijn er nog vele 
anderen waar ik met plezier en dankbaarheid aan terugdenk: Pierre (bedankt voor de opvolging van de 
vaccinstam-bevindingen!), Hein, Vicky, Deborah, Hugo (alias Huug Paddle ), Martine, Estelle, 
Sophie, Sarah, Matthias, Michaël, Pieter-Jan, Toon, Elke(s), Thibault, Bettina, Jean-Marie, Pascal, 
Michelle, Bart, ... ; te veel om op te noemen helaas, dus één grote MERCI!  
In het Merelbeekse bacteriologie-labo, twee jaar later, was ik om dezelfde redenen eigenlijk ook al 
snel ‘zeer geliefd’: “oei zijt ge daar nu weer met uw vracht stinkstalen?” Desondanks heeft iedereen mij 
daar toch ettelijke maanden verdragen  dus aan Iris (merci om meermaals de faecesvreugd te delen in 
de flowkast), Luca (buona fortuna lì in Francia!), Laetitia (ik maak werk van onze ‘Tales with Tails’!), 
Ruth, Silvana, Nele, Lien, Maxim, David, Marleen, Serge, Arlette, Roel, Elin, Alexander, ... : allemaal 
een welgemeende dankjewel! 
Al die ‘stinkstalen’ (“gezonde boerenlucht, jullie mietjes!” antwoordde ik meestal) kwamen 
uiteraard niet uit de lucht gevallen (gelukkig maar )… 
Voor de proeven van dit project speelden in de eerste plaats 13 varkenshouders en 1238 varkens 
namelijk een belangrijke rol; zij maakten meermaals het uitvoeren van de proeven mogelijk en stonden 
vele bloed/mest/speeksel/vleessap/orgaanmonsters af (wel degelijk respectievelijk ). Ook al kunnen 
enkel de eersten het nog horen: bedankt allemaal voor deze medewerking! Hoewel die broodnodig is 
om alle in vitro bevindingen in de praktijk te evalueren, is dat zeker niet evident… Daarnaast vermeld 
ik ook graag de kwaliteitsverantwoordelijken van de drie slachthuizen waar ik meerdere keren 
binnengevallen ben met mijn 10-koppig team in witte overallekes. Slachthuisstaalnames regelen 
verloopt niet altijd van een leien dakje (collega’s kunnen dat beamen ), maar ik ben deze mensen 
dankbaar voor hun hulp daarbij! 
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Voor de staalnames van beide transmissiestudies in de proefstallen te Machelen mocht ik bovendien 
rekenen op enkele stoere handige harry’s: Willem VC, Ronny, Dirk, Pierre, Marcel en Benny. Bedankt 
mannen voor alle hulp en humor in die intensieve maar leerzame tijd, ik vergeet jullie niet!  
Bij de veldproef-staalnames daarna was het niet altijd evident om voldoende enthousiastelingen te 
strikken, maar vele collega’s en studenten stonden mij vele malen bij in mijn bloed-mest-zweet-
slachthuisavonturen: Ilse (geniet van je eerste spruit Marie!), Ruben DC (idemdito papa!), Annelies 
(alles is relatief remember;), Emily (met zo’n mama komen beide dochters niets te kort), Jozefien (al 
vele jaren mijn rots in de branding!), Joren (een moedige ziel van de rundergroep van DI08), Rubén, 
Luca, Ilias, Béné, Philippe, Steven S., Wannes en Merel. Bedankt voor alle hulp liefste collegae, zelfs 
nàdat ik jullie eens onverwachts een twee-uur-durende rit aandeed in een auto met 63 walmende 
slachtafvalzakken!  
Het startschot van al die avonturen waren eigenlijk enkele staalname-trips met Rubén en Alfonso, 
die mij de kunst bijbrachten van het bloed nemen van schattige pasgeboren biggen tot bijtgrage 
slachtvarkens en zeugen. Jullie wijze woorden “we looove science” (en vooral de context toen) staan in 
mijn geheugen gegrift! Gracias y verduras!  
Een andere wijze uitspraak “mè tid en stutjes jong” komt van mijn start-to-run maatje Steven B., 
beter bekend als onze IT-superman. Merci voor alle EHBMO Stevie, let’s keep running mè stutjes!  
Els, gezeteld in dezelfde IT-bureau, maakte haar functie van ‘veterinaire ondersteuning’ meer dan 
waar! Deze veterinaire dankt je voor de steun! In het bureau daarnaast (ofte ‘den buro 48’), en meer 
bepaald ‘achter het muurke’, heb ik twee jaar mogen doorbrengen met supertoffe collega’svrienden: 
Béné (merci voor de sportuitjes en alle peptalk), Merel (alias MaxiMerel, in alle opzichten de max!), 
Philippe (slechts deze woorden nodig: wall-buddies rule jong! ), Steven S. (helemaal niet zo 
gereserveerd als ik initeel dacht, maar een keitoffe lieve kerel!), Loes (jouw donkere wolken hebben 
duidelijk plaats gemaakt voor een stralend zonnetje, ben blij!), Ilias (onze eerste Griekse aanwinst met 
een zalig gevoel voor humor, ευχαριστίες! ...en succes met the peace potion!), en Wannes (kom je nog 
een keer mee naar mijn volgende locatie? ). Aan beide nieuwelingen Marilena (de tweede Griekse 
aanwas, met ‘elaba’ al evenveel humor, σούπερ!) en Marjolijn (kersverse veelbelovende hollandse 
invloed): ik draag de wall-buddy-fakkel van Philippe en mij graag aan jullie beiden over! Weet en 
onthou dat ik jullie allemaal heeel dankbaar ben voor de gezellig tijd daar, en hoop dat we van tijd tot 
tijd nog eens samen zullen toosten op onze buro48-herinneringen...  
Niet alleen tijdens mijn eerste twee jaren in het CODA, maar ook in de laatste twee op de faculteit 
was er een hele ‘achterban’ die zorgde voor een toffe sfeer waar ik altijd met een glimlach aan zal 
terugdenken. Elk DI08-team droeg bij aan die aangename werksfeer, of het nu de Epi, M, of IVF naam 
droeg (en ongeacht de bijhorende geuren). Aan al deze mensen dus een warme dankjewel! Oh excuses, 
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Leïla en Sandra! Hoewel stankloos op het secretariaat, waren jullie ook een onmisbaar puzzelstukje in 
het geheel!  
Waar fijne collega’s het leven zoveel aangenamer maken, zijn vrienden onmisbaar in dit leven. Wie 
had gedacht dat de allereerste out-of-the-blue vraag van 6-jarige uk Karen “wil jij mijn beste vriendin 
zijn?” zolang zou standhouden?  Merci voor alle plezier, warmte en steun door dik en dun Karentje, 
joerdebest! Idemdito ben ik blij dat de middelbare Hemaco-bende (ondertussen ook al aan een tinnen 
jubileum toe en vergroot met enkele nakomelingen) de tand des tijds overleefde, en nu nog fijne 
momenten oplevert. In de veterinaire studentenjaren nadien was de groep misschien iets bescheidener, 
maar niettemin even sterk om nu nog regelmatig af te spreken, ook al zijn er uitgevlogen naar 
Nederland, la France, the UK of zelfs Ísland. Met Willem heb ik daarbovenop een hechte, zotte 
vriendenbende bijgekregen, die mij al veel hilarische afleiding en warmte bezorgde... Een dikke 
MERCI allemaal voor de vriendschap en steun de afgelopen jaren, mogen er nog vele 
schaterlachmomenten volgen!  
En ookal hadden zij net als deze vrienden niets te maken met Salmonella’s, varkens of andere 
veterinaire toestanden, mijn familie verdient hier zeker in de schijnwerpers te staan! Hoewel, ‘niets te 
maken’ klopt niet helemaal... Mijn liefste moems is namelijk verschillende keren moedig mee tussen de 
varkens gaan wroeten voor mijn staalnames toen ik helpers tekort kwam!  Niet alleen daarvoor, maar 
uiteraard ook voor alle moeder-dochter-warmte die ik tot nu toe mocht voelen, ben ik je hééél dankbaar 
mam! Dat warme nest waar ik uit gevlogen ben, dank ik uiteraard ook aan pap en broers! Paps, merci 
om ondanks de vele avondvergaderingen toch altijd paraat te staan voor ons! ‘k Zie jullie graag! Sander 
en Simon, liefste bro’s, eens de peuter-puber-jaren voorbij waren jullie best verdraaglijk hoor.. ;p 
Thanks voor al jullie PC-gerelateerde hulp als ik er weer eens punkhaar van kreeg, maar vooral om 
‘grote’ zus zo te steunen en te entertainen de afgelopen jaren. Op naar meer leute samen!  De rest van 
de De Ridder- en Bergmans-clan zeg ik één krachtige ‘Danku’ voor de vele moedgevende woorden en 
leuke bijeenkomsten! Eenzelfde dikke merci gaat naar mijn schone-Huylebroeck-familie, want jullie 
hebben me meteen thuis doen voelen in jullie vijfling-bende; jullie zijn fantastisch! 
Tot slot, is mijn allerlaatste maar allerminst-least plaatsje hier voor Willem. Veel toevalligheden (of 
bestaan die wel?) brachten ons samen, en zo donker als die eerste toevalligheid voor mij toen was, zo 
schitterend is het resultaat sindsdien al elke dag geweest... Ondanks de voorbije drukke tijden heb jij 
mij altijd nummer 1 doen voelen; weet dat je dat ook voor mij bent. 
Alles in mij houdt van alles aan jou. Jij bent mijn alles... 
 
  
 
 

